{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 344188, "items": [{"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T04:12:49Z", "timestamp": 1574827969523}, "reference-count": 66, "publisher": "SAGE Publications", "issue": "1", "license": [{"URL": "http://journals.sagepub.com/page/policies/text-and-data-mining-license", "start": {"date-parts": [[2002, 1, 1]], "date-time": "2002-01-01T00:00:00Z", "timestamp": 1009843200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["journals.sagepub.com"], "crossmark-restriction": true}, "short-container-title": ["Cancer Control"], "published-print": {"date-parts": [[2002, 1]]}, "DOI": "10.1177/107327480200900106", "type": "journal-article", "created": {"date-parts": [[2017, 8, 30]], "date-time": "2017-08-30T11:07:22Z", "timestamp": 1504091242000}, "page": "39-48", "update-policy": "http://dx.doi.org/10.1177/sage-journals-update-policy", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Advances in Gene Therapy for Malignant Melanoma"], "prefix": "10.1177", "volume": "9", "author": [{"given": "Maria G.", "family": "Sotomayor", "sequence": "first", "affiliation": [{"name": "Cutaneous Oncology Program at the H. Lee Moffitt Cancer Center &amp; Research Institute at the University of South Florida, Tampa, Florida"}]}, {"given": "Hua", "family": "Yu", "sequence": "additional", "affiliation": [{"name": "Immunology Program at the H. Lee Moffitt Cancer Center &amp; Research Institute at the University of South Florida, Tampa, Florida"}]}, {"given": "Scott", "family": "Antonia", "sequence": "additional", "affiliation": [{"name": "Thoracic Oncology Program at the H. Lee Moffitt Cancer Center &amp; Research Institute at the University of South Florida, Tampa, Florida"}]}, {"given": "Eduardo M.", "family": "Sotomayor", "sequence": "additional", "affiliation": [{"name": "Immunology Program at the H. Lee Moffitt Cancer Center &amp; Research Institute at the University of South Florida, Tampa, Florida"}]}, {"given": "Drew M.", "family": "Pardoll", "sequence": "additional", "affiliation": [{"name": "Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland."}]}], "member": "179", "published-online": {"date-parts": [[2017, 8, 30]]}, "reference": [{"key": "bibr1-107327480200900106", "author": "Atkins M.B.", "volume": "12", "first-page": "877", "year": "1998", "journal-title": "Hematol Oncol Clin North Am.", "DOI": "10.1016/S0889-8588(05)70029-0", "doi-asserted-by": "crossref"}, {"key": "bibr2-107327480200900106", "author": "Lukas J.", "volume": "55", "first-page": "4818", "year": "1995", "journal-title": "Cancer Res."}, {"key": "bibr3-107327480200900106", "author": "Castellano M.", "volume": "9", "first-page": "421", "year": "1999", "journal-title": "Melanoma Res.", "DOI": "10.1097/00008390-199910000-00001", "doi-asserted-by": "crossref"}, {"key": "bibr4-107327480200900106", "author": "Rosenberg S.A.", "volume": "10", "first-page": "281", "year": "1999", "journal-title": "Immunity.", "DOI": "10.1016/S1074-7613(00)80028-X", "doi-asserted-by": "crossref"}, {"key": "bibr5-107327480200900106", "author": "Chang A.E.", "first-page": "349", "year": "1999", "volume-title": "Gene Therapy of Cancer: Translational Approaches From Preclinical Studies to Clinical Implementation."}, {"key": "bibr6-107327480200900106", "author": "Freeman S.M.", "volume": "53", "first-page": "5274", "year": "1993", "journal-title": "Cancer Res."}, {"key": "bibr7-107327480200900106", "author": "Xu M.", "volume": "8", "first-page": "177", "year": "1997", "journal-title": "Hum Gene Ther.", "DOI": "10.1089/hum.1997.8.2-177", "doi-asserted-by": "crossref"}, {"key": "bibr8-107327480200900106", "author": "Vile R.G.", "volume": "54", "first-page": "6228", "year": "1994", "journal-title": "Cancer Res."}, {"key": "bibr9-107327480200900106", "author": "Blaese R.M.", "volume": "30", "first-page": "1190", "year": "1994", "journal-title": "Eur J Cancer.", "DOI": "10.1016/0959-8049(94)90482-0", "doi-asserted-by": "crossref"}, {"key": "bibr10-107327480200900106", "author": "Moolten F.L.", "volume": "1", "first-page": "279", "year": "1994", "journal-title": "Cancer Gene Ther."}, {"key": "bibr11-107327480200900106", "author": "Reid R.", "volume": "263", "first-page": "3898", "year": "1988", "journal-title": "J Biol Chem."}, {"key": "bibr12-107327480200900106", "author": "Gane E.", "volume": "350", "first-page": "1729", "year": "1997", "journal-title": "Lancet.", "DOI": "10.1016/S0140-6736(97)05535-9", "doi-asserted-by": "crossref"}, {"key": "bibr13-107327480200900106", "author": "Vile R.G.", "volume": "53", "first-page": "3860", "year": "1993", "journal-title": "Cancer Res."}, {"key": "bibr14-107327480200900106", "author": "Bonnekoh B.", "volume": "106", "first-page": "1163", "year": "1996", "journal-title": "J Invest Dermatol.", "DOI": "10.1111/1523-1747.ep12347786", "doi-asserted-by": "crossref"}, {"key": "bibr15-107327480200900106", "author": "Vile R.G.", "volume": "71", "first-page": "267", "year": "1997", "journal-title": "Int J Cancer.", "DOI": "10.1002/(SICI)1097-0215(19970410)71:2<267::AID-IJC23>3.0.CO;2-D", "doi-asserted-by": "crossref"}, {"key": "bibr16-107327480200900106", "author": "Klatzmann D.", "volume": "9", "first-page": "2585", "year": "1998", "journal-title": "Hum Gene Ther.", "DOI": "10.1089/hum.1998.9.17-2585", "doi-asserted-by": "crossref"}, {"key": "bibr17-107327480200900106", "author": "Levine A.J.", "volume": "88", "first-page": "323", "year": "1997", "journal-title": "Cell.", "DOI": "10.1016/S0092-8674(00)81871-1", "doi-asserted-by": "crossref"}, {"key": "bibr18-107327480200900106", "author": "Schneeberger A.", "volume": "25", "first-page": "509", "year": "2000", "journal-title": "Clin Exp Dermatol.", "DOI": "10.1046/j.1365-2230.2000.00694.x", "doi-asserted-by": "crossref"}, {"key": "bibr19-107327480200900106", "author": "Cirielli C.", "volume": "63", "first-page": "673", "year": "1995", "journal-title": "Int J Cancer.", "DOI": "10.1002/ijc.2910630512", "doi-asserted-by": "crossref"}, {"key": "bibr20-107327480200900106", "author": "Dummer R.", "volume": "7", "first-page": "1069", "year": "2000", "journal-title": "Cancer Gene Ther.", "DOI": "10.1038/sj.cgt.7700214", "doi-asserted-by": "crossref"}, {"key": "bibr21-107327480200900106", "author": "Tanner N.K.", "volume": "23", "first-page": "257", "year": "1999", "journal-title": "FEMS Microbiol Rev.", "DOI": "10.1111/j.1574-6976.1999.tb00399.x", "doi-asserted-by": "crossref"}, {"key": "bibr22-107327480200900106", "author": "Watanabe T.", "volume": "97", "first-page": "8490", "year": "2000", "journal-title": "Proc Natl Acad Sci U S A.", "DOI": "10.1073/pnas.150104097", "doi-asserted-by": "crossref"}, {"key": "bibr23-107327480200900106", "author": "Kawabe S.", "volume": "19", "first-page": "5359", "year": "2000", "journal-title": "Oncogene.", "DOI": "10.1038/sj.onc.1203935", "doi-asserted-by": "crossref"}, {"key": "bibr24-107327480200900106", "author": "Chin L.", "volume": "11", "first-page": "2822", "year": "1997", "journal-title": "Genes Dev.", "DOI": "10.1101/gad.11.21.2822", "doi-asserted-by": "crossref"}, {"key": "bibr25-107327480200900106", "author": "Arndt G.M.", "volume": "40", "first-page": "785", "year": "1997", "journal-title": "Genome.", "DOI": "10.1139/g97-802", "doi-asserted-by": "crossref"}, {"key": "bibr26-107327480200900106", "author": "Jansen B.", "volume": "5", "first-page": "271", "year": "1995", "journal-title": "Antisense Res Dev.", "DOI": "10.1089/ard.1995.5.271", "doi-asserted-by": "crossref"}, {"key": "bibr27-107327480200900106", "author": "Niu G.", "volume": "59", "first-page": "5059", "year": "1999", "journal-title": "Cancer Res."}, {"key": "bibr28-107327480200900106", "author": "Cochet O.", "volume": "58", "first-page": "1170", "year": "1998", "journal-title": "Cancer Res."}, {"key": "bibr29-107327480200900106", "author": "Putney S.D.", "volume": "9", "first-page": "451", "year": "1999", "journal-title": "Antisense Nucleic Acid Drug Dev.", "DOI": "10.1089/oli.1.1999.9.451", "doi-asserted-by": "crossref"}, {"key": "bibr30-107327480200900106", "author": "Darnell J.E.", "volume": "277", "first-page": "1630", "year": "1997", "journal-title": "Science.", "DOI": "10.1126/science.277.5332.1630", "doi-asserted-by": "crossref"}, {"key": "bibr31-107327480200900106", "author": "Bowman T.", "volume": "19", "first-page": "2474", "year": "2000", "journal-title": "Oncogene.", "DOI": "10.1038/sj.onc.1203527", "doi-asserted-by": "crossref"}, {"key": "bibr32-107327480200900106", "author": "Niu G.", "volume": "61", "first-page": "3276", "year": "2001", "journal-title": "Cancer Res."}, {"key": "bibr33-107327480200900106", "author": "Guerry D.", "first-page": "211", "year": "1998", "volume-title": "Cutaneous Oncology: Pathophysiology, Diagnosis and Management."}, {"key": "bibr34-107327480200900106", "author": "Rosenberg S.A.", "volume": "271", "first-page": "907", "year": "1994", "journal-title": "JAMA.", "DOI": "10.1001/jama.1994.03510360033032", "doi-asserted-by": "crossref"}, {"key": "bibr35-107327480200900106", "author": "Agarwala S.S.", "volume": "8", "first-page": "167", "year": "1996", "journal-title": "Curr Opin Oncol.", "DOI": "10.1097/00001622-199603000-00015", "doi-asserted-by": "crossref"}, {"key": "bibr36-107327480200900106", "author": "Pardoll D.M.", "volume": "5", "first-page": "719", "year": "1993", "journal-title": "Curr Opin Immunol.", "DOI": "10.1016/0952-7915(93)90127-E", "doi-asserted-by": "crossref"}, {"key": "bibr37-107327480200900106", "author": "Dranoff G.", "volume": "90", "first-page": "3539", "year": "1993", "journal-title": "Proc Natl Acad Sci U S A.", "DOI": "10.1073/pnas.90.8.3539", "doi-asserted-by": "crossref"}, {"key": "bibr38-107327480200900106", "author": "Huang A.Y.", "volume": "264", "first-page": "961", "year": "1994", "journal-title": "Science.", "DOI": "10.1126/science.7513904", "doi-asserted-by": "crossref"}, {"key": "bibr39-107327480200900106", "author": "Soiffer R.", "volume": "95", "first-page": "13141", "year": "1998", "journal-title": "Proc Natl Acad Sci U S A.", "DOI": "10.1073/pnas.95.22.13141", "doi-asserted-by": "crossref"}, {"key": "bibr40-107327480200900106", "author": "Pardoll D.M.", "volume": "4", "first-page": "525", "year": "1998", "journal-title": "Nat Med.", "DOI": "10.1038/nm0598supp-525", "doi-asserted-by": "crossref"}, {"key": "bibr41-107327480200900106", "author": "Borrello I.", "volume": "10", "first-page": "1983", "year": "1999", "journal-title": "Hum Gene Ther.", "DOI": "10.1089/10430349950017347", "doi-asserted-by": "crossref"}, {"key": "bibr42-107327480200900106", "author": "Simons J.W.", "volume": "57", "first-page": "1537", "year": "1997", "journal-title": "Cancer Res."}, {"key": "bibr43-107327480200900106", "author": "Huang A.Y.", "volume": "187", "first-page": "229", "year": "1994", "journal-title": "Ciba Found Symp."}, {"key": "bibr44-107327480200900106", "author": "Jaffee E.M.", "volume": "19", "first-page": "145", "year": "2001", "journal-title": "J Clin Oncol.", "DOI": "10.1200/JCO.2001.19.1.145", "doi-asserted-by": "crossref"}, {"key": "bibr45-107327480200900106", "author": "Gutzmer R.", "volume": "12", "first-page": "519", "year": "1998", "journal-title": "Hematol Oncol Clin North Am.", "DOI": "10.1016/S0889-8588(05)70006-X", "doi-asserted-by": "crossref"}, {"key": "bibr46-107327480200900106", "author": "Plautz G.E.", "volume": "90", "first-page": "4645", "year": "1993", "journal-title": "Proc Natl Acad Sci U S A.", "DOI": "10.1073/pnas.90.10.4645", "doi-asserted-by": "crossref"}, {"key": "bibr47-107327480200900106", "author": "Nabel G.J.", "volume": "90", "first-page": "11307", "year": "1993", "journal-title": "Proc Natl Acad Sci U S A.", "DOI": "10.1073/pnas.90.23.11307", "doi-asserted-by": "crossref"}, {"key": "bibr48-107327480200900106", "author": "Stopeck A.T.", "volume": "15", "first-page": "341", "year": "1997", "journal-title": "J Clin Oncol.", "DOI": "10.1200/JCO.1997.15.1.341", "doi-asserted-by": "crossref"}, {"key": "bibr49-107327480200900106", "author": "Hersh E.M.", "volume": "3", "first-page": "2623", "year": "1997", "journal-title": "Clin Cancer Res."}, {"key": "bibr50-107327480200900106", "author": "Karavodin L.M.", "volume": "9", "first-page": "2231", "year": "1998", "journal-title": "Hum Gene Ther.", "DOI": "10.1089/hum.1998.9.15-2231", "doi-asserted-by": "crossref"}, {"key": "bibr51-107327480200900106", "author": "Horton H.M.", "volume": "96", "first-page": "1553", "year": "1999", "journal-title": "Proc Natl Acad Sci U S A.", "DOI": "10.1073/pnas.96.4.1553", "doi-asserted-by": "crossref"}, {"key": "bibr52-107327480200900106", "author": "Fujii S.", "volume": "7", "first-page": "1220", "year": "2000", "journal-title": "Cancer Gene Ther.", "DOI": "10.1038/sj.cgt.7700224", "doi-asserted-by": "crossref"}, {"key": "bibr53-107327480200900106", "author": "Mukherji B.", "volume": "116", "first-page": "33", "year": "1990", "journal-title": "Immunol Rev.", "DOI": "10.1111/j.1600-065X.1990.tb00803.x", "doi-asserted-by": "crossref"}, {"key": "bibr54-107327480200900106", "author": "Topalian S.L.", "volume": "91", "first-page": "9461", "year": "1994", "journal-title": "Proc Natl Acad Sci U S A.", "DOI": "10.1073/pnas.91.20.9461", "doi-asserted-by": "crossref"}, {"key": "bibr55-107327480200900106", "author": "Melief C.J.", "volume": "145", "first-page": "167", "year": "1995", "journal-title": "Immunol Rev.", "DOI": "10.1111/j.1600-065X.1995.tb00081.x", "doi-asserted-by": "crossref"}, {"key": "bibr56-107327480200900106", "author": "Rosenberg S.A.", "volume": "323", "first-page": "570", "year": "1990", "journal-title": "N Engl J Med.", "DOI": "10.1056/NEJM199008303230904", "doi-asserted-by": "crossref"}, {"key": "bibr57-107327480200900106", "author": "Yee C.", "volume": "9", "first-page": "702", "year": "1997", "journal-title": "Curr Opin Immunol.", "DOI": "10.1016/S0952-7915(97)80052-0", "doi-asserted-by": "crossref"}, {"key": "bibr58-107327480200900106", "author": "Banchereau J.", "volume": "392", "first-page": "245", "year": "1998", "journal-title": "Nature.", "DOI": "10.1038/32588", "doi-asserted-by": "crossref"}, {"key": "bibr59-107327480200900106", "author": "Inaba K.", "volume": "176", "first-page": "1693", "year": "1992", "journal-title": "J Exp Med.", "DOI": "10.1084/jem.176.6.1693", "doi-asserted-by": "crossref"}, {"key": "bibr60-107327480200900106", "author": "Boczkowski D.", "volume": "184", "first-page": "465", "year": "1996", "journal-title": "J Exp Med.", "DOI": "10.1084/jem.184.2.465", "doi-asserted-by": "crossref"}, {"key": "bibr61-107327480200900106", "author": "Schuler G.", "volume": "186", "first-page": "1183", "year": "1997", "journal-title": "J Exp Med.", "DOI": "10.1084/jem.186.8.1183", "doi-asserted-by": "crossref"}, {"key": "bibr62-107327480200900106", "author": "Reeves M.E.", "volume": "56", "first-page": "5672", "year": "1996", "journal-title": "Cancer Res."}, {"key": "bibr63-107327480200900106", "author": "Ribas A.", "volume": "57", "first-page": "2865", "year": "1997", "journal-title": "Cancer Res."}, {"key": "bibr64-107327480200900106", "author": "Grewal I.S.", "volume": "273", "first-page": "1864", "year": "1996", "journal-title": "Science.", "DOI": "10.1126/science.273.5283.1864", "doi-asserted-by": "crossref"}, {"key": "bibr65-107327480200900106", "author": "Kikuchi T.", "volume": "96", "first-page": "91", "year": "2000", "journal-title": "Blood."}, {"key": "bibr66-107327480200900106", "author": "Sotomayor E.M.", "volume": "5", "first-page": "780", "year": "1999", "journal-title": "Nat Med.", "DOI": "10.1038/10503", "doi-asserted-by": "crossref"}], "container-title": ["Cancer Control"], "language": "en", "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.1177/107327480200900106", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/pdf/10.1177/107327480200900106", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 1, 7]], "date-time": "2018-01-07T09:48:01Z", "timestamp": 1515318481000}, "score": 38.89792, "issued": {"date-parts": [[2002, 1]]}, "references-count": 66, "journal-issue": {"published-online": {"date-parts": [[2017, 8, 30]]}, "published-print": {"date-parts": [[2002, 1]]}, "issue": "1"}, "alternative-id": ["10.1177/107327480200900106"], "URL": "http://dx.doi.org/10.1177/107327480200900106", "relation": {"cites": []}, "ISSN": ["1073-2748", "1073-2748"], "issn-type": [{"value": "1073-2748", "type": "print"}, {"value": "1073-2748", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T15:05:41Z", "timestamp": 1574521541571}, "publisher-location": "Oxford, UK", "reference-count": 71, "publisher": "Wiley-Blackwell", "isbn-type": [{"value": "9781405196260", "type": "print"}, {"value": "9781444394016", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9781444394016.ch17", "type": "book-chapter", "created": {"date-parts": [[2011, 6, 27]], "date-time": "2011-06-27T19:08:11Z", "timestamp": 1309201691000}, "page": "266-273", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Molecular Basis of B-cell Lymphomas"], "prefix": "10.1002", "author": [{"given": "Elizabeth M.", "family": "Sagatys", "sequence": "first", "affiliation": []}, {"given": "Eduardo M.", "family": "Sotomayor", "sequence": "additional", "affiliation": []}, {"given": "Jianguo", "family": "Tao", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2011, 3, 24]]}, "reference": [{"key": "10.1002/9781444394016.ch17-BIB1|cit1", "author": "Jaffe", "first-page": "158", "year": "2008", "volume-title": "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues"}, {"key": "10.1002/9781444394016.ch17-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "927", "DOI": "10.1038/ni.1626", "article-title": "Regulation of B cell fat.commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros", "volume": "9", "author": "Reynaud", "year": "2008", "journal-title": "Nat Immunol"}, {"key": "10.1002/9781444394016.ch17-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "920", "DOI": "10.1038/nri953", "article-title": "Lymphoid malignancies: the dark side of B-cell differentiation", "volume": "2", "author": "Shaffer", "year": "2002", "journal-title": "Nat Rev Immunol"}, {"key": "10.1002/9781444394016.ch17-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "495", "DOI": "10.1146/annurev.immunol.18.1.495", "article-title": "The RAG proteins and V(D)J recombination.complexes, ends, and transposition", "volume": "18", "author": "Fugmann", "year": "2000", "journal-title": "Annu Rev Immunol"}, {"key": "10.1002/9781444394016.ch17-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "4602", "DOI": "10.1182/blood-2003-11-3857", "article-title": "Utilization of Ig heavy chain variable, diversity, and joining gene segments in children with B-lineage acute lymphoblastic leukemia: implications for the mechanisms of VDJ recombination and for pathogenesis", "volume": "103", "author": "Li", "year": "2004", "journal-title": "Blood"}, {"key": "10.1002/9781444394016.ch17-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "2151", "DOI": "10.1084/jem.188.11.2151", "article-title": "Th.complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus", "volume": "188", "author": "Matsuda", "year": "1998", "journal-title": "J Exp Med"}, {"key": "10.1002/9781444394016.ch17-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1016/0167-5699(95)80166-9", "article-title": "The human immunoglobulin VH repertoire", "volume": "16", "author": "Cook", "year": "1995", "journal-title": "Immunol Today"}, {"key": "10.1002/9781444394016.ch17-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "583", "DOI": "10.1016/0092-8674(81)90400-1", "article-title": "Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes", "volume": "27", "author": "Ravetch", "year": "1981", "journal-title": "Cell"}, {"key": "10.1002/9781444394016.ch17-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "291", "DOI": "10.2174/156652406776894563", "article-title": "Lymphomaand the control of B cell growth and differentiation", "volume": "6", "author": "Rui", "year": "2006", "journal-title": "Curr Mol Med"}, {"key": "10.1002/9781444394016.ch17-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "62", "DOI": "10.1046/j.1365-3083.1997.d01-376.x", "article-title": "Selective usage of VH genes in adult human B lymphocyte repertoires", "volume": "45", "author": "Davidkova", "year": "1997", "journal-title": "Scand J Immunol"}, {"key": "10.1002/9781444394016.ch17-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "2716", "DOI": "10.1182/blood.V97.9.2716", "article-title": "Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of J(H)-proximal variable gene segments", "volume": "97", "author": "Mortuza", "year": "2001", "journal-title": "Blood"}, {"key": "10.1002/9781444394016.ch17-BIB12|cit12", "first-page": "190", "article-title": "Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction", "volume": "155", "author": "Brezinschek", "year": "1995", "journal-title": "J Immunol"}, {"key": "10.1002/9781444394016.ch17-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1046/j.1365-2141.1996.d01-1851.x", "article-title": "Molecular analysis of the leukaemic B cell in adult and childhood acute lymphoblastic leukaemia", "volume": "94", "author": "Coyle", "year": "1996", "journal-title": "Br J Haematol"}, {"key": "10.1002/9781444394016.ch17-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1016/j.immuni.2006.01.012", "article-title": "Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells", "volume": "24", "author": "Delogu", "year": "2006", "journal-title": "Immunity"}, {"key": "10.1002/9781444394016.ch17-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1016/j.immuni.2007.05.019", "article-title": "Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function", "volume": "27", "author": "Schebesta", "year": "2007", "journal-title": "Immunity"}, {"key": "10.1002/9781444394016.ch17-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "885", "DOI": "10.1016/0092-8674(94)90077-9", "article-title": "E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements", "volume": "79", "author": "Bain", "year": "1994", "journal-title": "Cell"}, {"key": "10.1002/9781444394016.ch17-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1038/376263a0", "article-title": "Failure of B-cell differentiation in mice lacking the transcription factor EBF", "volume": "376", "author": "Lin", "year": "1995", "journal-title": "Nature"}, {"key": "10.1002/9781444394016.ch17-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "508", "DOI": "10.1016/j.immuni.2009.01.012", "article-title": "Stepwise activation of enhancer and promoter regions of the B cel.commitment gene Pax5 in early lymphopoiesis", "volume": "30", "author": "Decker", "year": "2009", "journal-title": "Immunity"}, {"key": "10.1002/9781444394016.ch17-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "4771", "DOI": "10.1128/MCB.22.13.4771-4780.2002", "article-title": "Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells", "volume": "22", "author": "Lin", "year": "2002", "journal-title": "Mol Cell Biol"}, {"key": "10.1002/9781444394016.ch17-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "393", "DOI": "10.1084/jem.183.2.393", "article-title": "Transcription factor B-cell lineage-specific activator protein regulates the gene for human X-box binding protein 1", "volume": "183", "author": "Reimold", "year": "1996", "journal-title": "J Exp Med"}, {"key": "10.1002/9781444394016.ch17-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "300", "DOI": "10.1038/35085509", "article-title": "Plasma cell differentiation requires the transcription factor XBP-1", "volume": "412", "author": "Reimold", "year": "2001", "journal-title": "Nature"}, {"key": "10.1002/9781444394016.ch17-BIB22|cit22", "author": "Swerdlow", "year": "2008", "volume-title": "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues"}, {"key": "10.1002/9781444394016.ch17-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "1449", "DOI": "10.1016/S0002-9440(10)65399-0", "article-title": "Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization", "volume": "154", "author": "Li", "year": "1999", "journal-title": "Amer J Path"}, {"key": "10.1002/9781444394016.ch17-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "9638", "DOI": "10.1073/pnas.88.21.9638", "article-title": "PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma", "volume": "88", "author": "Rosenberg", "year": "1991", "journal-title": "Proc Natl Acad Sci. USA"}, {"key": "10.1002/9781444394016.ch17-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1097/MOH.0b013e328302c9c5", "article-title": "Mantle cell lymphoma: advances in biology and therapy", "volume": "15", "author": "Smith", "year": "2008", "journal-title": "Curr Opin Hematol"}, {"key": "10.1002/9781444394016.ch17-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "4315", "DOI": "10.1182/blood-2005-04-1753", "article-title": "Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling", "volume": "106", "author": "Fu", "year": "2005", "journal-title": "Blood"}, {"key": "10.1002/9781444394016.ch17-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "2199", "DOI": "10.1158/0008-5472.CAN-04-1526", "article-title": "CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus", "volume": "65", "author": "Hernandez", "year": "2005", "journal-title": "Cancer Res"}, {"key": "10.1002/9781444394016.ch17-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "238", "DOI": "10.1182/blood.V99.1.238", "article-title": "ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances", "volume": "99", "author": "Camacho", "year": "2002", "journal-title": "Blood"}, {"key": "10.1002/9781444394016.ch17-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "2773", "DOI": "10.1073/pnas.050400997", "article-title": "Mantle cell lymphoma is characterized by inactivation of theATMgene", "volume": "97", "author": "Schaffner", "year": "2000", "journal-title": "Proc Natl Acad SciUSA"}, {"key": "10.1002/9781444394016.ch17-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "5422", "DOI": "10.1182/blood-2006-11-057208", "article-title": "Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis", "volume": "109", "author": "Pinyol", "year": "2007", "journal-title": "Blood"}, {"key": "10.1002/9781444394016.ch17-BIB31|cit31", "first-page": "272", "article-title": "Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas", "volume": "89", "author": "Pinyol", "year": "1997", "journal-title": "Blood"}, {"key": "10.1002/9781444394016.ch17-BIB32|cit32", "first-page": "1591", "article-title": "Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity", "volume": "148", "author": "Jares", "year": "1996", "journal-title": "Amer J Pathol"}, {"key": "10.1002/9781444394016.ch17-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1146/annurev.iy.12.040194.001001", "article-title": "Germinal centers", "volume": "12", "author": "MacLennan", "year": "1994", "journal-title": "Annu Rev Immunol"}, {"key": "10.1002/9781444394016.ch17-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "56", "DOI": "10.1006/cimm.2000.1616", "article-title": "The CD40-inducible Bcl-2 family member A1 protects B cells from antigen receptor-mediated apoptosis", "volume": "200", "author": "Craxton", "year": "2000", "journal-title": "Cell Immunol"}, {"key": "10.1002/9781444394016.ch17-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "8910", "DOI": "10.1073/pnas.91.19.8910", "article-title": "BCL2 translocation frequency rises with age in humans", "volume": "91", "author": "Liu", "year": "1994", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/9781444394016.ch17-BIB36|cit36", "first-page": "1359", "article-title": "Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center", "volume": "88", "author": "Tuscano", "year": "1996", "journal-title": "Blood"}, {"key": "10.1002/9781444394016.ch17-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "1520", "DOI": "10.1056/NEJM199911113412007", "article-title": "Cellular origin of human B-cell lymphomas", "volume": "341", "author": "Kuppers", "year": "1999", "journal-title": "New Engl J Med"}, {"key": "10.1002/9781444394016.ch17-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.1038/nature02355", "article-title": "A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RA.complex", "volume": "428", "author": "Raghavan", "year": "2004", "journal-title": "Nature"}, {"key": "10.1002/9781444394016.ch17-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "254", "DOI": "10.1038/349254a0", "article-title": "Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)", "volume": "349", "author": "McDonnell", "year": "1991", "journal-title": "Nature"}, {"key": "10.1002/9781444394016.ch17-BIB40|cit40", "first-page": "1", "article-title": "E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells", "volume": "8", "author": "Strasser", "year": "1993", "journal-title": "Oncogene"}, {"key": "10.1002/9781444394016.ch17-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "589", "DOI": "10.1126/science.276.5312.589", "article-title": "Control of inflammation, cytokine expression, and germinal center formation by BCL-6", "volume": "276", "author": "Dent", "year": "1997", "journal-title": "Science"}, {"key": "10.1002/9781444394016.ch17-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1038/ng0697-161", "article-title": "The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation", "volume": "16", "author": "Ye", "year": "1997", "journal-title": "Nat Genet"}, {"key": "10.1002/9781444394016.ch17-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.1097/MOH.0b013e328302c7df", "article-title": "B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma", "volume": "15", "author": "Ci", "year": "2008", "journal-title": "Curr Opin Hematol"}, {"key": "10.1002/9781444394016.ch17-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1016/S1074-7613(00)00020-0", "article-title": "BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control", "volume": "13", "author": "Shaffer", "year": "2000", "journal-title": "Immunity"}, {"key": "10.1002/9781444394016.ch17-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "1922", "DOI": "10.4049/jimmunol.169.4.1922", "article-title": "Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 proto-oncogene", "volume": "169", "author": "Vasanwala", "year": "2002", "journal-title": "J Immunol"}, {"key": "10.1002/9781444394016.ch17-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "841", "DOI": "10.1038/nature06547", "article-title": "Two levels of protection for the B cell genome during somatic hypermutation", "volume": "451", "author": "Liu", "year": "2008", "journal-title": "Nature"}, {"key": "10.1002/9781444394016.ch17-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "108", "DOI": "10.1038/ng.2007.35", "article-title": "AID is required for germinal center-derived lymphomagenesis", "volume": "40", "author": "Pasqualucci", "year": "2008", "journal-title": "Nat Genet"}, {"key": "10.1002/9781444394016.ch17-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "22565", "DOI": "10.1074/jbc.M803490200", "article-title": "BCL6- mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent manner", "volume": "283", "author": "Ranuncolo", "year": "2008", "journal-title": "J Biol Chem"}, {"key": "10.1002/9781444394016.ch17-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "635", "DOI": "10.1038/nature03147", "article-title": "The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells", "volume": "432", "author": "Phan", "year": "2004", "journal-title": "Nature"}, {"key": "10.1002/9781444394016.ch17-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1016/j.bcmd.2008.02.003", "article-title": "BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells", "volume": "41", "author": "Ranuncolo", "year": "2008", "journal-title": "Blood Cells, Molecules & Diseases"}, {"key": "10.1002/9781444394016.ch17-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "1054", "DOI": "10.1038/ni1245", "article-title": "BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells", "volume": "6", "author": "Phan", "year": "2005", "journal-title": "Nat Immunol"}, {"key": "10.1002/9781444394016.ch17-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "596", "DOI": "10.1126/science.276.5312.596", "article-title": "Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation", "volume": "276", "author": "Lin", "year": "1997", "journal-title": "Science"}, {"key": "10.1002/9781444394016.ch17-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "280", "DOI": "10.1016/j.ccr.2007.08.011", "article-title": "A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma", "volume": "12", "author": "Saito", "year": "2007", "journal-title": "Cancer Cell"}, {"key": "10.1002/9781444394016.ch17-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "224", "DOI": "10.1038/sj.onc.1209775", "article-title": "STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas", "volume": "26", "author": "Walker", "year": "2007", "journal-title": "Oncogene"}, {"key": "10.1002/9781444394016.ch17-BIB55|cit55", "doi-asserted-by": "crossref", "first-page": "22", "DOI": "10.1038/nri2217", "article-title": "Germinal centres: role in B-cell physiology and malignancy", "volume": "8", "author": "Klein", "year": "2008", "journal-title": "Nat Rev Immunol"}, {"key": "10.1002/9781444394016.ch17-BIB56|cit56", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1038/35085588", "article-title": "Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas", "volume": "412", "author": "Pasqualucci", "year": "2001", "journal-title": "Nature"}, {"key": "10.1002/9781444394016.ch17-BIB57|cit57", "doi-asserted-by": "crossref", "first-page": "4031", "DOI": "10.1128/MCB.15.8.4031", "article-title": "A link between increased transforming activity of lymphomaderived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain", "volume": "15", "author": "Hoang", "year": "1995", "journal-title": "Mol Cell Biol"}, {"key": "10.1002/9781444394016.ch17-BIB58|cit58", "doi-asserted-by": "crossref", "first-page": "1031", "DOI": "10.1016/S1097-2765(02)00520-8", "article-title": "c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogeneinduced genetic instability", "volume": "9", "author": "Vafa", "year": "2002", "journal-title": "Molecular Cell"}, {"key": "10.1002/9781444394016.ch17-BIB59|cit59", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1038/nature05953", "article-title": "Non-transcriptional control of DNA replication by c-Myc", "volume": "448", "author": "Dominguez-Sola", "year": "2007", "journal-title": "Nature"}, {"key": "10.1002/9781444394016.ch17-BIB60|cit60", "doi-asserted-by": "crossref", "first-page": "807", "DOI": "10.1038/nature03845", "article-title": "Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants", "volume": "436", "author": "Hemann", "year": "2005", "journal-title": "Nature"}, {"key": "10.1002/9781444394016.ch17-BIB61|cit61", "first-page": "2741", "article-title": "Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma", "volume": "8", "author": "Yano", "year": "1993", "journal-title": "Oncogene"}, {"key": "10.1002/9781444394016.ch17-BIB62|cit62", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1016/j.ejcb.2007.05.006", "article-title": "IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells", "volume": "86", "author": "Teng", "year": "2007", "journal-title": "Euro J Cell Biol"}, {"key": "10.1002/9781444394016.ch17-BIB63|cit63", "doi-asserted-by": "crossref", "first-page": "226", "DOI": "10.1038/ng1097-226", "article-title": "Deregulation of MUM1/IRF4by chromosomal translocation in multiple myeloma", "volume": "17", "author": "Iida", "year": "1997", "journal-title": "Nat Genet"}, {"key": "10.1002/9781444394016.ch17-BIB64|cit64", "doi-asserted-by": "crossref", "first-page": "1812", "DOI": "10.1038/sj.leu.2401563", "article-title": "MUM1/IRF4-IgH fusion inmultiplemyeloma", "volume": "13", "author": "Yoshida", "year": "1999", "journal-title": "Leukemia"}, {"key": "10.1002/9781444394016.ch17-BIB65|cit65", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1097/PAP.0b013e31802f0495", "article-title": "New transcription factors in diagnostic hematopathology", "volume": "14", "author": "Ponzoni", "year": "2007", "journal-title": "Adv Anat Pathol"}, {"key": "10.1002/9781444394016.ch17-BIB66|cit66", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1016/S1074-7613(02)00335-7", "article-title": "Blimp-1 orchestrates plasma cell differentiation by extinguishing thematureBcell gene expression program", "volume": "17", "author": "Shaffer", "year": "2002", "journal-title": "Immunity"}, {"key": "10.1002/9781444394016.ch17-BIB67|cit67", "first-page": "3", "article-title": "Warner-Lambert/Parke-Davis Award lecture. Cellular and molecular mechanisms that direct leukocyte traffic", "volume": "136", "author": "Butcher", "year": "1990", "journal-title": "Amer J Pathol"}, {"key": "10.1002/9781444394016.ch17-BIB68|cit68", "doi-asserted-by": "crossref", "first-page": "2041", "DOI": "10.1200/JCO.2001.19.7.2041", "article-title": "Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection", "volume": "19", "author": "Morgner", "year": "2001", "journal-title": "J Clin Oncol"}, {"key": "10.1002/9781444394016.ch17-BIB69|cit69", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1056/NEJMoa013376", "article-title": "Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection", "volume": "347", "author": "Hermine", "year": "2002", "journal-title": "New Engl J Med"}, {"key": "10.1002/9781444394016.ch17-BIB70|cit70", "doi-asserted-by": "crossref", "first-page": "493", "DOI": "10.1016/S1367-5931(02)00343-5", "article-title": "Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer", "volume": "6", "author": "Adams", "year": "2002", "journal-title": "Curr Opin Chem Biol"}, {"key": "10.1002/9781444394016.ch17-BIB71|cit71", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1016/S1535-6108(02)00127-7", "article-title": "Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics", "volume": "2", "author": "Letai", "year": "2002", "journal-title": "Cancer Cell"}], "container-title": ["Advances in Malignant Hematology"], "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/9781444394016.ch17", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 12]], "date-time": "2019-06-12T11:58:13Z", "timestamp": 1560340693000}, "score": 28.327019, "issued": {"date-parts": [[2011, 3, 24]]}, "ISBN": ["9781444394016", "9781405196260"], "references-count": 71, "URL": "http://dx.doi.org/10.1002/9781444394016.ch17", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T16:14:31Z", "timestamp": 1574871271542}, "reference-count": 142, "publisher": "Springer Science and Business Media LLC", "issue": "10", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1997, 10, 1]], "date-time": "1997-10-01T00:00:00Z", "timestamp": 875664000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mol Med"], "published-print": {"date-parts": [[1997, 10]]}, "DOI": "10.1007/bf03401703", "type": "journal-article", "created": {"date-parts": [[2018, 8, 30]], "date-time": "2018-08-30T10:28:21Z", "timestamp": 1535624901000}, "page": "636-651", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Recent Advances in the Treatment of Malignant Melanoma with Gene Therapy"], "prefix": "10.1007", "volume": "3", "author": [{"given": "Evan M.", "family": "Hersh", "sequence": "first", "affiliation": []}, {"given": "Alison T.", "family": "Stopeck", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[1997, 10, 1]]}, "reference": [{"key": "BF03401703_CR1", "doi-asserted-by": "publisher", "first-page": "5", "DOI": "10.3322/canjclin.47.1.5", "volume": "47", "author": "SL Parker", "year": "1997", "unstructured": "Parker SL, Tong T, Bolden S, et al. (1997) Cancer statistics, 1997. CA Cancer J. Clin. 47: 5\u201327.", "journal-title": "CA Cancer J. Clin."}, {"key": "BF03401703_CR2", "doi-asserted-by": "publisher", "first-page": "611", "DOI": "10.1093/jnci/81.8.611", "volume": "81", "author": "M Thorn", "year": "1989", "unstructured": "Thorn M, Adami HA, Bergstrom R, et al. (1989) Trends in survival from malignant melanoma: Remarkable improvement in 23 years. J. Natl. Cancer Inst 81: 611\u2013618.", "journal-title": "J. Natl. Cancer Inst"}, {"key": "BF03401703_CR3", "author": "CM Balch", "first-page": "165", "year": "1992", "unstructured": "Balch CM, Soong S, Shaw HM, et al. (1992) An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, et al. (eds). Cutaneous Melanoma. J.B. Lippincott, New York, pp. 165\u2013187.", "volume-title": "Cutaneous Melanoma"}, {"key": "BF03401703_CR4", "first-page": "5330", "volume": "55", "author": "ABH Bakker", "year": "1995", "unstructured": "Bakker ABH, Marland G, deBoer AJ, et al. (1995) Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res. 55: 5330\u20135334.", "journal-title": "Cancer Res."}, {"key": "BF03401703_CR5", "author": "Y Kawakami", "first-page": "53", "year": "1995", "unstructured": "Kawakami Y, Robbins PF. (1995) Genes coding for tumor antigens recognized by T lymphocytes. In: DeVita VT, Jr., Hellman S, Rosenberg SA (eds). Biologic Therapy of Cancer. J. B. Lippincott, Philadelphia, pp. 53\u201364.", "volume-title": "Biologic Therapy of Cancer"}, {"key": "BF03401703_CR6", "doi-asserted-by": "publisher", "first-page": "932", "DOI": "10.1093/jnci/83.13.932", "volume": "83", "author": "P Aebersold", "year": "1991", "unstructured": "Aebersold P, Hyatt C, Johnson S, et al. (1991) Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: Association with clinical response. J. Natl. Cancer Inst. 83: 932\u2013937.", "journal-title": "J. Natl. Cancer Inst."}, {"key": "BF03401703_CR7", "doi-asserted-by": "publisher", "first-page": "1764", "DOI": "10.1084/jem.154.6.1764", "volume": "154", "author": "AP Albino", "year": "1981", "unstructured": "Albino AP, Lloyd KO, Houghton AN, et al. (1981) Heterogeneity in surface antigens and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. J. Exp. Med. 154: 1764\u20131778.", "journal-title": "J. Exp. Med."}, {"key": "BF03401703_CR8", "doi-asserted-by": "publisher", "first-page": "873", "DOI": "10.1084/jem.144.4.873", "volume": "144", "author": "H Shiku", "year": "1976", "unstructured": "Shiku H, Takahashi T, Oettgen HF, et al. (1976) Cell surface antigens of human malignant melanoma. J. Exp. Med. 144: 873\u2013881.", "journal-title": "J. Exp. Med."}, {"key": "BF03401703_CR9", "doi-asserted-by": "publisher", "first-page": "784", "DOI": "10.1084/jem.145.3.784", "volume": "145", "author": "H Shiku", "year": "1977", "unstructured": "Shiku H, Takahashi T, Resnick LA, et al. (1977) Cell surface antigens of human malignant melanoma. J. Exp. Med. 145: 784\u2013789.", "journal-title": "J. Exp. Med."}, {"key": "BF03401703_CR10", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1084/jem.180.1.1", "volume": "180", "author": "AN Houghton", "year": "1994", "unstructured": "Houghton AN. (1994) Cancer antigens: Immune recognition of self and altered self. J. Exp. Med. 180: 1\u20134.", "journal-title": "J. Exp. Med."}, {"key": "BF03401703_CR11", "doi-asserted-by": "publisher", "first-page": "53", "DOI": "10.1084/jem.158.1.53", "volume": "158", "author": "AN Houghton", "year": "1983", "unstructured": "Houghton AN, Brooks H, Cote RJ, et al. (1983) Detection of cell surface and intracellular antigens by human monoclonal antibodies. J. Exp. Med. 158: 53\u201365.", "journal-title": "J. Exp. Med."}, {"key": "BF03401703_CR12", "doi-asserted-by": "publisher", "first-page": "1643", "DOI": "10.1126/science.1840703", "volume": "254", "author": "P Br\u00fcggen van der", "year": "1991", "unstructured": "van der Br\u00fcggen P, Traversari C, Chomez P, et al. (1991) A gene encoding an antigen recognized by cytologic T lymphocytes on a human melanoma. Science 254: 1643\u20131647.", "journal-title": "Science"}, {"key": "BF03401703_CR13", "doi-asserted-by": "publisher", "first-page": "1635", "DOI": "10.1093/jnci/88.22.1635", "volume": "88", "author": "SA Rosenberg", "year": "1996", "unstructured": "Rosenberg SA. (1996) Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens. J. Natl Cancer Inst. 88: 1635\u20131644.", "journal-title": "J. Natl Cancer Inst."}, {"key": "BF03401703_CR14", "doi-asserted-by": "publisher", "first-page": "1903", "DOI": "10.1016/0959-8049(93)90548-T", "volume": "29A", "author": "S Carrel", "year": "1993", "unstructured": "Carrel S, Rimoldi D. (1993) Melanoma-associated antigens. Eur. J. Cancer 29A: 1903\u20131907.", "journal-title": "Eur. J. Cancer"}, {"key": "BF03401703_CR15", "doi-asserted-by": "publisher", "first-page": "489", "DOI": "10.1084/jem.178.2.489", "volume": "178", "author": "V Brichard", "year": "1993", "unstructured": "Brichard V, Van Pel A, Wolfel T, et al. (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489\u2013495.", "journal-title": "J. Exp. Med."}, {"key": "BF03401703_CR16", "first-page": "3124", "volume": "54", "author": "PF Robbins", "year": "1994", "unstructured": "Robbins PF, El-Gamil M, Kawakami Y, Stevens E, Yanelli JR, Rosenberg SA. (1994) Recognition of tyrosinase by tumorinfiltrating lymphocytes from a patient responding to immunotherapy [published erratum in Cancer Res (1994) 54: 3952]. Cancer Res. 54: 3124\u20133126.", "journal-title": "Cancer Res."}, {"key": "BF03401703_CR17", "doi-asserted-by": "publisher", "first-page": "1281", "DOI": "10.1126/science.3633135", "volume": "231", "author": "JR Wolfgang", "year": "1986", "unstructured": "Wolfgang JR, Real FX, Spengler BA, et al. (1986) Human melanoma proteoglycan: Expression in hybrids controlled by intrinsic and extrinsic signals. Science 231: 1281\u20131284.", "journal-title": "Science"}, {"key": "BF03401703_CR18", "doi-asserted-by": "publisher", "first-page": "836", "DOI": "10.1002/ijc.2910480609", "volume": "48", "author": "S Carrel", "year": "1991", "unstructured": "Carrel S, Dore J-F, Ruiter DJ, et al. (1991) The EORTC melanoma group exchange program: Evaluation of a multicenter monoclonal antibody study. Int. J. Cancer 48: 836\u2013847.", "journal-title": "Int. J. Cancer"}, {"key": "BF03401703_CR19", "doi-asserted-by": "publisher", "first-page": "209", "DOI": "10.1097/00008390-199306000-00010", "volume": "3", "author": "RA Reisfeld", "year": "1993", "unstructured": "Reisfeld RA (1993) International Consensus Conferences on Human Melanoma Antigens. Meeting Report. Melanoma Res. 3: 209\u2013217.", "journal-title": "Melanoma Res."}, {"key": "BF03401703_CR20", "doi-asserted-by": "publisher", "first-page": "1219", "DOI": "10.1084/jem.160.4.1219", "volume": "160", "author": "FX Real", "year": "1984", "unstructured": "Real FX, Mattes MJ, Houghton AN, Oettgen HF, Lloyd KO, Old LJ. (1984) Class I (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody. J. Exp. Med. 160: 1219.", "journal-title": "J. Exp. Med."}, {"key": "BF03401703_CR21", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1007/BF00046839", "volume": "10", "author": "DA Cheresh", "year": "1991", "unstructured": "Cheresh DA. (1991) Structure, function, and biological properties of integrin \u03b1v\u03b23 on human melanoma cells. Cancer Metastasis Rev. 10: 3\u201310.", "journal-title": "Cancer Metastasis Rev."}, {"key": "BF03401703_CR22", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1097/00008390-199304000-00006", "volume": "3", "author": "M Luca", "year": "1993", "unstructured": "Luca M, Hunt B, Bucana CD, Johnson JP, Fidler IF, Bar-Eli M. (1993) Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res. 3: 35\u201341.", "journal-title": "Melanoma Res."}, {"key": "BF03401703_CR23", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.1097/00002371-199106000-00001", "volume": "10", "author": "SS Horn", "year": "1991", "unstructured": "Horn SS, Topalian SL, Simonis T, et al. (1991) Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: Analysis by human lymphocyte antigen restriction. J. Immunother. 10: 153\u2013164.", "journal-title": "J. Immunother."}, {"key": "BF03401703_CR24", "doi-asserted-by": "publisher", "first-page": "921", "DOI": "10.1084/jem.179.3.921", "volume": "179", "author": "B Gaugier", "year": "1994", "unstructured": "Gaugier B, Van den Eynde B, van der Bruggen P, et al. (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179: 921\u2013930.", "journal-title": "J. Exp. Med."}, {"key": "BF03401703_CR25", "first-page": "1619", "volume": "2", "author": "J Li", "year": "1996", "unstructured": "Li J, Yang Y, Fujie T, et al. (1996) Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma. Clin. Cancer Res. 2: 1619\u20131625.", "journal-title": "Clin. Cancer Res."}, {"key": "BF03401703_CR26", "doi-asserted-by": "publisher", "first-page": "1005", "DOI": "10.1084/jem.179.3.1005", "volume": "179", "author": "ABH Bakker", "year": "1994", "unstructured": "Bakker ABH, Schreurs MWJ, de Boer AJ, et al. (1994) Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179: 1005\u20131009.", "journal-title": "J. Exp. Med."}, {"key": "BF03401703_CR27", "doi-asserted-by": "publisher", "first-page": "3515", "DOI": "10.1073/pnas.91.9.3515", "volume": "91", "author": "Y Kawakami", "year": "1994", "unstructured": "Kawakami Y, Eliyahu S, Delgado CH, et al. (1994) Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91: 3515\u20133519.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "BF03401703_CR28", "first-page": "1", "volume": "10", "author": "Y Kawakami", "year": "1996", "unstructured": "Kawakami Y, Robbins PF, Wang RF, et al. (1996) Identification of melanoma antigens recognized by T lymphocytes and their use in the immunotherapy of cancer. Princ. Practices of Oncol. 10: 1\u201320.", "journal-title": "Princ. Practices of Oncol."}, {"key": "BF03401703_CR29", "doi-asserted-by": "publisher", "first-page": "716", "DOI": "10.1126/science.7513441", "volume": "264", "author": "AL Cox", "year": "1994", "unstructured": "Cox AL, Skipper J, Chen Y, et al. (1994) Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264: 716\u2013720.", "journal-title": "Science"}, {"key": "BF03401703_CR30", "first-page": "90", "volume": "1", "author": "SA Rosenberg", "year": "1995", "unstructured": "Rosenberg, SA. (1995) The development of new cancer therapies based on the molecular identification of cancer regression antigens. Cancer J. Sci. Am. 1: 90\u2013100.", "journal-title": "Cancer J. Sci. Am."}, {"key": "BF03401703_CR31", "first-page": "1019", "volume": "48", "author": "SG Duinen van", "year": "1988", "unstructured": "van Duinen SG, Ruiter DJ, Broecker EB, et al. (1988) Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma. Cancer Res. 48: 1019\u20131025.", "journal-title": "Cancer Res."}, {"key": "BF03401703_CR32", "doi-asserted-by": "publisher", "first-page": "755", "DOI": "10.1093/jnci/82.9.755", "volume": "82", "author": "JS Weber", "year": "1990", "unstructured": "Weber JS, Rosenberg SA. (1990) Effects of murine tumor class I major histocompatibility complex expression on antitumor activity of tumor-infiltrating lymphocytes. J. Natl. Cancer Inst. 82: 755\u2013761.", "journal-title": "J. Natl. Cancer Inst."}, {"key": "BF03401703_CR33", "first-page": "5818", "volume": "48", "author": "JS Weber", "year": "1988", "unstructured": "Weber JS, Rosenberg SA. (1988) Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro. Cancer Res. 48: 5818\u20135824.", "journal-title": "Cancer Res."}, {"key": "BF03401703_CR34", "doi-asserted-by": "crossref", "first-page": "3261", "DOI": "10.1182/blood.V84.10.3261.3261", "volume": "84", "author": "EC Guinan", "year": "1994", "unstructured": "Guinan EC, Gribben JG, Boussiotis VA, et al. (1994) Pivotal role of the B7: CD 28 pathway in transplantation tolerance and tumor immunity. Blood 84: 3261\u20133282.", "journal-title": "Blood"}, {"key": "BF03401703_CR35", "doi-asserted-by": "publisher", "first-page": "198", "DOI": "10.1016/0167-5699(92)90153-X", "volume": "13", "author": "M Howard", "year": "1992", "unstructured": "Howard M, O\u2019Garra A. (1992) Biological properties of interleukin 10. Immunol. Today 13: 198\u2013200.", "journal-title": "Immunol. Today"}, {"key": "BF03401703_CR36", "doi-asserted-by": "publisher", "first-page": "291", "DOI": "10.1007/BF01541395", "volume": "16", "author": "AC Fuchs", "year": "1996", "unstructured": "Fuchs AC, Granowitz EV, Shapiro L, et al. (1996) Clinical, hematologic, and immunologic effects of interleukin-10 in humans. J. Clin. Immunol. 16: 291\u2013304.", "journal-title": "J. Clin. Immunol."}, {"key": "BF03401703_CR37", "first-page": "1383", "volume": "2", "author": "T Sato", "year": "1996", "unstructured": "Sato T, McKue P, Kazuhiro M, et al. (1996) Interleukin 10 production by human melanoma. Clin. Cancer Res. 2: 1383\u20131390.", "journal-title": "Clin. Cancer Res."}, {"key": "BF03401703_CR38", "doi-asserted-by": "publisher", "first-page": "597", "DOI": "10.1146/annurev.cb.06.110190.003121", "volume": "6", "author": "J Massague", "year": "1990", "unstructured": "Massague J. (1990) The transforming growth factor-\u03b2 family. Annu. Rev. Cell Biol. 6: 597\u2013641.", "journal-title": "Annu. Rev. Cell Biol."}, {"key": "BF03401703_CR39", "first-page": "42", "volume": "4", "author": "JA Park", "year": "1997", "unstructured": "Park JA, Kurt RA, Wang E, Schluter SF, Hersh EM, Akporiaye ET. (1997) Expression of an antisense TGF-\u03b2l transgene reduces tumorigenicity of EMT 6 mammary tumor cells. Cancer Gene Ther. 4: 42\u201350.", "journal-title": "Cancer Gene Ther."}, {"key": "BF03401703_CR40", "doi-asserted-by": "publisher", "first-page": "144", "DOI": "10.1038/nm0297-144", "volume": "3", "author": "EH Sage", "year": "1997", "unstructured": "Sage EH. (1997) Terms of attachment: SPARC and tumorigenesis. Nature Med. 3: 144\u2013146.", "journal-title": "Nature Med."}, {"key": "BF03401703_CR41", "doi-asserted-by": "publisher", "first-page": "171", "DOI": "10.1038/nm0297-171", "volume": "3", "author": "MF Ledda", "year": "1997", "unstructured": "Ledda MF, Adris S, Bravo AI, et al. (1997) Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nature Med. 3: 171\u2013176.", "journal-title": "Nature Med."}, {"key": "BF03401703_CR42", "doi-asserted-by": "publisher", "first-page": "1449", "DOI": "10.1126/science.7533326", "volume": "267", "author": "S Nagata", "year": "1995", "unstructured": "Nagata S, Goldstein P. (1995) The Fas death factor. Science 267: 1449\u20131456.", "journal-title": "Science"}, {"key": "BF03401703_CR43", "doi-asserted-by": "publisher", "first-page": "404", "DOI": "10.1016/0952-7915(93)90060-6", "volume": "5", "author": "S Apasov", "year": "1993", "unstructured": "Apasov S, Redegeld F, Sitkovsky M. (1993) Cell-mediated cytotoxicity: Contact and secreted factors. Curr. Opin. Immunol. 5: 404\u2013410.", "journal-title": "Curr. Opin. Immunol."}, {"key": "BF03401703_CR44", "first-page": "2133", "volume": "142", "author": "ASF Chong", "year": "1989", "unstructured": "Chong ASF, Scuderi P, Grimes WJ, and Hersh EM. (1989) Tumor targets stimulate IL-2 activated killer cells to produce interferon-\u03b3 and tumor necrosis factor. J. Immunol. 142: 2133\u20132139.", "journal-title": "J. Immunol."}, {"key": "BF03401703_CR45", "doi-asserted-by": "publisher", "first-page": "1361", "DOI": "10.1038/nm1296-1361", "volume": "2", "author": "S Strand", "year": "1996", "unstructured": "Strand S, Hofmann WJ, Hug H, et al. (1996) Lymphocyte apoptosis induced by CD9 5 (APO-1/Fas) ligand-expressingtumor cells\u2014 A mechanism of immune evasion? Nature Med. 2: 1361\u20131366.", "journal-title": "Nature Med."}, {"key": "BF03401703_CR46", "doi-asserted-by": "publisher", "first-page": "165", "DOI": "10.1038/nm0297-165", "volume": "3", "author": "K-I Seino", "year": "1997", "unstructured": "Seino K-I, Kayagaki N, Okumura K, et al. (1997) Antitumor effect of locally produced CD95 ligand. Nature Med. 3: 165\u2013170.", "journal-title": "Nature Med."}, {"key": "BF03401703_CR47", "doi-asserted-by": "publisher", "first-page": "1363", "DOI": "10.1126/science.274.5291.1363", "volume": "274", "author": "M Hahne", "year": "1996", "unstructured": "Hahne M, Rimoldi D, Schroter M, et al. (1996) Melanoma cell expression of Fas (Apo-l/CD95) ligand: Implications for tumor immune escape. Science 274: 1363\u20131366.", "journal-title": "Science"}, {"key": "BF03401703_CR48", "doi-asserted-by": "publisher", "first-page": "1223", "DOI": "10.1084/jem.182.5.1223", "volume": "182", "author": "PR Galle", "year": "1995", "unstructured": "Galle PR, Hoffman WJ, Walczak H (1995) Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182: 1223\u20131230.", "journal-title": "J. Exp. Med."}, {"key": "BF03401703_CR49", "doi-asserted-by": "publisher", "first-page": "1856", "DOI": "10.1126/science.273.5283.1856", "volume": "273", "author": "M Dean", "year": "1996", "unstructured": "Dean M, et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CCR5 structural gene. Science 273: 1856\u20131862.", "journal-title": "Science"}, {"key": "BF03401703_CR50", "doi-asserted-by": "publisher", "first-page": "1306", "DOI": "10.1038/nm1296-1306", "volume": "2", "author": "S Nagata", "year": "1996", "unstructured": "Nagata S. (1996) Fas ligand and immune evasion. Nature Med. 2: 1306\u20131307.", "journal-title": "Nature Med."}, {"key": "BF03401703_CR51", "doi-asserted-by": "publisher", "first-page": "1189", "DOI": "10.1126/science.270.5239.1189", "volume": "270", "author": "T Griffith", "year": "1995", "unstructured": "Griffith T, Brunner T, Fletcher S, Green D, Ferguson T. (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189\u20131192.", "journal-title": "Science"}, {"key": "BF03401703_CR52", "doi-asserted-by": "publisher", "first-page": "1367", "DOI": "10.1038/nm1296-1367", "volume": "2", "author": "CD Gimmi", "year": "1996", "unstructured": "Gimmi CD, Morrison BW, Mainprice BA, et al. (1996) Breast cancer-associated antigen. DF3/MUC1, induces apoptosis of activated human T cells. Nature Med. 2: 1367\u20131370.", "journal-title": "Nature Med."}, {"key": "BF03401703_CR53", "doi-asserted-by": "publisher", "first-page": "1363", "DOI": "10.1126/science.274.5291.1363", "volume": "274", "author": "M Hahne", "year": "1996", "unstructured": "Hahne M, Rimddi D, Schroter M (1996) Melanoma cell expression of Fas(Apo-l/CD95) ligand: Implications for tumor immune escape. Science 274: 1363\u20131366.", "journal-title": "Science"}, {"key": "BF03401703_CR54", "first-page": "1825", "volume": "2", "author": "K Kono", "year": "1996", "unstructured": "Kono K, Ressing M, Brandt RMP, et al. (1996) Decreased expression of signaltransducing \u03b6 chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin. Cancer Res. 2: 1825\u20131828.", "journal-title": "Clin. Cancer Res."}, {"key": "BF03401703_CR55", "first-page": "1327", "volume": "1", "author": "AH Zea", "year": "1995", "unstructured": "Zea AH, Curti BD, Longo CD, Alvord WG, Srobl SL, Mizoguchi H, Creekmore SP, O\u2019Shea JJ, Powers GC, Urba WJ, Ochoa AC. (1995) Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin. Cancer Res. 1: 1327\u20131335.", "journal-title": "Clin. Cancer Res."}, {"key": "BF03401703_CR56", "first-page": "483", "volume": "3", "author": "DI Gabrilovich", "year": "1997", "unstructured": "Gabrilovich DI, Corak J, Ciernik IF, et al. (1997) Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin. Cancer Res. 3: 483\u2013490.", "journal-title": "Clin. Cancer Res."}, {"key": "BF03401703_CR57", "first-page": "589", "volume": "15", "author": "MJ Mastrangelo", "year": "1988", "unstructured": "Mastrangelo MJ, Schultz S, Kane M, et al. (1988) Newer immunologie approaches to the treatment of patients with melanoma. Semin. Oncol. 15: 589\u2013594.", "journal-title": "Semin. Oncol."}, {"key": "BF03401703_CR58", "doi-asserted-by": "publisher", "first-page": "1858", "DOI": "10.1200/JCO.1990.8.11.1858", "volume": "8", "author": "D Berd", "year": "1990", "unstructured": "Berd D, Maguire H, Jr, McCue P, et al. (1990) Treatment of metastatic melanoma with an autologous tumor-cell vaccine: Clinical and immunologic results in 64 patients. J. Clin. Oncol. 8: 1858\u20131867.", "journal-title": "J. Clin. Oncol."}, {"key": "BF03401703_CR59", "first-page": "2731", "volume": "51", "author": "D Berd", "year": "1991", "unstructured": "Berd D, Murphy G, Maguire H, Jr, Mastrangelo MJ. (1991) Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases. Cancer Res. 51: 2731.", "journal-title": "Cancer Res."}, {"key": "BF03401703_CR60", "doi-asserted-by": "publisher", "first-page": "856", "DOI": "10.1200/JCO.1990.8.5.856", "volume": "8", "author": "MS Mitchell", "year": "1990", "unstructured": "Mitchell MS, Harel W, Kempf R, et al. (1990) Active-specific immunotherapy for melanoma. J. Clin. Oncol. 8: 856\u2013869.", "journal-title": "J. Clin. Oncol."}, {"key": "BF03401703_CR61", "doi-asserted-by": "publisher", "first-page": "463", "DOI": "10.1097/00000658-199210000-00010", "volume": "216", "author": "DL Morton", "year": "1992", "unstructured": "Morton DL, Foshag U, Hoon DSB, et al. (1992) Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann. Surg. 216: 463\u2013482.", "journal-title": "Ann. Surg."}, {"key": "BF03401703_CR62", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1007/BF02071529", "volume": "16", "author": "P Hersey", "year": "1992", "unstructured": "Hersey P. (1992) Active immunotherapy with viral lysates of micrometastases following surgical removal of high risk melanoma. World J. Surg. 16: 251\u2013260.", "journal-title": "World J. Surg."}, {"key": "BF03401703_CR63", "doi-asserted-by": "publisher", "first-page": "2911", "DOI": "10.1073/pnas.84.9.2911", "volume": "84", "author": "PO Livingston", "year": "1987", "unstructured": "Livingston PO, Natoli EJ, Calves MJ, et al. (1987) Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients. Proc. Natl. Acad. Sci. USA 84: 2911\u20132915.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "BF03401703_CR64", "first-page": "37", "volume": "3", "author": "JM Cormier", "year": "1997", "unstructured": "Cormier JM, Sallgaller ML, Prevette T, et al. (1997) Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-l/melan A. Cancer J. 3: 37\u201344.", "journal-title": "Cancer J."}, {"key": "BF03401703_CR65", "doi-asserted-by": "publisher", "first-page": "96", "DOI": "10.1097/00001622-199401000-00014", "volume": "6", "author": "T Fujiwara", "year": "1994", "unstructured": "Fujiwara T, Grimm EA, Roth JA. (1994) Gene therapeutics and gene therapy for cancer. Curr. Opin. Oncol. 6: 96\u2013105.", "journal-title": "Curr. Opin. Oncol."}, {"key": "BF03401703_CR66", "first-page": "113", "volume": "13", "author": "A Porgador", "year": "1994", "unstructured": "Porgador A, Feldman M, Eisenbach L. (1994) Immunotherapy of tumor metastasis via gene therapy. Natl. Immunol 13: 113\u2013130.", "journal-title": "Natl. Immunol"}, {"key": "BF03401703_CR67", "first-page": "131", "volume": "13", "author": "RH Goldfarb", "year": "1994", "unstructured": "Goldfarb RH, Whiteside TL, Basse PH, et al. (1994) Natural killer cells and gene therapy: Potential of gene transfection for optimizing effector cell functions and for targeting gene products into tumor metastases. Nat. Immun. 13: 131\u2013140.", "journal-title": "Nat. Immun."}, {"key": "BF03401703_CR68", "doi-asserted-by": "publisher", "first-page": "323", "DOI": "10.1016/0163-7258(94)90029-9", "volume": "63", "author": "W Uckert", "year": "1994", "unstructured": "Uckert W, Walther W. (1994) Retrovirusmediated gene transfer in cancer therapy. Pharmacol Ther. 63: 323\u2013347.", "journal-title": "Pharmacol Ther."}, {"key": "BF03401703_CR69", "doi-asserted-by": "publisher", "first-page": "436", "DOI": "10.1007/BF02303818", "volume": "1", "author": "AR Miller", "year": "1994", "unstructured": "Miller AR, McBride WH, Hunt K, et al. (1994) Cytokine mediated gene therapy for cancer. Ann. Surg. Oncol 1: 436\u2013450.", "journal-title": "Ann. Surg. Oncol"}, {"key": "BF03401703_CR70", "first-page": "223", "volume": "8", "author": "S Ettinghausen", "year": "1995", "unstructured": "Ettinghausen S, Rosenberg SA. (1995) Immunotherapy and gene therapy of cancer. Adv. Surg. 8: 223\u2013254.", "journal-title": "Adv. Surg."}, {"key": "BF03401703_CR71", "doi-asserted-by": "publisher", "first-page": "3539", "DOI": "10.1073/pnas.90.8.3539", "volume": "90", "author": "G Dranoff", "year": "1993", "unstructured": "Dranoff G, Jaffee E, Lazenby A, et al. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl Acad. Sci. USA 90: 3539\u20133543.", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BF03401703_CR72", "first-page": "39", "volume": "3", "author": "MJ Area", "year": "1996", "unstructured": "Area MJ, Krauss JC, Aruga A, et al. (1996) Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor. Cancer Gene Ther. 3: 39\u201347.", "journal-title": "Cancer Gene Ther."}, {"key": "BF03401703_CR73", "first-page": "139", "volume": "4", "author": "DW Ju", "year": "1997", "unstructured": "Ju DW, Cao X, Acres B. (1997) Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a murine melanoma model. (1997) Cancer Gene Ther. 4: 139\u2013144.", "journal-title": "Cancer Gene Ther."}, {"key": "BF03401703_CR74", "doi-asserted-by": "publisher", "first-page": "1853", "DOI": "10.1089/hum.1996.7.15-1853", "volume": "7", "author": "H Qin", "year": "1996", "unstructured": "Qin H, Chatterjee SK. (1996) Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF. Hum. Gene Ther. 7: 1853\u20131860.", "journal-title": "Hum. Gene Ther."}, {"key": "BF03401703_CR75", "doi-asserted-by": "publisher", "first-page": "716", "DOI": "10.1007/BF01209118", "volume": "122", "author": "DW Ju", "year": "1996", "unstructured": "Ju DW, Cao X, Acres B. (1996) Active specific immunotherapy of pulmonary metastasis with vaccinia melanoma oncolysate prepared from granulocyte/macrophage\u2014colony \u2014stimulating\u2014factor\u2014gene\u2014encoded vaccinia virus. J. Cancer Res. Clin. Oncol 122: 716\u2013722.", "journal-title": "J. Cancer Res. Clin. Oncol"}, {"key": "BF03401703_CR76", "doi-asserted-by": "publisher", "first-page": "397", "DOI": "10.1016/0092-8674(90)90591-2", "volume": "60", "author": "ER Fearon", "year": "1990", "unstructured": "Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B, Frost P. (1990) Interleukin-2 production by tumour cells bypasses T helper function in the generation of an antitumor response. Cell 60: 397\u2013403.", "journal-title": "Cell"}, {"key": "BF03401703_CR77", "doi-asserted-by": "publisher", "first-page": "368", "DOI": "10.1126/science.7678351", "volume": "259", "author": "SE Townsend", "year": "1993", "unstructured": "Townsend SE, Allison JP. (1993) Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259: 368\u2013370.", "journal-title": "Science"}, {"key": "BF03401703_CR78", "doi-asserted-by": "publisher", "first-page": "523", "DOI": "10.1084/jem.179.2.523", "volume": "179", "author": "L Chen", "year": "1994", "unstructured": "Chen L, McGowan P, Ashe S, et al. (1994) Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 179: 523\u2013532.", "journal-title": "J. Exp. Med."}, {"key": "BF03401703_CR79", "first-page": "175", "volume": "3", "author": "SE Parker", "year": "1996", "unstructured": "Parker SE, Khatibi S, Margalith M, et al. (1996) Plasmid DNA gene therapy: Studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo. Cancer Gene Ther. 3: 175\u2013185.", "journal-title": "Cancer Gene Ther."}, {"key": "BF03401703_CR80", "first-page": "1535", "volume": "7", "author": "DM Mahvi", "year": "1996", "unstructured": "Mahvi DM, Burkholder JK, Turner J, et al. (1996) Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: Implications for a clinically relevant tumor vaccine. 7: 1535\u20131543.", "journal-title": "Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: Implications for a clinically relevant tumor vaccine"}, {"key": "BF03401703_CR81", "first-page": "542", "volume": "3", "author": "JP Yang", "year": "1996", "unstructured": "Yang JP, Huang L. (1996) Direct gene transfer to mouse melanoma by intratumor injection of free DNA. Gene Ther. 3: 542\u2013548.", "journal-title": "Gene Ther."}, {"key": "BF03401703_CR82", "doi-asserted-by": "publisher", "first-page": "283", "DOI": "10.1002/ijc.2910510218", "volume": "51", "author": "TS Kim", "year": "1992", "unstructured": "Kim TS, Russell SJ, Collins MKL, et al. (1992) Immunity to B16 melanoma in mice immunized with IL-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens. Int. J. Cancer 51: 283\u2013289.", "journal-title": "Int. J. Cancer"}, {"key": "BF03401703_CR83", "first-page": "632", "volume": "38", "author": "EV Zoeten", "year": "1997", "unstructured": "Zoeten EV, Sun T, Cohen EP. (1997) Abstract 4243: Transfection of genomic DNA from murine melanoma cells into interleukin-2 secreting semi-allogeneic mouse fibroblasts results in a cellular immunogen that can prolong the lives of mice with melanoma. Proc. Am. Assoc. Cancer Res. 38: 632.", "journal-title": "Proc. Am. Assoc. Cancer Res."}, {"key": "BF03401703_CR84", "first-page": "1104", "volume": "3", "author": "F Quinton-Colonna", "year": "1996", "unstructured": "Quinton-Colonna F, Devauchelle P, Fradelizi D, et al. (1996) Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2. Gene Ther. 3: 1104\u20131112.", "journal-title": "Gene Ther."}, {"key": "BF03401703_CR85", "doi-asserted-by": "publisher", "first-page": "6", "DOI": "10.1038/bjc.1996.308", "volume": "74", "author": "SJ Hollingsworth", "year": "1996", "unstructured": "Hollingsworth SJ, Darling D, Gaken J, et al. (1996) Abstract 1: The effect of combined expression of interleukin-2 and interleukin-4 on the tumorgenicity and treatment of B16F10 melanoma. Br. J. Cancer 74: 6\u201315.", "journal-title": "Br. J. Cancer"}, {"key": "BF03401703_CR86", "first-page": "316", "volume": "2", "author": "K Kato", "year": "1995", "unstructured": "Kato K, Yamada K, Wakimoto H. (1995) Abstract P-30. Combination gene therapy with B7 and IL-12 for lung metastasis of mouse lung carcinoma. Cancer Gene Ther. 2: 316.", "journal-title": "Cancer Gene Ther."}, {"key": "BF03401703_CR87", "first-page": "33", "volume": "4", "author": "Z Abdel-Wahab", "year": "1997", "unstructured": "Abdel-Wahab Z, Dar M, Osanto S, et al. (1997) Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon. Cancer Gene Ther. 4: 33\u201341.", "journal-title": "Cancer Gene Ther."}, {"key": "BF03401703_CR88", "first-page": "421", "volume": "3", "author": "X Cao", "year": "1996", "unstructured": "Cao X, Chen G, Zhang W, et al. (1996) Enhanced efficacy of combination of IL-2 gene and IL-6 gene-transfected tumor cells in the treatment of established metastatic tumors. Gene Ther. 3: 421\u2013426.", "journal-title": "Gene Ther."}, {"key": "BF03401703_CR89", "doi-asserted-by": "publisher", "first-page": "91", "DOI": "10.1007/BF01742535", "volume": "33", "author": "J Nowak", "year": "1991", "unstructured": "Nowak J, Cohen EP, Graf LH, Jr. (1991) Cytotoxic activity toward mouse melanoma following immunization of mice with transfected cells expressing a human melanoma-associated antigen. Cancer Immunol. Immunother. 33: 91\u201396.", "journal-title": "Cancer Immunol. Immunother."}, {"key": "BF03401703_CR90", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1093/jnci/86.4.299", "volume": "86", "author": "R Khokha", "year": "1994", "unstructured": "Khokha R. (1994) Suppression of the tumorigenic and metastatic abilities of murine B16\u2013F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J. Natl. Cancer Inst. 86: 299\u2013304.", "journal-title": "J. Natl. Cancer Inst."}, {"key": "BF03401703_CR91", "first-page": "175", "volume": "38", "author": "T Oku", "year": "1997", "unstructured": "Oku T, Tjuvajev J, Miyagawa T, et al. (1997) Abstract 1170: Modulation of intracerebral human melanoma xenografts growth by sense and anti-sense VEGF gene therapy: Effects on angiogenesis, vascular permeability, and tumor proliferation. Proc. Am. Assoc. Cancer Res. 38: 175.", "journal-title": "Proc. Am. Assoc. Cancer Res."}, {"key": "BF03401703_CR92", "first-page": "175", "volume": "38", "author": "T Ohkawa", "year": "1997", "unstructured": "Ohkawa T, Suzuki T, Irie A, et al. (1997) Adenoviral-mediated delivery of an anti-Hras hammerhead ribozyme in athymic mice bearing human malignant melanoma. Proc. Am. Assoc. Cancer Res. 38: 175.", "journal-title": "Proc. Am. Assoc. Cancer Res."}, {"key": "BF03401703_CR93", "doi-asserted-by": "publisher", "first-page": "479", "DOI": "10.1089/hum.1996.7.4-479", "volume": "7", "author": "EM Elder", "year": "1996", "unstructured": "Elder EM, Lotze MT, Whiteside TL. (1996) Abstract 16: Successful culture and selection of cytokine gene-modified human dermal fibroblasts for the biologic therapy of patients with cancer. Hum. Gene Ther. 7: 479\u2013487.", "journal-title": "Hum. Gene Ther."}, {"key": "BF03401703_CR94", "first-page": "12", "volume": "38", "author": "S Dessureault", "year": "1997", "unstructured": "Dessureault S, Graham F, Gallinger S. (1997) Abstract 75: Efficient adenoviralmediated B7-1 gene transfer in freshly resected human tumors. Proc. Am. Assoc. Cancer Res. 38: 12.", "journal-title": "Proc. Am. Assoc. Cancer Res."}, {"key": "BF03401703_CR95", "unstructured": "Hersh EM, Stopeck AT, Brailey J, et al. (1997) Transduction of fresh and cultured human tumor cells with adenovirus expressing \u03b2-galactosidase. In press."}, {"key": "BF03401703_CR96", "first-page": "17", "volume": "4", "author": "JF Arthur", "year": "1997", "unstructured": "Arthur JF, Butterfield LH, Roth MD, et al. (1997) Abstract 14: A comparison of gene transfer methods in human dendritic cells. Gene Ther. 4: 17\u201325.", "journal-title": "Gene Ther."}, {"key": "BF03401703_CR97", "doi-asserted-by": "publisher", "first-page": "284", "DOI": "10.1111/j.1749-6632.1996.tb52678.x", "volume": "795", "author": "L Zitvogel", "year": "1996", "unstructured": "Zitvogel L, Couderc B, Mayordomo JI, et al. (1996) IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo. Ann. N Y Acad. Sciences 795: 284\u2013293.", "journal-title": "Ann. N Y Acad. Sciences"}, {"key": "BF03401703_CR98", "first-page": "S18", "volume": "3", "author": "EM Hersh", "year": "1996", "unstructured": "Hersh EM, Stopeck AT, Warnecke J, et al. (1996) Abstract P-28: In vitro studies of tumor cell transfection with plasmid DNA in a cationic lipid vector. Cancer Gene Ther. 3: S18.", "journal-title": "Cancer Gene Ther."}, {"key": "BF03401703_CR99", "first-page": "S23", "volume": "3", "author": "PR Clark", "year": "1996", "unstructured": "Clark PR, Stopeck AT, Wang Q, et al. (1996) Abstract P-48: Enhanced adenoviral transduction and transgene expression in vitro using polycations and cationic lipids. Cancer Gene Ther. 3: S23.", "journal-title": "Cancer Gene Ther."}, {"key": "BF03401703_CR100", "first-page": "192", "volume": "3", "author": "MR Albertini", "year": "1996", "unstructured": "Albertini MR, Emier CA, Schell K, et al. (1996) Dual expression of human leukocyte antigen molecules and the B7-1 costimulatory molecule (CD80) on human melanoma cells after particile-mediated gene transfer. Cancer Gene Ther. 3: 192\u2013201.", "journal-title": "Cancer Gene Ther."}, {"key": "BF03401703_CR101", "first-page": "241", "volume": "38", "author": "MR Parkhurst", "year": "1997", "unstructured": "Parkhurst MR, Kang X, Rosenberg SA, et al. (1997) Abstract 1618: Induction of tumor reactive CTL using cos or B cells transfected with genes encoding the melanoma antigens MART-1 or gp100. Proc. Am. Assoc. Cancer Res. 38: 241.", "journal-title": "Proc. Am. Assoc. Cancer Res."}, {"key": "BF03401703_CR102", "first-page": "949", "volume": "53", "author": "A Uchiyama", "year": "1993", "unstructured": "Uchiyama A, Hoon DS, Morisaki T, et al. (1993) Abstract 5: Transfection of interleukin-2 gene into human melanoma cells augments cellular immune response. Cancer Res. 53: 949\u2013952.", "journal-title": "Cancer Res."}, {"key": "BF03401703_CR103", "doi-asserted-by": "publisher", "first-page": "1139", "DOI": "10.1089/hum.1994.5.9-1139", "volume": "5", "author": "F Arienti", "year": "1994", "unstructured": "Arienti F, Sule-Suso J, Melani C, et al. (1994) Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes. Hum. Gene Ther. 5: 1139\u20131150.", "journal-title": "Hum. Gene Ther."}, {"key": "BF03401703_CR104", "unstructured": "Finke S, Trojaneck B, Moller P, et al. (1997) Increase of cytotoxic sensitivity of primary human melanoma cells transfected with the interleukin-7 gene. Cancer Gene Ther. 4: in press."}, {"key": "BF03401703_CR105", "doi-asserted-by": "publisher", "first-page": "342", "DOI": "10.1007/BF01741329", "volume": "32", "author": "S Morecki", "year": "1991", "unstructured": "Morecki S, Karson E, Cornetta K, et al. (1991) Retrovirus-mediated gene transfer into CD4+ and CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells. Cancer Immunol. Immunother. 32: 342\u2013352.", "journal-title": "Cancer Immunol. Immunother."}, {"key": "BF03401703_CR106", "first-page": "437a", "volume": "16", "author": "RE Royal", "year": "1997", "unstructured": "Royal RE, Reeves ME, Rosenberg SA, et al. (1997) Abstract 1567: Dendritic cells transduced with the gene encoding GP100 generate specific anti-melanoma T cells. Proc. ASCO 16: 437a.", "journal-title": "Proc. ASCO"}, {"key": "BF03401703_CR107", "unstructured": "Anonymous. (1996) Clinical protocols worldwide. Cancer Gene Ther. 3: 265\u2013278."}, {"key": "BF03401703_CR108", "unstructured": "Anonymous. (1995) Section III: Gene therapy clinical trials worldwide. https://doi.org/www.appleton-lange.com/genetherapy/trials . In: Sobol RE, Scanion KJ (eds). The Internet Book of Gene Therapy/Cancer Therapeutics. Apple ton and Lange, Stamford, CT, pp. 283\u2013296."}, {"key": "BF03401703_CR109", "doi-asserted-by": "publisher", "first-page": "775", "DOI": "10.1089/hum.1997.8.6-775", "volume": "8", "author": "T Marcel", "year": "1997", "unstructured": "Marcel T, Grausz JD. (1997) The TMC Worldwide Gene Therapy Enrollment Report, End 1996. Hum. Gene Ther. 8: 775\u2013800.", "journal-title": "Hum. Gene Ther."}, {"key": "BF03401703_CR110", "doi-asserted-by": "publisher", "first-page": "570", "DOI": "10.1056/NEJM199008303230904", "volume": "323", "author": "SA Rosenberg", "year": "1990", "unstructured": "Rosenberg SA, Aebersold Paul, Cornetta K, et al. (1990) Gene transfer into humans\u2014 Immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. New Engl. J. Med. 323: 570\u2013578.", "journal-title": "New Engl. J. Med."}, {"key": "BF03401703_CR111", "unstructured": "Rosenberg SA. (1993) Meeting Abstract 30: Gene therapy of cancer. Specific Immunotherapy of Cancer with Vaccines. January 21\u201324, 1993, Washington, DC."}, {"key": "BF03401703_CR112", "author": "Q Cai", "first-page": "163", "year": "1995", "unstructured": "Cai Q, Rubin JT, Lotze MT. (1995) Genetically marking human cells\u2014Results of the first clinical gene transfer studies. In: Sobol RE, Scanlon KJ (eds). The Internet Book of Gene Therapy/Cancer Therapeutics. Appleton and Lange, Stamford, CT, pp. 163\u2013174.", "volume-title": "The Internet Book of Gene Therapy/Cancer Therapeutics"}, {"key": "BF03401703_CR113", "doi-asserted-by": "publisher", "first-page": "410", "DOI": "10.1200/JCO.1995.13.2.410", "volume": "13", "author": "Y Merrouche", "year": "1995", "unstructured": "Merrouche Y, Negrier S, Bain C, et al. (1995) Abstract 7: Clinical application of retroviral gene transfer in oncology: Results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin. J. Clin. Oncol. 13: 410\u2013418.", "journal-title": "J. Clin. Oncol."}, {"key": "BF03401703_CR114", "doi-asserted-by": "publisher", "first-page": "184", "DOI": "10.1007/s002770050159", "volume": "72", "author": "T Licht", "year": "1996", "unstructured": "Licht T, Pastan I, Gottesman MM, et al. (1996) Abstract 5: The multidrug-resistance gene in gene therapy of cancer and hematopoietic disorders. Ann. Hematol. 72: 184\u2013193.", "journal-title": "Ann. Hematol."}, {"key": "BF03401703_CR115", "first-page": "46", "volume": "23", "author": "ON Koc", "year": "1996", "unstructured": "Koc ON, Allay JA, Lee K, et al. (1996) Abstract 82: Transfer of drug resistance genes into hematopoietic progenitors to improve chemotherapy tolerance. Semin. Oncol. 23: 46\u201365.", "journal-title": "Semin. Oncol."}, {"key": "BF03401703_CR116", "first-page": "489a", "volume": "16", "author": "EM Rankin", "year": "1997", "unstructured": "Rankin EM, Kremers B, Gallee M, et al. (1997) Abstract 1760: Immunomodulation following vaccination with autologous, GM-CSF transduced and irradiated tumor cells in patients with advanced melanoma. Proc. ASCO. 16: 489a.", "journal-title": "Proc. ASCO."}, {"key": "BF03401703_CR117", "first-page": "489a", "volume": "16", "author": "R Soiffer", "year": "1997", "unstructured": "Soiffer R, Lynch T, Mihm M, et al. (1997) Abstract 1759: Induction of anti-tumor immunity by autologous melanoma vaccines genetically engineered to secrete granulocyte-macrophage colony-stimulating factor (G-CSF). Proc. ASCO. 16: 489a.", "journal-title": "Proc. ASCO."}, {"key": "BF03401703_CR118", "first-page": "492a", "volume": "16", "author": "J Nemunaitis", "year": "1997", "unstructured": "Nemunaitis J, Bohart C, Fong T, et al. (1997) Abstract 1774: Phase I trial of retroviral vector-mediated \u03b3-interferon (\u03b3-IFN) gene transfer into autologous tumor cells in patients with metastatic melanoma. Proc. ASCO. 16: 492a.", "journal-title": "Proc. ASCO."}, {"key": "BF03401703_CR119", "first-page": "171", "volume": "1", "author": "ZA Abdel-Wahab", "year": "1994", "unstructured": "Abdel-Wahab ZA, Osanto S, Darrow TL, et al. (1994) Abstract 45: Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity. Cancer Gene Ther. 1: 171\u2013179.", "journal-title": "Cancer Gene Ther."}, {"key": "BF03401703_CR120", "first-page": "438a", "volume": "16", "author": "H Tahara", "year": "1997", "unstructured": "Tahara H, Zitvogel L, Storkus WJ, et al. (1997) Abstract 1568: Antitumor effects in patients with melanoma, head and neck and breast cancer in a phase I/II clinical trial of interleukin-12 (IL-12) gene therapy. Proc. ASCO. 16: 438a.", "journal-title": "Proc. ASCO."}, {"key": "BF03401703_CR121", "doi-asserted-by": "publisher", "first-page": "238", "DOI": "10.1097/00002371-199505000-00006", "volume": "17", "author": "Y Suminami", "year": "1995", "unstructured": "Suminami Y, Elder EM, Lotze MT, et al. (1995) Abstract 85: In situ interleukin-4 gene expression in cancer patients treated with genetically modified tumor vaccine. J. Immunother. Emphasis Tumor Immunol. 17: 238\u2013248.", "journal-title": "J. Immunother. Emphasis Tumor Immunol."}, {"key": "BF03401703_CR122", "first-page": "441a", "volume": "16", "author": "ML Meyers", "year": "1997", "unstructured": "Meyers ML, Minasian L, Motzer RJ, et al. (1997) Abstract 1581: Immunization with HLA-A2 matched allogeneic tumor cells that secrete interleukin-2 of (IL-2) patients with metastatic melanoma or metastatic renal cell carcinoma. Proc. ASCO. 16: 441a.", "journal-title": "Proc. ASCO."}, {"issue": "Suppl 2", "key": "BF03401703_CR123", "first-page": "S17", "volume": "1", "author": "S Osanto", "year": "1994", "unstructured": "Osanto S, Weijl N, Brouwenstijn N, et al. (1994) Meeting abstract 61: Gene therapy of melanoma patients. Gene Ther. 1(Suppl 2): S17.", "journal-title": "Gene Ther."}, {"key": "BF03401703_CR124", "doi-asserted-by": "publisher", "first-page": "1955", "DOI": "10.1089/hum.1996.7.16-1955", "volume": "7", "author": "F Arienti", "year": "1996", "unstructured": "Arienti F, Sule-Suso J, Belli F, et al. (1996) Abstract 70: Limited anti-tumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells. Hum. Gene Ther. 7: 1955\u20131963.", "journal-title": "Hum. Gene Ther."}, {"key": "BF03401703_CR125", "first-page": "A2751", "volume": "36", "author": "MJ Mastrangelo", "year": "1995", "unstructured": "Mastrangelo MJ, Maguire HA, Jr, McCue PA. (1995) Abstract 107: Localized gene therapy for melanoma using vaccinia vectors: Anti-vaccinia immunity does not prevent tumor infection/transfection following repeated injections. Proc. Annu. Meet. Am. Assoc. Cancer Res. 36: A2751.", "journal-title": "Proc. Annu. Meet. Am. Assoc. Cancer Res."}, {"key": "BF03401703_CR126", "first-page": "11", "volume": "38", "author": "EC Lattime", "year": "1997", "unstructured": "Lattime EC, Maguire HC, Jr, Eisenlohr LC, et al. (1997) Abstract 71: Gene therapy using intratumoral (IT) recombinant GM-CSF encoding vaccinia virus in patients with melanoma. Proc. Am. Assoc. Cancer Res. 38: 11.", "journal-title": "Proc. Am. Assoc. Cancer Res."}, {"key": "BF03401703_CR127", "first-page": "443a", "volume": "16", "author": "J Nemunaitis", "year": "1997", "unstructured": "Nemunaitis J, Fong T, Sajjadi N, et al. (1997) Abstract 1590: Phase I trial of \u03b3-interferon (\u03b3-IFN) retroviral vector to administered intra-tumor to patients with metastatic carcinoma. Proc. ASCO. 16: 443a.", "journal-title": "Proc. ASCO."}, {"key": "BF03401703_CR128", "doi-asserted-by": "publisher", "first-page": "1791", "DOI": "10.1089/hum.1996.7.15-1791", "volume": "7", "author": "PL Feigner", "year": "1997", "unstructured": "Feigner PL. (1997) Improvements in cationic liposomes for in vivo gene transfer (editorial). Hum. Gene Ther. 7: 1791\u20131793.", "journal-title": "Hum. Gene Ther."}, {"key": "BF03401703_CR129", "doi-asserted-by": "publisher", "first-page": "11307", "DOI": "10.1073/pnas.90.23.11307", "volume": "90", "author": "GJ Nabel", "year": "1993", "unstructured": "Nabel GJ, Nabel EG, Yang ZY, et al. (1993) Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA 90: 11307\u201311311.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "BF03401703_CR130", "doi-asserted-by": "publisher", "first-page": "15388", "DOI": "10.1073/pnas.93.26.15388", "volume": "93", "author": "GJ Nabel", "year": "1996", "unstructured": "Nabel GJ, Gordon D, Bishop DK, et al. (1996) Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes. Proc. Natl. Acad. Sci. USA 93: 15388.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "BF03401703_CR131", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1007/s002620050303", "volume": "43", "author": "LA DeBruyne", "year": "1996", "unstructured": "DeBruyne LA, Chang AE, Cameron MJ, et al. (1996) Direct transfer of foreign MHC gene into human melanoma alters T cell receptor V\u03b2 usage by tumor infiltrating lymphocytes. Cancer Immunol. Immunother. 43: 49\u201358.", "journal-title": "Cancer Immunol. Immunother."}, {"key": "BF03401703_CR132", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1200/JCO.1997.15.1.341", "volume": "15", "author": "AT Stopeck", "year": "1997", "unstructured": "Stopeck AT, Hersh EM, Akporiaye ET, et al. (1997) Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma. J. Clin. Oncol. 15: 341\u2013349.", "journal-title": "J. Clin. Oncol."}, {"key": "BF03401703_CR133", "doi-asserted-by": "publisher", "first-page": "419", "DOI": "10.1038/sj.gt.3300396", "volume": "4", "author": "J Rubin", "year": "1997", "unstructured": "Rubin J, Galanis E, Pitot HC, et al. (1997) Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7. Gene Ther. 4: 419\u2013425.", "journal-title": "Gene Ther."}, {"key": "BF03401703_CR134", "first-page": "242", "volume": "14", "author": "NJ Vogelzang", "year": "1995", "unstructured": "Vogelzang NJ, Sudakoff G, McKay S, et al. (1995) A phase I study of intra-lesional (IL) gene therapy in metastatic renal cell cancer (RCC). Proc. Am. Soc. Clin. Oncol. 14: 242.", "journal-title": "Proc. Am. Soc. Clin. Oncol."}, {"key": "BF03401703_CR135", "first-page": "220", "volume": "36", "author": "ET Akporiaye", "year": "1995", "unstructured": "Akporiaye ET, Schluter S, Harris DT, et al. (1995) Abstract 1308: Expression of intratumorally injected HLA-B7 gene: Results from a phase I clinical trial. Proc. Am. Assoc. Cancer Res. 36: 220.", "journal-title": "Proc. Am. Assoc. Cancer Res."}, {"key": "BF03401703_CR136", "first-page": "220", "volume": "36", "author": "D Harris", "year": "1995", "unstructured": "Harris D, Akporiaye E, Schluter S, et al. (1995) Abstract 1312: Direct gene transfer of histocompatibility antigens for immunotherapy of melanoma, colon and renal cancers. Proc. Am. Assoc. Cancer Res. 36: 220.", "journal-title": "Proc. Am. Assoc. Cancer Res."}, {"key": "BF03401703_CR137", "first-page": "342", "volume": "37", "author": "HKB Silver", "year": "1996", "unstructured": "Silver HKB, Klasa RJ, Bally MB, et al. (1996) Phase I gene therapy study of HLA-B7 transduction by direct injection in malignant melanoma. Proc. Am. Assoc. Cancer Res. 37: 342.", "journal-title": "Proc. Am. Assoc. Cancer Res."}, {"key": "BF03401703_CR138", "first-page": "S11", "volume": "3", "author": "EM Hersh", "year": "1996", "unstructured": "Hersh EM, Nabel G, Silver H, et al. (1996) Abstract 0-1: Intratumoral injection of plasmid DNA in cationic lipid vectors for cancer gene therapy. Cancer Gene Ther. 3: S11.", "journal-title": "Cancer Gene Ther."}, {"key": "BF03401703_CR139", "first-page": "S11", "volume": "3", "author": "DS Heo", "year": "1996", "unstructured": "Heo DS, Yoon SJ, Kim WS, et al. (1996) Abstract 0-2: Locoregional response and increased NK activity after intratumoral gene therapy with HLA-B7/\u03b22-microglobulin gene. Cancer Gene Ther. 3: S11.", "journal-title": "Cancer Gene Ther."}, {"key": "BF03401703_CR140", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1097/00002371-199501000-00001", "volume": "17", "author": "WL Wahl", "year": "1995", "unstructured": "Wahl WL, Strome SE, Nabel GJ, et al. (1995) Generation of therapeutic T-lymphocytes after in vivo tumor transfection with an allogeneic class I major histocompatibility complex gene. J. Immunother. 17: 1.", "journal-title": "J. Immunother."}, {"key": "BF03401703_CR141", "first-page": "235", "volume": "15", "author": "A Stopeck", "year": "1996", "unstructured": "Stopeck A, Hersh E, Warneke J. (1996) Abstract 577: Results of a phase I study of direct gene transfer of interleukin-2 (IL-2) formulated with cationic lipid vector, leuvectin, in patients with metastatic solid tumors. Proc. ASCO 15: 235.", "journal-title": "Proc. ASCO"}, {"key": "BF03401703_CR142", "unstructured": "Orkin SH, Motulsky AG (1996) Report and recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy. NIH Home Page, https://doi.org/www.nih.gov/news/panelrep.html , pp 1\u201345."}], "container-title": ["Molecular Medicine"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF03401703.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF03401703/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF03401703.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 23]], "date-time": "2019-10-23T07:03:45Z", "timestamp": 1571814225000}, "score": 27.986082, "issued": {"date-parts": [[1997, 10]]}, "references-count": 142, "journal-issue": {"published-print": {"date-parts": [[1997, 10]]}, "issue": "10"}, "alternative-id": ["BF03401703"], "URL": "http://dx.doi.org/10.1007/bf03401703", "relation": {"cites": []}, "ISSN": ["1076-1551", "1528-3658"], "issn-type": [{"value": "1076-1551", "type": "print"}, {"value": "1528-3658", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T08:27:46Z", "timestamp": 1574238466468}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "SUPPLEMENT 1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Melanoma Research"], "published-print": {"date-parts": [[1996, 9]]}, "DOI": "10.1097/00008390-199609001-00121", "type": "journal-article", "created": {"date-parts": [[2006, 10, 20]], "date-time": "2006-10-20T08:58:16Z", "timestamp": 1161334696000}, "page": "S48", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Current strategies for immunotherapy of malignant melanoma"], "prefix": "10.1097", "volume": "6", "author": [{"given": "S. N.", "family": "Wagner", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "Wagner", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Goos", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Melanoma Research"], "language": "en", "deposited": {"date-parts": [[2018, 2, 8]], "date-time": "2018-02-08T21:15:31Z", "timestamp": 1518124531000}, "score": 27.9222, "subtitle": ["implications from development of gene therapy and identification of tumour-associated antigens"], "issued": {"date-parts": [[1996, 9]]}, "references-count": 0, "journal-issue": {"issue": "SUPPLEMENT 1"}, "URL": "http://dx.doi.org/10.1097/00008390-199609001-00121", "ISSN": ["0960-8931"], "issn-type": [{"value": "0960-8931", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T18:23:21Z", "timestamp": 1574533401205}, "publisher-location": "Boston, MA", "reference-count": 20, "publisher": "Springer US", "isbn-type": [{"value": "9781461374442", "type": "print"}, {"value": "9781461553571", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1998]]}, "DOI": "10.1007/978-1-4615-5357-1_47", "type": "book-chapter", "created": {"date-parts": [[2011, 8, 8]], "date-time": "2011-08-08T01:46:01Z", "timestamp": 1312767961000}, "page": "305-310", "source": "Crossref", "is-referenced-by-count": 3, "title": ["A DNA Vaccine against Malignant Melanoma Coexpressing Antigen and Cytokine"], "prefix": "10.1007", "author": [{"given": "M.", "family": "Nawrath", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Heinrich", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Strack", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Pavlovic", "sequence": "additional", "affiliation": []}, {"given": "Karin", "family": "Moelling", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "47_CR1", "doi-asserted-by": "publisher", "first-page": "1745", "DOI": "10.1126/science.8456302", "volume": "259", "author": "JB Ulmer", "year": "1993", "unstructured": "JB Ulmer, JJ Donnelly, SE Parker, GH Rhodes, PL Feigner, VJ Dwarki, SH Gromkowski, RR Deck, CM DeWitt, A Friedman et al, 1993: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745\u20131749", "journal-title": "Science"}, {"issue": "8", "key": "47_CR2", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.1016/0966-842X(96)10048-2", "volume": "4", "author": "DE Hassett", "year": "1996", "unstructured": "DE Hassett, JL Whitton, 1996: DNA immunization. Trends Microbio 4 (8), 307\u2013312", "journal-title": "Trends Microbio"}, {"key": "47_CR3", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1016/S0952-7915(96)80042-2", "volume": "8", "author": "JB Ulmer", "year": "1996", "unstructured": "JB Ulmer, JC Sadoff and MA Liu, 1996: DNA vaccines. Curr op Immunol 8, 531\u2013536", "journal-title": "DNA vaccines. Curr op Immunol"}, {"issue": "2", "key": "47_CR4", "first-page": "229", "volume": "73", "author": "SN Wagner", "year": "1995", "unstructured": "SN Wagner, C Wagner, H H\u00f6fler, MJ Atkinson, M Goos, 1995: Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45-Identification as melanocyte-specific pmell7 cDNA. Lab Invest 73 (2), 229\u2013235", "journal-title": "Lab Invest"}, {"key": "47_CR5", "author": "K Moelling", "first-page": "195", "year": "1997", "unstructured": "K Moelling, B Strack, M Nawrath, J Heinrich, C D\u00f6hring, SN Wagner and J Pavlovic, 1997: Development of a DNA vaccine against malignant melanoma. Strategies for Immunointerventions in Dermatology (G Burg and R Dummer, eds), Springer Verlag, 195\u2013206", "volume-title": "Dermatology"}, {"key": "47_CR6", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.1016/S1074-7613(95)80001-8", "volume": "2", "author": "Z Ziang", "year": "1995", "unstructured": "Z Ziang, HC Ertl, 1995: Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2, 129\u2013135", "journal-title": "Immunity"}, {"key": "47_CR7", "first-page": "59", "volume": "2", "author": "RM Conry", "year": "1995", "unstructured": "RM Conry, AF LoBuglio, F Loechel, SE Moore, LA Sumerel, DL Barlow, DT Curiel, 1995: A carcionem-bryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Ther 2, 59\u201365", "journal-title": "Gene Ther"}, {"key": "47_CR8", "author": "WW Nichols", "first-page": "30", "year": "1995", "unstructured": "WW Nichols, BJ Ledwith, SV Manam and PJ Troilo, 1995: Potential DNA vaccine integration into host cell genome. Annals of the New York Academy of Sciences 772 (MA Liu, MR Hillemann, R Kurth, eds), 30\u201338", "volume-title": "Annals of the New York Academy of Sciences 772"}, {"key": "47_CR9", "doi-asserted-by": "publisher", "first-page": "777", "DOI": "10.1089/dna.1993.12.777", "volume": "9", "author": "DL Montgomery", "year": "1993", "unstructured": "DL Montgomery, JW Shiver, KR Leander, HC Perry, A Friedman, D Martinez, JB Ulmer, JJ Donnelly, MA Liu, 1993: Heterologous and homologous protection against influenza A by DNA vaccination: Optimization of DNA Vectors. DNA Cell Biol 9, 777\u2013783", "journal-title": "DNA Cell Biol"}, {"key": "47_CR10", "doi-asserted-by": "publisher", "first-page": "419", "DOI": "10.1089/hum.1993.4.4-419", "volume": "4", "author": "M Manthorpe", "year": "1993", "unstructured": "M Manthorpe, F Cornefert-Jensen, J Hartikka, J Feigner, A Rundell, M Margalith, V Dwarki, 1993: Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice. Hum Gene Ther 4, 419\u2013431", "journal-title": "Hum Gene Ther"}, {"key": "47_CR11", "unstructured": "J Heinrich, B Strack, M Nawrath, J Pavlovic, K Moelling, 19XX: Immunization with naked DNA coex-pressing antigen and cytokine via IRES. DNA Vaccines: Methods and Protocols, Methods in Molecular Medicine vol XX, ed. D Lowrie and R Whalen, series editor JM Walker, in press"}, {"key": "47_CR12", "first-page": "3266", "volume": "41", "author": "IT Fidler", "year": "1981", "unstructured": "IT Fidler, IR Hart, 1981: Biological and experimental consequences of the zonal composition of solid tumors. Cancer Res 41, 3266\u20133267", "journal-title": "Cancer Res"}, {"key": "47_CR13", "first-page": "127", "volume": "3", "author": "K Moelling", "year": "1997", "unstructured": "K Moelling, 1997: DNA for genetic vaccination and therapy. Cytokines Cellular and Molecular Therapy 3, 127\u2013136", "journal-title": "Cytokines Cellular and Molecular Therapy"}, {"key": "47_CR14", "first-page": "700", "volume": "156", "author": "Y Zhai", "year": "1996", "unstructured": "Y Zhai, JC Yang, Y Kawakami, P Spiess, SC Wadsworth, LM Cardoza, LA Couture, AE Smith, SA Rosenberg, 1996: Antigen-Specific tumor vaccines. J Immunol 156, 700\u2013710", "journal-title": "J Immunol"}, {"key": "47_CR15", "doi-asserted-by": "publisher", "first-page": "1513", "DOI": "10.1093/nar/7.6.1513", "volume": "7", "author": "HC Birnboim", "year": "1979", "unstructured": "HC Birnboim and J Doly, 1979: A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucl Acids Res 7, 1513\u20131522", "journal-title": "Nucl Acids Res"}, {"key": "47_CR16", "doi-asserted-by": "publisher", "first-page": "152", "DOI": "10.1038/356152a0", "volume": "356", "author": "DC Tang", "year": "1992", "unstructured": "DC Tang, M DeVit, SA Johnston, 1992: Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152\u2013154", "journal-title": "Nature"}, {"issue": "7", "key": "47_CR17", "doi-asserted-by": "publisher", "first-page": "3183", "DOI": "10.1073/pnas.94.7.3183", "volume": "94", "author": "V Bronte", "year": "1997", "unstructured": "V. Bronte, MW Carroll, TJ Goletz, M Wang, WW Overwijk, F Marincola, SA Rosenberg, B Moss, NP Restifo, 1997: Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc Natl Acad Sci USA 94 (7), 3183\u20138", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "47_CR18", "doi-asserted-by": "publisher", "first-page": "1137", "DOI": "10.1084/jem.186.7.1137", "volume": "7", "author": "S Gurunathan", "year": "1997", "unstructured": "S Gurunathan, DL Sacks, DR Brown, SL Reiner, H Charest, N Glaichenhaus and RA Seder, 1997: Vaccination with DNA Encoding the Immunodominant LACK Parasite Antigen Confers Protective Immunity to Mice Infected with Leishmania major. J Ex Med 7, 1137\u20131147", "journal-title": "J Ex Med"}, {"issue": "5", "key": "47_CR19", "doi-asserted-by": "publisher", "first-page": "526", "DOI": "10.1038/nm0597-526", "volume": "3", "author": "JD Boyer", "year": "1997", "unstructured": "JD Boyer, KE Ugen, B Wang, M Agadjanyan, L Gilbert, ML Bagarazzi, M Chattergoon, P Frost, A Javadian, WV Williams, Y Refaeli, RB Ciccarelli, D McCallus, L Coney and DB Weiner, 1997: Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Med 3 (5), 526\u2013532.", "journal-title": "Nature Med"}, {"key": "47_CR20", "doi-asserted-by": "publisher", "first-page": "9378", "DOI": "10.1073/pnas.94.17.9378", "volume": "94", "author": "NL Letvin", "year": "1997", "unstructured": "NL Letvin, DC Montefiori, Y Yasutomi, HC Perry, ME Davies, C Lekutis, M Alroy, DC Freed, CI Lord, LK Handt, MA Liu and JW Shiver, 1997: Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci USA 94, 9378\u20139383", "journal-title": "Proc Natl Acad Sci USA"}], "container-title": ["Advances in Experimental Medicine and Biology", "Gene Therapy of Cancer"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4615-5357-1_47", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 31]], "date-time": "2019-03-31T05:49:52Z", "timestamp": 1554011392000}, "score": 27.662762, "issued": {"date-parts": [[1998]]}, "ISBN": ["9781461374442", "9781461553571"], "references-count": 20, "URL": "http://dx.doi.org/10.1007/978-1-4615-5357-1_47", "relation": {"cites": []}, "ISSN": ["0065-2598"], "issn-type": [{"value": "0065-2598", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T05:15:08Z", "timestamp": 1575177308679}, "reference-count": 10, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2013, 2, 1]], "date-time": "2013-02-01T00:00:00Z", "timestamp": 1359676800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Gene Ther"], "published-print": {"date-parts": [[2013, 3]]}, "DOI": "10.1038/cgt.2013.3", "type": "journal-article", "created": {"date-parts": [[2013, 2, 1]], "date-time": "2013-02-01T11:19:03Z", "timestamp": 1359717543000}, "page": "208-210", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Gene electrotransfer of siRNAs against CD146 inhibits migration and invasion of human malignant melanoma cells SK-MEL28"], "prefix": "10.1038", "volume": "20", "author": [{"given": "V", "family": "Todorovic", "sequence": "first", "affiliation": []}, {"given": "G", "family": "Sersa", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Cemazar", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2013, 2, 1]]}, "reference": [{"key": "BFcgt20133_CR1", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.2478/v10019-010-0008-x", "volume": "44", "author": "P Strojan", "year": "2010", "unstructured": "Strojan P . Role of radiotherapy in melanoma management. Radiol Oncol 2010; 44: 1\u201312.", "journal-title": "Radiol Oncol"}, {"key": "BFcgt20133_CR2", "doi-asserted-by": "publisher", "first-page": "300", "DOI": "10.2174/156652310791823425", "volume": "10", "author": "M Cemazar", "year": "2010", "unstructured": "Cemazar M, Jarm T, Sersa G . Cancer electrogene therapy with interleukin-12. Curr Gene Ther 2010; 10: 300\u2013311.", "journal-title": "Curr Gene Ther"}, {"key": "BFcgt20133_CR3", "doi-asserted-by": "publisher", "first-page": "4", "DOI": "10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P", "volume": "189", "author": "IM Shih", "year": "1999", "unstructured": "Shih IM . The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 1999; 189: 4\u201311.", "journal-title": "J Pathol"}, {"key": "BFcgt20133_CR4", "doi-asserted-by": "publisher", "first-page": "1666", "DOI": "10.1158/1541-7786.MCR-07-2200", "volume": "6", "author": "GJ Wu", "year": "2008", "unstructured": "Wu GJ, Fu P, Wang SW, Wu MW . Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model. Mol Cancer Res 2008; 6: 1666\u20131677.", "journal-title": "Mol Cancer Res"}, {"key": "BFcgt20133_CR5", "doi-asserted-by": "publisher", "first-page": "313", "DOI": "10.1038/sj.cr.7310039", "volume": "16", "author": "Y Kang", "year": "2006", "unstructured": "Kang Y, Wang F, Feng J, Yang D, Yang X, Yan X . Knockdown of CD146 reduces the migration and proliferation of human endothelial cells. Cell Res 2006; 16: 313\u2013318.", "journal-title": "Cell Res"}, {"key": "BFcgt20133_CR6", "first-page": "5106", "volume": "62", "author": "L Mills", "year": "2002", "unstructured": "Mills L, Tellez C, Huang S, Baker C, McCarty M, Green L et al. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. Cancer Res 2002; 62: 5106\u20135114.", "journal-title": "Cancer Res"}, {"key": "BFcgt20133_CR7", "doi-asserted-by": "publisher", "first-page": "399", "DOI": "10.1038/sj.cgt.7700454", "volume": "9", "author": "M Cemazar", "year": "2002", "unstructured": "Cemazar M, Sersa G, Wilson J, Tozer GM, Hart SL, Grosel A et al. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector. Cancer Gene Ther 2002; 9: 399\u2013406.", "journal-title": "Cancer Gene Ther"}, {"key": "BFcgt20133_CR8", "doi-asserted-by": "publisher", "first-page": "734", "DOI": "10.1111/j.1755-148X.2011.00879.x", "volume": "24", "author": "P Quaglino", "year": "2011", "unstructured": "Quaglino P, Osella-Abate S, Marenco F, Nardo T, Gado C, Novelli M et al. FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy. Pigm Cell Melanoma Res 2011; 24: 734\u2013736.", "journal-title": "Pigm Cell Melanoma Res"}, {"key": "BFcgt20133_CR9", "doi-asserted-by": "publisher", "first-page": "32", "DOI": "10.2478/v10019-012-0010-6", "volume": "46", "author": "V Todorovic", "year": "2012", "unstructured": "Todorovic V, Sersa G, Mlakar V, Glavac D, Cemazar M . Assessment of the tumourigenic and metastatic properties of SK-MEL28 melanoma cells surviving electrochemotherapy with bleomycin. Radiol Oncol 2012; 46: 32\u201345.", "journal-title": "Radiol Oncol"}, {"key": "BFcgt20133_CR10", "doi-asserted-by": "publisher", "first-page": "1375", "DOI": "10.4161/cbt.5.10.3241", "volume": "5", "author": "K Watson-Hurst", "year": "2006", "unstructured": "Watson-Hurst K, Becker D . The role of N-cadherin, MCAM and beta3 integrin in melanoma progression, proliferation, migration and invasion. Cancer Biol Ther 2006; 5: 1375\u20131382.", "journal-title": "Cancer Biol Ther"}], "container-title": ["Cancer Gene Therapy"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/cgt20133.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/cgt20133", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/cgt20133.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 14]], "date-time": "2019-04-14T01:19:53Z", "timestamp": 1555204793000}, "score": 26.717846, "issued": {"date-parts": [[2013, 2, 1]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[2013, 3]]}, "issue": "3"}, "alternative-id": ["BFcgt20133"], "URL": "http://dx.doi.org/10.1038/cgt.2013.3", "relation": {"cites": []}, "ISSN": ["0929-1903", "1476-5500"], "issn-type": [{"value": "0929-1903", "type": "print"}, {"value": "1476-5500", "type": "electronic"}], "subject": ["Molecular Medicine", "Cancer Research", "Molecular Biology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T11:36:43Z", "timestamp": 1574249803443}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Melanoma Research"], "published-print": {"date-parts": [[1993, 3]]}, "DOI": "10.1097/00008390-199303000-00023", "type": "journal-article", "created": {"date-parts": [[2006, 12, 13]], "date-time": "2006-12-13T16:31:37Z", "timestamp": 1166027497000}, "page": "10", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Present status of adjuvant systemic therapy of malignant melanoma"], "prefix": "10.1097", "volume": "3", "author": [{"given": "Z.", "family": "Mechl", "sequence": "first", "affiliation": []}, {"given": "M. A.", "family": "Al-Jarallah", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Melanoma Research"], "language": "en", "deposited": {"date-parts": [[2018, 2, 8]], "date-time": "2018-02-08T23:52:21Z", "timestamp": 1518133941000}, "score": 25.963783, "subtitle": ["27"], "issued": {"date-parts": [[1993, 3]]}, "references-count": 0, "journal-issue": {"issue": "1"}, "URL": "http://dx.doi.org/10.1097/00008390-199303000-00023", "ISSN": ["0960-8931"], "issn-type": [{"value": "0960-8931", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T14:21:23Z", "timestamp": 1575469283563}, "edition-number": "1", "reference-count": 1, "publisher": "CRC Press", "isbn-type": [{"value": "9780429276514", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2019, 5, 17]]}, "DOI": "10.1201/9780429276514-6", "type": "book-chapter", "created": {"date-parts": [[2019, 7, 2]], "date-time": "2019-07-02T10:56:02Z", "timestamp": 1562064962000}, "page": "75-86", "source": "Crossref", "is-referenced-by-count": 0, "title": ["HLA and Malignant Melanoma"], "prefix": "10.1201", "author": [{"given": "Florence M.", "family": "Demenais", "sequence": "first", "affiliation": []}], "member": "301", "reference": [{"key": "ref6", "unstructured": "Clark, W. H., Jr. , Reimer, R. R. , Greene, M. H. , Ainsworth, A. M. , and Mastrangelo, M. J. , Origin of familial melanoma from heritable melanocytic lesions: the B-K mole syndrome, Arch. Dermatol., 114, 732, 1978.", "DOI": "10.1001/archderm.1978.01640170032006", "doi-asserted-by": "crossref"}], "container-title": ["Hereditary Malignant Melanoma"], "deposited": {"date-parts": [[2019, 7, 31]], "date-time": "2019-07-31T00:51:04Z", "timestamp": 1564534264000}, "score": 25.215372, "issued": {"date-parts": [[2019, 5, 17]]}, "ISBN": ["9780429276514"], "references-count": 1, "URL": "http://dx.doi.org/10.1201/9780429276514-6", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:49:20Z", "timestamp": 1574246960533}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Melanoma Research"], "published-print": {"date-parts": [[1997, 4]]}, "DOI": "10.1097/00008390-199704000-00024", "type": "journal-article", "created": {"date-parts": [[2006, 11, 22]], "date-time": "2006-11-22T22:41:11Z", "timestamp": 1164235271000}, "page": "160", "source": "Crossref", "is-referenced-by-count": 0, "title": ["14 Gene therapy"], "prefix": "10.1097", "volume": "7", "author": [{"given": "V. M.", "family": "Macaulay", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Melanoma Research"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T08:32:46Z", "timestamp": 1518165166000}, "score": 25.140116, "subtitle": ["what is it?"], "issued": {"date-parts": [[1997, 4]]}, "references-count": 0, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.1097/00008390-199704000-00024", "ISSN": ["0960-8931"], "issn-type": [{"value": "0960-8931", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T11:36:44Z", "timestamp": 1574249804078}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Melanoma Research"], "published-print": {"date-parts": [[1993, 3]]}, "DOI": "10.1097/00008390-199303000-00047", "type": "journal-article", "created": {"date-parts": [[2006, 12, 13]], "date-time": "2006-12-13T16:31:37Z", "timestamp": 1166027497000}, "page": "16", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Gene therapy of experimental tumor"], "prefix": "10.1097", "volume": "3", "author": [{"given": "M. P.", "family": "Colmbo", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Melanoma Research"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T09:21:45Z", "timestamp": 1518168105000}, "score": 25.140116, "subtitle": ["52"], "issued": {"date-parts": [[1993, 3]]}, "references-count": 0, "journal-issue": {"issue": "1"}, "URL": "http://dx.doi.org/10.1097/00008390-199303000-00047", "ISSN": ["0960-8931"], "issn-type": [{"value": "0960-8931", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T21:30:51Z", "timestamp": 1574458251593}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 1, 1]], "date-time": "2006-01-01T00:00:00Z", "timestamp": 1136073600000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "start": {"date-parts": [[2016, 10, 7]], "date-time": "2016-10-07T00:00:00Z", "timestamp": 1475798400000}, "delay-in-days": 3932, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular Therapy"], "published-print": {"date-parts": [[2006]]}, "DOI": "10.1016/j.ymthe.2006.08.1030", "type": "journal-article", "created": {"date-parts": [[2010, 8, 24]], "date-time": "2010-08-24T12:47:46Z", "timestamp": 1282654066000}, "page": "S362", "source": "Crossref", "is-referenced-by-count": 0, "title": ["939. Adenovirus-Mediated TA-p73\u03b2 Gene Transfer Leads to Chemosensitization of Human Malignant Melanoma"], "prefix": "10.1016", "volume": "13", "author": [{"given": "Sebastian", "family": "Tuve", "sequence": "first", "affiliation": []}, {"given": "Tomas", "family": "Racek", "sequence": "additional", "affiliation": []}, {"given": "Annett", "family": "Niemetz", "sequence": "additional", "affiliation": []}, {"given": "Julia", "family": "Schultz", "sequence": "additional", "affiliation": []}, {"given": "Maria S.", "family": "Soengas", "sequence": "additional", "affiliation": []}, {"given": "Brigitte M.", "family": "P\u00fctzer", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Molecular Therapy"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1525001606012925?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1525001606012925?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 8]], "date-time": "2018-12-08T16:21:40Z", "timestamp": 1544286100000}, "score": 24.756845, "issued": {"date-parts": [[2006]]}, "references-count": 0, "alternative-id": ["S1525001606012925"], "URL": "http://dx.doi.org/10.1016/j.ymthe.2006.08.1030", "ISSN": ["1525-0016"], "issn-type": [{"value": "1525-0016", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:11:50Z", "timestamp": 1574241110355}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Melanoma Research"], "published-print": {"date-parts": [[1999, 6]]}, "DOI": "10.1097/00008390-199906000-00036", "type": "journal-article", "created": {"date-parts": [[2006, 10, 31]], "date-time": "2006-10-31T10:51:39Z", "timestamp": 1162291899000}, "page": "316", "source": "Crossref", "is-referenced-by-count": 0, "title": ["21 Gene therapy for melanoma"], "prefix": "10.1097", "volume": "9", "author": [{"given": "V. M.", "family": "Macaulay", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Melanoma Research"], "language": "en", "deposited": {"date-parts": [[2018, 2, 8]], "date-time": "2018-02-08T17:58:16Z", "timestamp": 1518112696000}, "score": 24.600296, "subtitle": ["an update"], "issued": {"date-parts": [[1999, 6]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/00008390-199906000-00036", "ISSN": ["0960-8931"], "issn-type": [{"value": "0960-8931", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T07:12:02Z", "timestamp": 1574493122462}, "publisher-location": "Vienna", "reference-count": 30, "publisher": "Springer Vienna", "isbn-type": [{"value": "9783709173411", "type": "print"}, {"value": "9783709165133", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1997]]}, "DOI": "10.1007/978-3-7091-6513-3_20", "type": "book-chapter", "created": {"date-parts": [[2012, 7, 28]], "date-time": "2012-07-28T23:50:26Z", "timestamp": 1343519426000}, "page": "105-110", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Anti-Angiogenic Gene Therapy of Malignant Glioma"], "prefix": "10.1007", "author": [{"given": "A.", "family": "Stratmann", "sequence": "first", "affiliation": []}, {"given": "M. R.", "family": "Machein", "sequence": "additional", "affiliation": []}, {"given": "Karl H.", "family": "Plate", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "20_CR1", "author": "RO Barnard", "first-page": "60", "year": "1986", "unstructured": "Barnard RO (1986) The pathology of brain tumours. In: Bee-hen NM (ed) Tumours of the brain. Springer, Berlin Heidelberg New York Tokyo, pp 60\u201370", "volume-title": "Tumours of the brain"}, {"key": "20_CR2", "first-page": "521", "volume": "114", "author": "G Breier", "year": "1992", "unstructured": "Breier G, Albrecht U, Sterrer S, Risau W (1992) Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114: 521\u2013532", "journal-title": "Development"}, {"key": "20_CR3", "doi-asserted-by": "publisher", "first-page": "8502", "DOI": "10.1073/pnas.93.16.8502", "volume": "93", "author": "SY Cheng", "year": "1996", "unstructured": "Cheng SY, Huang HJS, Nagane M, Ji XD, Wang DG, Shin CCY, Arap W, Huang CM, Cavenee WK (1996) Suppression of glioblastoma angiogenicity and tumourigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci USA 93: 8502\u20138507", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "20_CR4", "first-page": "172", "volume": "56", "author": "KP Claffey", "year": "1996", "unstructured": "Claffey KP, Brown LF, Delaguila LF, Tognazzi K, Yeo KT, Manseau EJ, Dvorak HF (1996) Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumour growth, angiogenesis, and experimental metastasis. Cancer Res 56: 172\u2013181", "journal-title": "Cancer Res"}, {"key": "20_CR5", "doi-asserted-by": "publisher", "first-page": "1470", "DOI": "10.1172/JCI114322", "volume": "84", "author": "DT Conolly", "year": "1989", "unstructured": "Conolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J (1989) Tumour vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470\u20131478", "journal-title": "J Clin Invest"}, {"key": "20_CR6", "doi-asserted-by": "publisher", "first-page": "989", "DOI": "10.1126/science.1312256", "volume": "255", "author": "C Vries De", "year": "1992", "unstructured": "De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989\u2013991", "journal-title": "Science"}, {"key": "20_CR7", "doi-asserted-by": "publisher", "first-page": "1897", "DOI": "10.1101/gad.8.16.1897", "volume": "8", "author": "DJ Dumont", "year": "1994", "unstructured": "Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML (1994) Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8: 1897\u20131909", "journal-title": "Genes Dev"}, {"key": "20_CR8", "doi-asserted-by": "publisher", "first-page": "4", "DOI": "10.1093/jnci/82.1.4", "volume": "82", "author": "J Folkman", "year": "1990", "unstructured": "Folkman J (1990) What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 82: 4\u20136", "journal-title": "J Natl Cancer Inst"}, {"key": "20_CR9", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1038/nm0195-27", "volume": "1", "author": "J Folkman", "year": "1995", "unstructured": "Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27\u201331", "journal-title": "Nat Med"}, {"key": "20_CR10", "doi-asserted-by": "publisher", "first-page": "66", "DOI": "10.1038/376066a0", "volume": "376", "author": "GH Fong", "year": "1995", "unstructured": "Fong GH, Rossant J, Gertsenstein M, Breitman M (1995) Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66\u201370", "journal-title": "Nature"}, {"key": "20_CR11", "first-page": "368", "volume": "146", "author": "E Hatva", "year": "1995", "unstructured": "Hatva E, Kaipainen A, Mentula P, J\u00e4\u00e4skel\u00e4inen J, Paetau A, Haltia M, Alitalo K (1995) Expression of endothelial cellspecific receptor tyrosine kinases and growth factors in human brain tumours. Am J Pathol 146: 368\u2013378", "journal-title": "Am J Pathol"}, {"key": "20_CR12", "doi-asserted-by": "publisher", "first-page": "19761", "DOI": "10.1074/jbc.270.44.26460", "volume": "270", "author": "E Ikeda", "year": "1995", "unstructured": "Ikeda E, Achen MG, Breier G, Risau W (1995) Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270: 19761\u201319766", "journal-title": "J Biol Chem"}, {"key": "20_CR13", "doi-asserted-by": "publisher", "first-page": "841", "DOI": "10.1038/362841a0", "volume": "362", "author": "JB Kim", "year": "1993", "unstructured": "Kim JB, Li B, Winer J, Armanini M, Gillet N, Philipps HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841\u2013844", "journal-title": "Nature"}, {"key": "20_CR14", "doi-asserted-by": "publisher", "first-page": "1306", "DOI": "10.1126/science.2479986", "volume": "246", "author": "DW Leung", "year": "1989", "unstructured": "Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306\u20131309", "journal-title": "Science"}, {"key": "20_CR15", "doi-asserted-by": "publisher", "first-page": "835", "DOI": "10.1016/0092-8674(93)90573-9", "volume": "72", "author": "B Millauer", "year": "1993", "unstructured": "Millauer B, Wizigmann-Voos S, Schn\u00fcren H, Martinez R, Moller N, Risau W, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835\u2013846", "journal-title": "Cell"}, {"key": "20_CR16", "doi-asserted-by": "publisher", "first-page": "576", "DOI": "10.1038/367576a0", "volume": "367", "author": "B Millauer", "year": "1994", "unstructured": "Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative flk-1 mutant. Nature 367: 576\u2013579", "journal-title": "Nature"}, {"key": "20_CR17", "first-page": "1615", "volume": "56", "author": "B Millauer", "year": "1996", "unstructured": "Millauer B, Longhi MP, Plate KH, Shawver LK, Risau W, Ullrich A, Strawn LM (1996) Dominant-negative inhibition of flk-1 suppresses the growth of many tumour types in vivo. Cancer Res 56: 1615\u20131620", "journal-title": "Cancer Res"}, {"key": "20_CR18", "doi-asserted-by": "crossref", "first-page": "1698", "DOI": "10.1128/MCB.12.4.1698", "volume": "12", "author": "J Partanen", "year": "1992", "unstructured": "Partanen J, Armstrong E, M\u00e4kel\u00e4 TP, Korhonen J, Sandberg M, Renkonen R, Knuutila S, Huebner K, Alitalo K (1992) A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 12: 1698\u20131707", "journal-title": "Mol Cell Biol"}, {"key": "20_CR19", "doi-asserted-by": "publisher", "first-page": "845", "DOI": "10.1038/359845a0", "volume": "359", "author": "KH Plate", "year": "1992", "unstructured": "Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845\u2013847", "journal-title": "Nature"}, {"key": "20_CR20", "first-page": "5822", "volume": "53", "author": "KH Plate", "year": "1993", "unstructured": "Plate KH, Breier G, Millauer B, Ullrich A, Risau W (1993) Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumour angiogenesis. Cancer Res 53: 5822\u20135827", "journal-title": "Cancer Res"}, {"key": "20_CR21", "doi-asserted-by": "publisher", "first-page": "207", "DOI": "10.1111/j.1750-3639.1994.tb00835.x", "volume": "4", "author": "KH Plate", "year": "1994", "unstructured": "Plate KH, Breier G, Risau W (1994) Molecular mechanisms of developmental and tumour angiogenesis. Brain Pathol 4: 207\u2013218", "journal-title": "Brain Pathol"}, {"key": "20_CR22", "doi-asserted-by": "publisher", "first-page": "520", "DOI": "10.1002/ijc.2910590415", "volume": "59", "author": "KH Plate", "year": "1994", "unstructured": "Plate KH, Breier G, Weich HA, Mennel HD, Risau W (1994) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59: 520\u2013529", "journal-title": "Int J Cancer"}, {"key": "20_CR23", "doi-asserted-by": "publisher", "first-page": "339", "DOI": "10.1002/glia.440150313", "volume": "15", "author": "KH Plate", "year": "1995", "unstructured": "Plate KH, Risau W (1995) Angiogenesis in malignant gliomas. Glia 15: 339\u2013347", "journal-title": "Glia"}, {"key": "20_CR24", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1097/00001813-199502000-00001", "volume": "6", "author": "JW Rak", "year": "1995", "unstructured": "Rak JW, St Croix BD, Kerbel RS (1995) Consequences of angiogenesis for tumour progression, metastasis and cancer therapy. Anticancer Drugs 6: 3\u201318", "journal-title": "Anticancer Drugs"}, {"key": "20_CR25", "first-page": "393", "volume": "56", "author": "M Saleh", "year": "1996", "unstructured": "Saleh M, Stacker SA, Wilks AF (1996) Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56: 393\u2013401", "journal-title": "Cancer Res"}, {"key": "20_CR26", "doi-asserted-by": "publisher", "first-page": "70", "DOI": "10.1038/376070a0", "volume": "376", "author": "TN Sato", "year": "1995", "unstructured": "Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fuji-wara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Quin Y (1995) Distinct roles of the receptor tyrosine kinases tie-1 and tie-2 in blood vessel formation. Nature 376: 70\u201374", "journal-title": "Nature"}, {"key": "20_CR27", "first-page": "957", "volume": "119", "author": "H Schn\u00fcren", "year": "1993", "unstructured": "Schn\u00fcren H, Risau W (1993) Expression of tie-2, a member of novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 119: 957\u2013968", "journal-title": "Development"}, {"key": "20_CR28", "doi-asserted-by": "publisher", "first-page": "62", "DOI": "10.1038/376062a0", "volume": "376", "author": "F Shalaby", "year": "1995", "unstructured": "Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC (1995) Failure of blood-island formation and vasculogenesis in flk-1-deficient mice. Nature 376: 62\u201366", "journal-title": "Nature"}, {"key": "20_CR29", "first-page": "3540", "volume": "56", "author": "LM Strawn", "year": "1996", "unstructured": "Strawn LM, McMahon G, App H, Schreck R, Kuchler WR, Longhi MP, Hui TH, Tang C, Levitzki A, Gazit A, Chen I, Keri G, Orfi L, Risau W, Flamme I, Ullrich A, Hirth KP, Shawver LK (1996) Flk-1 as a target for tumour growth inhibition. Cancer Res 56: 3540\u20133545", "journal-title": "Cancer Res"}, {"key": "20_CR30", "doi-asserted-by": "publisher", "first-page": "1579", "DOI": "10.1016/0006-291X(92)90483-2", "volume": "187", "author": "BI Terman", "year": "1992", "unstructured": "Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz C, B\u00f6hlen P (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 187: 1579\u20131586", "journal-title": "Biochem Biophys Res Commun"}], "container-title": ["Advances in Stereotactic and Functional Neurosurgery 12"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-7091-6513-3_20", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 30]], "date-time": "2019-03-30T08:18:57Z", "timestamp": 1553933937000}, "score": 24.431849, "issued": {"date-parts": [[1997]]}, "ISBN": ["9783709173411", "9783709165133"], "references-count": 30, "URL": "http://dx.doi.org/10.1007/978-3-7091-6513-3_20", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:07:46Z", "timestamp": 1574122066789}, "reference-count": 26, "publisher": "Mary Ann Liebert Inc", "issue": "8", "license": [{"URL": "http://www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/", "start": {"date-parts": [[1999, 5, 20]], "date-time": "1999-05-20T00:00:00Z", "timestamp": 927158400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Human Gene Therapy"], "published-print": {"date-parts": [[1999, 5, 20]]}, "DOI": "10.1089/10430349950017941", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T22:05:44Z", "timestamp": 1027721144000}, "page": "1261-1268", "source": "Crossref", "is-referenced-by-count": 56, "title": ["Gene Therapy with Autologous, Interleukin 2-Secreting Tumor Cells in Patients with Malignant Melanoma"], "prefix": "10.1089", "volume": "10", "author": [{"given": "K.", "family": "Palmer", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Moore", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Everard", "sequence": "additional", "affiliation": []}, {"given": "J.D.", "family": "Harris", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Rodgers", "sequence": "additional", "affiliation": []}, {"given": "R.C.", "family": "Rees", "sequence": "additional", "affiliation": []}, {"given": "A.K.", "family": "Murray", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Mascari", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Kirkwood", "sequence": "additional", "affiliation": []}, {"given": "P.G.", "family": "Riches", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Fisher", "sequence": "additional", "affiliation": []}, {"given": "J.M.", "family": "Thomas", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Harries", "sequence": "additional", "affiliation": []}, {"given": "S.R.D.", "family": "Johnston", "sequence": "additional", "affiliation": []}, {"given": "M.K.L.", "family": "Collins", "sequence": "additional", "affiliation": []}, {"given": "M.E.", "family": "Gore", "sequence": "additional", "affiliation": []}], "member": "278", "container-title": ["Human Gene Therapy"], "language": "en", "link": [{"URL": "http://www.liebertpub.com/doi/pdf/10.1089/10430349950017941", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 8]], "date-time": "2018-08-08T22:15:40Z", "timestamp": 1533766540000}, "score": 24.093409, "issued": {"date-parts": [[1999, 5, 20]]}, "references-count": 26, "journal-issue": {"published-print": {"date-parts": [[1999, 5, 20]]}, "issue": "8"}, "alternative-id": ["10.1089/10430349950017941"], "URL": "http://dx.doi.org/10.1089/10430349950017941", "ISSN": ["1043-0342", "1557-7422"], "issn-type": [{"value": "1043-0342", "type": "print"}, {"value": "1557-7422", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T07:35:33Z", "timestamp": 1574408133551}, "publisher-location": "Boston, MA", "reference-count": 93, "publisher": "Springer US", "isbn-type": [{"value": "9781461289838", "type": "print"}, {"value": "9781461317517", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1988]]}, "DOI": "10.1007/978-1-4613-1751-7_8", "type": "book-chapter", "created": {"date-parts": [[2011, 10, 12]], "date-time": "2011-10-12T05:28:23Z", "timestamp": 1318397303000}, "page": "123-153", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Radioimmunoimaging of malignant melanoma with monoclonal antibodies"], "prefix": "10.1007", "author": [{"given": "James L.", "family": "Murray", "sequence": "first", "affiliation": []}, {"given": "Lamk M.", "family": "Lamki", "sequence": "additional", "affiliation": []}, {"given": "Michael G.", "family": "Rosenblum", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "8_CR1", "first-page": "365", "volume": "69", "author": "TR Fears", "year": "1982", "unstructured": "Fears TR, Scotto J: Changes in skin cancer morbidity between 1971\u201372 and 1977\u201378. J Natl Cancer Inst 69:365\u2013370, 1982.", "journal-title": "J Natl Cancer Inst"}, {"key": "8_CR2", "author": "AS Coates", "first-page": "275", "year": "1985", "unstructured": "Coates AS, Durant JR: Chemotherapy for metastatic melanoma. In: Cutaneous melanoma: Clinical management and treatment results worldwide, Balch CM, Milton GW (eds). Philadelphia: J.B. Lippincott, 1985, pp. 275\u2013282.", "volume-title": "Cutaneous melanoma: Clinical management and treatment results worldwide"}, {"key": "8_CR3", "doi-asserted-by": "publisher", "first-page": "495", "DOI": "10.1038/256495a0", "volume": "256", "author": "G Kohler", "year": "1975", "unstructured": "Kohler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495\u2013497, 1975.", "journal-title": "Nature"}, {"key": "8_CR4", "doi-asserted-by": "publisher", "first-page": "215", "DOI": "10.3109/07357908309041361", "volume": "1", "author": "M Herlyn", "year": "1983", "unstructured": "Herlyn M, Steplewski Z, Herlyn I, et al: Production and characterization of monoclonal antibodies against human malignant melanoma. Cancer Invest 1:215\u2013224, 1983.", "journal-title": "Cancer Invest"}, {"issue": "1", "key": "8_CR5", "doi-asserted-by": "publisher", "first-page": "2", "DOI": "10.1016/S0001-2998(85)80039-8", "volume": "15", "author": "FH Deland", "year": "1985", "unstructured": "Deland FH, Goldenberg DM: Diagnosis and treatment of neoplasms with radionuclide-labeled antibodies. Semin Nucl Med 15(1):2\u201311, 1985.", "journal-title": "Semin Nucl Med"}, {"key": "8_CR6", "first-page": "121", "volume": "1", "author": "DM Goldenberg", "year": "1982", "unstructured": "Goldenberg DM, Deland FH: History and status of tumor imaging with radiolabeled antibodies. J Biol Resp Modif 1:121\u2013132, 1982.", "journal-title": "J Biol Resp Modif"}, {"key": "8_CR7", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1148/116.2.445", "volume": "116", "author": "T Ghose", "year": "1975", "unstructured": "Ghose T, Tai J, Aquino J, Guclu A, Norvell ST, MacDonald AS: Tumor localization of 131I-labeled antibodies by radionuclide imaging. Radiology 116:445\u2013448, 1975.", "journal-title": "Radiology"}, {"key": "8_CR8", "doi-asserted-by": "publisher", "first-page": "1646", "DOI": "10.1002/1097-0142(197511)36:5<1646::AID-CNCR2820360518>3.0.CO;2-A", "volume": "36", "author": "T Ghose", "year": "1975", "unstructured": "Ghose T, Guclu A, Tai J, MacDonald AS, Norvell ST, Aquino J: Antibody as a carrier of 131I in cancer diagnosis and treatment. Cancer 36:1646\u20131657, 1975.", "journal-title": "Cancer"}, {"key": "8_CR9", "doi-asserted-by": "publisher", "first-page": "671", "DOI": "10.1111/j.1749-6632.1976.tb41739.x", "volume": "277", "author": "T Ghose", "year": "1976", "unstructured": "Ghose T, Tai J, Novell ST, Guclu A, MacDonald AS: Antibodies as carriers of radionuclides and cytotoxic drugs in the treatment and diagnosis of cancer. Ann NY Acad Sci 277:671\u2013689, 1976.", "journal-title": "Ann NY Acad Sci"}, {"key": "8_CR10", "doi-asserted-by": "publisher", "first-page": "1384", "DOI": "10.1056/NEJM197806222982503", "volume": "298", "author": "DM Goldenberg", "year": "1978", "unstructured": "Goldenberg DM, DeLand F, Kim E, et al: Use of radiolabeled antibodies to carcino-embryonic antigen for the detection and localization of diverse cancers by external photo-scanning. N Engl J Med 298:1384\u20131388, 1978.", "journal-title": "N Engl J Med"}, {"key": "8_CR11", "first-page": "823", "volume": "69", "author": "T Ghose", "year": "1982", "unstructured": "Ghose T, Ferrone S, Imai K, et al: Imaging of human melanoma xenografts in nude mice with a radiolabeled monoclonal antibody. J Nat Cancer Inst 69:823\u2013826, 1982.", "journal-title": "J Nat Cancer Inst"}, {"key": "8_CR12", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1002/ijc.2910280307", "volume": "28", "author": "BS Wilson", "year": "1981", "unstructured": "Wilson BS, Kohzoh I, Natali PG, Ferrone S: Distribution and characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer 28:293\u2013300, 1981.", "journal-title": "Int J Cancer"}, {"key": "8_CR13", "first-page": "4150", "volume": "45", "author": "KM Hwang", "year": "1985", "unstructured": "Hwang KM, Fodstad O, Oldham RK, Morgan AC Jr: Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice. Cancer Res 45:4150\u20134155, 1985.", "journal-title": "Cancer Res"}, {"key": "8_CR14", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1089/hyb.1.1981.1.27", "volume": "1", "author": "AC Morgan", "year": "1981", "unstructured": "Morgan AC, Galloway DR, Reisfeld RA: Production and characterization of monoclonal antibody to a melanoma specific glycoprotein. Hybridoma 1:27\u201336, 1981.", "journal-title": "Hybridoma"}, {"key": "8_CR15", "first-page": "1172", "volume": "26", "author": "PL Beaumier", "year": "1985", "unstructured": "Beaumier PL, Krohn KA, Carrasquillo JA, et al. Melanoma localization in nude mice with monoclonal Fab against p97. J Nucl Med 26:1172\u20131179, 1985.", "journal-title": "J Nucl Med"}, {"key": "8_CR16", "first-page": "539", "volume": "127", "author": "JP Brown", "year": "1981", "unstructured": "Brown JP, Nishiyama K, Hellstrom I, et al: Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies. J Immunol 127:539\u2013546, 1981.", "journal-title": "J Immunol"}, {"key": "8_CR17", "doi-asserted-by": "publisher", "first-page": "539", "DOI": "10.1073/pnas.78.1.539", "volume": "78", "author": "JP Brown", "year": "1981", "unstructured": "Brown JP, Woodbury RG, Hart CE, et al: Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc Natl Acad Sci (USA) 78:539\u2013543, 1981.", "journal-title": "Proc Natl Acad Sci (USA)"}, {"key": "8_CR18", "first-page": "845", "volume": "17", "author": "D Pressman", "year": "1957", "unstructured": "Pressman D, Day ED, Blau M: The use of paired labeling in the determination of tumor-localizing antibodies. Cancer Res 17:845\u2013850, 1957.", "journal-title": "Cancer Res"}, {"issue": "2", "key": "8_CR19", "first-page": "123", "volume": "24", "author": "SM Larson", "year": "1983", "unstructured": "Larson SM, Brown JP, Wright PW, Carrasquillo JA, Hellstrom I, Hellstrom KE: Imaging of melanoma with I-131-labeled monoclonal antibodies. J Nucl Med 24(2): 123\u2013129, 1983.", "journal-title": "J Nucl Med"}, {"key": "8_CR20", "first-page": "3046", "volume": "40", "author": "FH DeLand", "year": "1980", "unstructured": "DeLand FH, Kimm EE, Simmons G, Goldenberg DM: Imaging approach in radioimmuno-detection. Cancer Res 40:3046\u20133049, 1980.", "journal-title": "Cancer Res"}, {"key": "8_CR21", "doi-asserted-by": "publisher", "first-page": "363", "DOI": "10.1002/path.1711410313", "volume": "141", "author": "DS Fairweather", "year": "1983", "unstructured": "Fairweather DS, Bradwell AR, Dykes PW: Nuclear imaging techniques with radiolabeled antibodies. J Pathol 141:363\u2013378, 1983.", "journal-title": "J Pathol"}, {"key": "8_CR22", "doi-asserted-by": "publisher", "first-page": "2101", "DOI": "10.1172/JCI111175", "volume": "72", "author": "SM Larson", "year": "1983", "unstructured": "Larson SM, Carrasquillo JA, Krohn KA, et al: Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. J Clin Invest 72:2101\u20132114, 1983.", "journal-title": "J Clin Invest"}, {"key": "8_CR23", "first-page": "3378", "volume": "45", "author": "GL Buraggi", "year": "1985", "unstructured": "Buraggi GL, Callegaro L, Mariani G, et al: Imaging with 131I-labeled monoclonal antibodies to a high molecular weight melanoma-associated antigen in patients with melanoma: Efficacy of whole immunoglobulin and its F(ab\u2019)2 fragments. Cancer Res 45:3378\u20133387, 1985.", "journal-title": "Cancer Res"}, {"key": "8_CR24", "first-page": "538", "volume": "26", "author": "SM Larson", "year": "1985", "unstructured": "Larson SM: Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy. J Nucl Med 26:538\u2013545, 1985.", "journal-title": "J Nucl Med"}, {"key": "8_CR25", "doi-asserted-by": "publisher", "first-page": "314", "DOI": "10.1136/jcp.34.3.314", "volume": "34", "author": "V Moshakis", "year": "1981", "unstructured": "Moshakis V, McIlhinney RAJ, Raghaven D: Monoclonal antibodies to detect human tumors: An experimental approach. J Clin Pathol 34:314\u2013319, 1981.", "journal-title": "J Clin Pathol"}, {"key": "8_CR26", "first-page": "3183", "volume": "46", "author": "AA Epenetos", "year": "1986", "unstructured": "Epenetos AA, Snook D, Durbin H, et al: Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms. Cancer Res 46:3183\u20133191, 1986.", "journal-title": "Cancer Res"}, {"key": "8_CR27", "first-page": "3036", "volume": "40", "author": "WC Eckelman", "year": "1980", "unstructured": "Eckelman WC, Paik CH, Reba RC: Radiolabeling of antibodies. Cancer Res 40:3036\u20133042, 1980.", "journal-title": "Cancer Res"}, {"key": "8_CR28", "first-page": "4267", "volume": "243", "author": "WF Benisek", "year": "1968", "unstructured": "Benisek WF, Richards FM: Attachment of metal chelating functional groups to hen egg-white lysozyme. J Biol Chem 243:4267\u20134271, 1968.", "journal-title": "J Biol Chem"}, {"key": "8_CR29", "doi-asserted-by": "publisher", "first-page": "581", "DOI": "10.1016/S0006-291X(77)80018-1", "volume": "177", "author": "GE Krejcarek", "year": "1977", "unstructured": "Krejcarek GE, Tucker KL: Covalent attachment of chelating groups to macromolecules. Biochem Biophys Res Comm 177:581\u2013585, 1977.", "journal-title": "Biochem Biophys Res Comm"}, {"key": "8_CR30", "first-page": "493", "volume": "26", "author": "DA Goodwin", "year": "1985", "unstructured": "Goodwin DA, Meares CF, McCall MJ, et al: Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse. J Nucl Med 26:493\u2013502, 1985.", "journal-title": "J Nucl Med"}, {"key": "8_CR31", "first-page": "482", "volume": "26", "author": "CH Paik", "year": "1985", "unstructured": "Paik CH, Hong JJ, Ebbert MA, Heald SC, Reba RC, Eckelman WC: Relative reactivity of DTPA immunoreactive antibody\u2014DTPA conjugates, and nonimmunoreactive antibody\u2014 DTPA conjugates toward 111In. J Nucl Med 26:482\u2013487, 1985.", "journal-title": "J Nucl Med"}, {"key": "8_CR32", "first-page": "448", "volume": "26", "author": "RA Fawwaz", "year": "1985", "unstructured": "Fawwaz RA, Wang TST, Estabrook A, et al: Immunoreactivity and biodistribution of 111In-labeled monoclonal antibody to a human high-molecular-weight melanoma-associated antigen. J Nucl Med 26:448\u2013492, 1985.", "journal-title": "J Nucl Med"}, {"key": "8_CR33", "first-page": "750", "volume": "26", "author": "H Sakahara", "year": "1985", "unstructured": "Sakahara H, Endo K, Nakashima T, et al: Effect of DTPA conjugation on the antigen binding activity and biodistribution of monoclonal antibodies against alpha-fetoprotein. J Nucl Med 26:750\u2013755, 1985.", "journal-title": "J Nucl Med"}, {"key": "8_CR34", "first-page": "267", "volume": "82", "author": "JM Metzger", "year": "1973", "unstructured": "Metzger JM, Seeker-Walker RH, Krohn KA, Welch MJ, Potchin EJ: Unsatisfactory biologic behavior of I*-fibrenogen labeled by the chloramic T method. J Lab Clin Med 82:267\u2013275, 1973.", "journal-title": "J Lab Clin Med"}, {"key": "8_CR35", "author": "P Stern", "first-page": "245", "year": "1982", "unstructured": "Stern P, Hagan P, Halpern S, et al: The effect of radiolabel on the kinetics of the monoclonal anti-CEA in a nude mouse-colon tumor model. In: Hybridomas in cancer diagnosis and treatment, Mitchell MS, Oettgen HF (eds). New York: Raven Press, 1982, pp. 245\u2013253.", "volume-title": "Hybridomas in cancer diagnosis and treatment"}, {"key": "8_CR36", "first-page": "5347", "volume": "43", "author": "SE Halpern", "year": "1983", "unstructured": "Halpern SE, Hagan PL, Garver PR, et al: Stability, characterization, and kinetics of 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models. Cancer Res 43:5347\u20135355, 1983.", "journal-title": "Cancer Res"}, {"key": "8_CR37", "first-page": "4429", "volume": "43", "author": "MI Bernhard", "year": "1987", "unstructured": "Bernhard MI, Hwang KM, Foon KA, et al: Localization of 111In- and 125I-labeled monoclonal antibody in guinea pigs bearing line 10 hepatocarcinoma tumors. Cancer Res 43:4429\u20134433, 1987.", "journal-title": "Cancer Res"}, {"key": "8_CR38", "first-page": "235", "volume": "6", "author": "SE Halpern", "year": "1987", "unstructured": "Halpern SE, Dillman RO: Problems associated with radioimmunodetection and possibilities for future solutions. J Biol Resp Modif 6:235\u2013262, 1987.", "journal-title": "J Biol Resp Modif"}, {"key": "8_CR39", "author": "JL Murray", "first-page": "143", "year": "1985", "unstructured": "Murray JL, Hersh EM, Rosenblum MG, et al: Radioimmunoimaging in malignant melanoma using 111indium-labeled anti-p97 monoclonal antibody. In: Monoclonal antibodies: Diagnostic and therapeutic use in tumor and transplantation, Chatterjee S (ed). Littleton, Mass.: PSG Publishing, 1985, pp. 143\u2013153.", "volume-title": "Monoclonal antibodies: Diagnostic and therapeutic use in tumor and transplantation"}, {"key": "8_CR40", "first-page": "2376", "volume": "45", "author": "JL Murray", "year": "1985", "unstructured": "Murray JL, Rosenblum MG, Sobol RE, et al: Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5. Cancer Res 45:2376\u20132381, 1985.", "journal-title": "Cancer Res"}, {"key": "8_CR41", "first-page": "2382", "volume": "45", "author": "MG Rosenblum", "year": "1985", "unstructured": "Rosenblum MG, Murray JL, Haynie TP, et al: Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma. Cancer Res 45: 2382\u20132386, 1985.", "journal-title": "Cancer Res"}, {"key": "8_CR42", "first-page": "25", "volume": "28", "author": "JL Murray", "year": "1987", "unstructured": "Murray JL, Rosenblum MG, Lamki L, et al: Clinical parameters related to optimal tumor localization of 111indium-labeled mouse antimelanoma monoclonal antibody ZME 018. J Nucl Med 28:25\u201333, 1987.", "journal-title": "J Nucl Med"}, {"key": "8_CR43", "first-page": "3", "volume": "3", "author": "JL Murray", "year": "1987", "unstructured": "Murray JL, Rosenblum MG, Lamki L, Haynie TP, Hersh EM: Radioimmunoimaging in malignant melanoma patients using 111indium-labeled antimelanoma monoclonal antibody (ZME 018) to a high molecular weight antigen Kd200. NCI Monographs 3:3\u20139, 1987.", "journal-title": "NCI Monographs"}, {"key": "8_CR44", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1007/BF00252958", "volume": "20", "author": "MG Rosenblum", "year": "1987", "unstructured": "Rosenblum MG, Murray JL, Lamki L, et al: Comparative clinical pharmacology of the two antimelanoma antibodies, ZME 018 and 96.5, labeled with 111indium. Cancer Chemother Pharmacol 20:41\u201347, 1987.", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "8_CR45", "unstructured": "Halpern SE, Dillman RO, Witztum KF, et al: Radioimmunodetection of melanoma utilizing 111In-96.5 monoclonal antibody: A preliminary report. Radiology 155:493\u2013499.", "DOI": "10.1148/radiology.155.2.3983401", "doi-asserted-by": "crossref"}, {"key": "8_CR46", "first-page": "25", "volume": "3", "author": "A Taylor", "year": "1987", "unstructured": "Taylor A, Milton W, Eyre H, et al: Radioimmunodetection of human melanoma utilizing 111In-labeled monoclonal antibodies. NCI Monographs 3:25\u201331, 1987.", "journal-title": "NCI Monographs"}, {"key": "8_CR47", "doi-asserted-by": "crossref", "first-page": "1247", "DOI": "10.1200/JCO.1987.5.8.1247", "volume": "5", "author": "JM Kirkwood", "year": "1987", "unstructured": "Kirkwood JM, Neuman RD, Zoghbi S, et al: Scintigraphic detection of metastatic melanoma using indium-111/DTPA conjugated anti-gp 240 antibody (ZME 018). J Clin Oncol 5:1247\u20131255, 1987.", "journal-title": "J Clin Oncol"}, {"key": "8_CR48", "first-page": "4817", "volume": "46", "author": "AG Siccardi", "year": "1986", "unstructured": "Siccardi AG, Buraggi GL, Callegaro L, et al: Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. Cancer Res 46:4817\u20134822, 1986.", "journal-title": "Cancer Res"}, {"issue": "2", "key": "8_CR49", "doi-asserted-by": "publisher", "first-page": "184", "DOI": "10.1016/0047-0740(84)90059-7", "volume": "11", "author": "RT Morrison", "year": "1984", "unstructured": "Morrison RT, Lyster DM, Alcorn L, Rhodes BA, Breslow K, Burchiel SW: Radioimmunoimaging with 99mTc monoclonal antibodies: Clinical studies. Int J Nucl Med Biol 11(2): 184\u2013188, 1984.", "journal-title": "Int J Nucl Med Biol"}, {"key": "8_CR50", "author": "J Eary", "year": "1987", "unstructured": "Eary J, Schroff R, Abrams P, et al: Radioimaging of melanoma with TC-99 m labeled monoclonal antibodies. Proc AACR 356 (abstract), 1987.", "volume-title": "Radioimaging of melanoma with TC-99 m labeled monoclonal antibodies"}, {"key": "8_CR51", "first-page": "957", "volume": "27", "author": "AR Fitzberg", "year": "1986", "unstructured": "Fitzberg AR: Radiopharmaceutical chemistry V: Antibodies. J Nucl Med 27:957\u2013958, 1986.", "journal-title": "J Nucl Med"}, {"key": "8_CR52", "first-page": "2154", "volume": "45", "author": "WT Anderson", "year": "1985", "unstructured": "Anderson WT, Strand M: Stability, targeting, and biodistribution of scandium-46- and gallium-67-labeled monoclonal antibody in erythroleukemic mice. Cancer Res 45:2154\u20132158, 1985.", "journal-title": "Cancer Res"}, {"key": "8_CR53", "author": "OA Gansow", "first-page": "215", "year": "1984", "unstructured": "Gansow OA, Atcher RW, Link DW, et al: Generator-produced Bi-212 chelated to chemically modified monoclonal antibody for use in radiotherapy. In: Radionuclide generators: New systems for nuclear medicine applications, Knapp FF Jr, Butler JA (eds). Washington, D.C.: American Chemical Society, 241:215\u2013230, 1984.", "volume-title": "Radionuclide generators: New systems for nuclear medicine applications", "DOI": "10.1021/bk-1984-0241.ch015", "doi-asserted-by": "publisher"}, {"issue": "4", "key": "8_CR54", "doi-asserted-by": "publisher", "first-page": "241", "DOI": "10.1016/0047-0740(83)90087-6", "volume": "10", "author": "WJ Bateman", "year": "1983", "unstructured": "Bateman WJ, Vaughan ADM, Brown G: Tumor localization of 211At-labeled monoclonal antibody to a subcutaneous human heterograft in the nude mouse II:. Int J Nucl Med 10(4):241\u2013242, 1983.", "journal-title": "Int J Nucl Med"}, {"key": "8_CR55", "first-page": "221", "volume": "2", "author": "BW Wessels", "year": "1985", "unstructured": "Wessels BW, Tryba S, Griffith H, et al: Direct absorbed doses measurements of Y-90 labeled melanoma monoclonal antibodies in tumored mice. Cancer Drug Deliv 2:221\u2013222, 1985.", "journal-title": "Cancer Drug Deliv"}, {"key": "8_CR56", "doi-asserted-by": "publisher", "first-page": "1318", "DOI": "10.1002/1097-0142(19841001)54:7<1318::AID-CNCR2820540715>3.0.CO;2-J", "volume": "54", "author": "BD Mann", "year": "1984", "unstructured": "Mann BD, Cohen MB, Saxton RE, et al: Imaging of human tumor xenografts in nude mice with monoclonal antibodies: Limitations of specificity due to nonspecific uptake of antibody. Cancer 54:1318\u20131327, 1984.", "journal-title": "Cancer"}, {"key": "8_CR57", "first-page": "2111", "volume": "132", "author": "B Bailou", "year": "1984", "unstructured": "Bailou B, Jaffe R, Taylor RJ, Solter D, Hakala TR: Tumor radioimmunolocation: Differential antibody retention by antigenic normal tissue and tumor. J Immunol 132:2111\u20132116, 1984.", "journal-title": "J Immunol"}, {"key": "8_CR58", "first-page": "3157", "volume": "46", "author": "DF Hayes", "year": "1986", "unstructured": "Hayes DF, Zalutsky MR, Kaplan W, et al: Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancer. Cancer Res 46:3157\u20133163, 1986.", "journal-title": "Cancer Res"}, {"key": "8_CR59", "first-page": "736", "volume": "43", "author": "D Colcher", "year": "1983", "unstructured": "Colcher D, Zalutsky ML, Kaplan W, Kube D, Austin F, Schlom J: Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody. Cancer Res 43:736\u2013742, 1983.", "journal-title": "Cancer Res"}, {"key": "8_CR60", "first-page": "3157", "volume": "46", "author": "R Dillman", "year": "1984", "unstructured": "Dillman R, Beuregard J, Sobol R, et al: Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells. Cancer Res 46:3157\u20133163, 1984.", "journal-title": "Cancer Res"}, {"key": "8_CR61", "first-page": "1530", "volume": "135", "author": "DL Shawler", "year": "1985", "unstructured": "Shawler DL, Bartholomew RM, Smith LM, Dillman RO: Human murine response to multiple injections of murine monoclonal IgG. J Immunol 135:1530\u20131535, 1985.", "journal-title": "J Immunol"}, {"key": "8_CR62", "first-page": "879", "volume": "45", "author": "RW Schroff", "year": "1985", "unstructured": "Schroff RW, Foon KA, Beatty SM, Oldham RK, Morgan AC Jr: Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Research 45:879\u2013885, 1985.", "journal-title": "Cancer Research"}, {"issue": "3", "key": "8_CR63", "doi-asserted-by": "publisher", "first-page": "283", "DOI": "10.1016/0277-5379(85)90126-9", "volume": "21", "author": "D Bron", "year": "1985", "unstructured": "Bron D, Delforge A, Stryckmans P: Human monoclonal antibodies: New approaches and perspectives in cancer. Eur J Cancer Clin Oncol 21 (3):283\u2013285, 1985.", "journal-title": "Eur J Cancer Clin Oncol"}, {"key": "8_CR64", "first-page": "2490", "volume": "46", "author": "J Kan-Mitchell", "year": "1986", "unstructured": "Kan-Mitchell J, Imam A, Kempf RA, Taylor CR, Mitchell MS: Human monoclonal antibodies directed against melanoma tumor-associated antigens. Cancer Res 46:2490\u20132496, 1986.", "journal-title": "Cancer Res"}, {"key": "8_CR65", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1016/0003-2697(83)90131-8", "volume": "131", "author": "CO Beauchamp", "year": "1983", "unstructured": "Beauchamp CO, Gonias SL, Menapace DP, Pizzo SV: A new procedure for the synthesis of polyethylene glycol-protein adducts: Effects on function, receptor recognition, and clearance of superoxide dismutase, lactoferrin, and alpha2-macroglobulin. Ann Biochem 131:25\u201333, 1983.", "journal-title": "Ann Biochem"}, {"key": "8_CR66", "doi-asserted-by": "publisher", "first-page": "455", "DOI": "10.1126/science.4012325", "volume": "229", "author": "JL Marx", "year": "1985", "unstructured": "Marx JL: Antibodies made to order. Science 229:455\u2013456, 1985.", "journal-title": "Science"}, {"key": "8_CR67", "first-page": "1418", "volume": "26", "author": "P Hagan", "year": "1985", "unstructured": "Hagan P, Halpern S, Chen A, et al: In vivo kinetics of radiolabeled monoclonal anti-CEA antibodies in animal models. J Nucl Med 26:1418\u20131423, 1985.", "journal-title": "J Nucl Med"}, {"key": "8_CR68", "doi-asserted-by": "publisher", "first-page": "865", "DOI": "10.1126/science.6879183", "volume": "221", "author": "Z Steplewski", "year": "1983", "unstructured": "Steplewski Z, Lubeck MD, Koprowski H: Human macrophages armed with murine immunoglobulin G2a antibodies to tumor destroy human cancer cells. Science 221:865\u2013867, 1983.", "journal-title": "Science"}, {"key": "8_CR69", "first-page": "384", "volume": "28", "author": "JL Murray", "year": "1987", "unstructured": "Murray JL, Lamki LM, Rosenblum MG, Carlo DJ, Unger MW: Effect of escalating doses of nonimmunoreactive (NIR) Mo Ab 96.5 A on liver uptake of tumor-specific (111In)-MoAb 96.5C. Proc AACR 28:384 (abstract), 1987.", "journal-title": "Proc AACR"}, {"key": "8_CR70", "doi-asserted-by": "publisher", "first-page": "171", "DOI": "10.1038/296171a0", "volume": "296", "author": "JP Brown", "year": "1982", "unstructured": "Brown JP, Hevick RM, Hellstrom I, Hellstrom KE, Doolittle RF, Dreyer WJ: Human melanoma-associated antigen p97 is structurally and functionally related to transferrin. Nature 296:171\u2013173, 1982.", "journal-title": "Nature"}, {"key": "8_CR71", "first-page": "1746", "volume": "27", "author": "MC Ward", "year": "1986", "unstructured": "Ward MC, Roberts KR, Westwood JH, Coombes RCC, McCready VR: The effect of chelating agents on the distribution of monoclonal antibodies in mice. J Nucl Med 27:1746\u20131750, 1986.", "journal-title": "J Nucl Med"}, {"key": "8_CR72", "doi-asserted-by": "publisher", "first-page": "1334", "DOI": "10.1126/science.7146917", "volume": "218", "author": "JN Weinstein", "year": "1982", "unstructured": "Weinstein JN, Parker RJ, Keenan AM, Dower SK, Morse HC III, Sieber SM: Monoclonal antibodies in lymphatics: Toward the diagnosis and therapy of tumor metastases. Science 218:1334\u20131337, 1982.", "journal-title": "Science"}, {"key": "8_CR73", "first-page": "34", "volume": "28", "author": "WB Nelp", "year": "1987", "unstructured": "Nelp WB, Eary JF, Jones RF, et al: Preliminary studies of monoclonal antibody lymphoscintigraphy in malignant melanoma. J Nucl Med 28:34\u201341, 1987.", "journal-title": "J Nucl Med"}, {"key": "8_CR74", "first-page": "213", "volume": "6", "author": "M Frontiera", "year": "1987", "unstructured": "Frontiera M, Schmelter R, Chu H, et al: Immunolymphoscintigraphy with radiolabeled monoclonal antibodies in patients with malignant melanoma. Proc ASCO 6:213 (abstract), 1987.", "journal-title": "Proc ASCO"}, {"key": "8_CR75", "first-page": "47", "volume": "3", "author": "DR Stickney", "year": "1987", "unstructured": "Stickney DR, Gridley DS, Kirk GA: Enhancement of monoclonal antibody (MoAb) binding to melanoma with single dose radiation or hyperthermia. NCI Monographs 3:47\u201352, 1987.", "journal-title": "NCI Monographs"}, {"key": "8_CR76", "first-page": "4109", "volume": "45", "author": "L Davies de", "year": "1985", "unstructured": "Davies C de L, Rofstad EK, Lindmo T: Hyperthermia-induced changes in antigen expression on human FME melanoma cells. Cancer Res 45:4109\u20134115, 1985.", "journal-title": "Cancer Res"}, {"key": "8_CR77", "first-page": "4904", "volume": "45", "author": "Z Krizan", "year": "1985", "unstructured": "Krizan Z, Murray JL, Hersh EM, et al: Increased labeling of human melanoma cells in vitro using combinations of monoclonal antibodies recognizing separate cell surface ante-genic determinants. Cancer Res 45:4904\u20134909, 1985.", "journal-title": "Cancer Res"}, {"key": "8_CR78", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1002/ijc.2910340104", "volume": "34", "author": "C Cillo", "year": "1984", "unstructured": "Cillo C, Mach JP, Schreyer M, Carrel S: Antigenic heterogeneity of clones and subclones from human melanoma cell lines demonstrated by a panel of monoclonal antibodies and flow microfluorimetry analysis. Int J Cancer 34:11\u201320, 1984.", "journal-title": "Int J Cancer"}, {"key": "8_CR79", "first-page": "1951", "volume": "21", "author": "SW Burchiel", "year": "1982", "unstructured": "Burchiel SW, Imai K, Ferrone S, Warner NL: Heterogeneity of cell surface antigen expression on human melanoma cells: Analysis with monoclonal antibodies and flow cytometry. Prog Cancer Res Ther 21:1951, 1982.", "journal-title": "Prog Cancer Res Ther"}, {"key": "8_CR80", "doi-asserted-by": "publisher", "first-page": "949", "DOI": "10.1002/1097-0142(19830915)52:6<949::AID-CNCR2820520602>3.0.CO;2-2", "volume": "52", "author": "ME Dantas", "year": "1983", "unstructured": "Dantas ME, Brown JP, Thomas MR, Robinson WA, Glode LM: Detection of melanoma cells in bone marrow using monoclonal antibodies: A comparison of fluorescence activated cell sorting (FACS) and conventional immunofluorescence (IF). Cancer 52:949\u2013953, 1983.", "journal-title": "Cancer"}, {"key": "8_CR81", "first-page": "1739", "volume": "27", "author": "DL Minz", "year": "1986", "unstructured": "Minz DL, Alavi A, Koprowski H, Herlyn D: Improved radioimmunoimaging of human tumor xenografts by a mixture of monoclonal antibody F(ab\u2019)2; fragments. J Nucl Med 27:1739\u20131745, 1986.", "journal-title": "J Nucl Med"}, {"key": "8_CR82", "first-page": "3208", "volume": "44", "author": "JW Greiner", "year": "1984", "unstructured": "Greiner JW, Hand PH, Noguchi P, Fisher PB, Pestka S, Schlom J: Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment. Cancer Res 44:3208\u20133214, 1984.", "journal-title": "Cancer Res"}, {"issue": "3", "key": "8_CR83", "first-page": "1649", "volume": "133", "author": "P Giacomini", "year": "1984", "unstructured": "Giacomini P, Aguzzi A, Pestka S, Fisher PB, Ferrone S: Modulation by recombinant DNA leukocyte (\u03b1) and fibroblast (\u00df) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells. J Immunol 133(3): 1649\u20131655, 1984.", "journal-title": "J Immunol"}, {"key": "8_CR84", "first-page": "152", "volume": "7", "author": "JL Murray", "year": "1988", "unstructured": "Murray JL, Stuckey SE, Pillow JK, Rosenblum MG, Carlo DJ, Gutterman JU: Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma associated surface antigens. J Biol Resp Modif 7:152\u2013161, 1988.", "journal-title": "J Biol Resp Modif"}, {"key": "8_CR85", "doi-asserted-by": "publisher", "first-page": "895", "DOI": "10.1126/science.3580039", "volume": "235", "author": "JW Greiner", "year": "1987", "unstructured": "Greiner JW, Guadagni F, Noguchi P, et al: Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo. Science 235:895\u2013898, 1987.", "journal-title": "Science"}, {"key": "8_CR86", "doi-asserted-by": "crossref", "first-page": "160", "DOI": "10.1093/jnci/80.3.160", "volume": "80", "author": "MG Rosenblum", "year": "1987", "unstructured": "Rosenblum MG, Lamki LM, Murray JL, Carlo DJ, Gutterman JU: Interferon-induced changes in the pharmacokinetics and tumor uptake of 111In-labeled anti-melanoma antibody 96.5 in melanoma patients. JNCI 80:160\u2013165, 1987.", "journal-title": "JNCI"}, {"key": "8_CR87", "first-page": "5744", "volume": "44", "author": "D Colcher", "year": "1984", "unstructured": "Colcher D, Kennan AM, Larson SM, Schlom J: Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts. Cancer Res 44:5744\u20135751, 1984.", "journal-title": "Cancer Res"}, {"key": "8_CR88", "first-page": "1536", "volume": "45", "author": "CC Badger", "year": "1985", "unstructured": "Badger CC, Krohn KA, Peterson AV, Schulman H, Bernstein ID: Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody. Cancer Res 45:1536\u20131544, 1985.", "journal-title": "Cancer Res"}, {"key": "8_CR89", "doi-asserted-by": "publisher", "first-page": "502", "DOI": "10.1126/science.6836294", "volume": "220", "author": "RT Proffitt", "year": "1983", "unstructured": "Proffitt RT, Williams LE, Presant CA, et al: Liposomal blockage of the reticuloendothelial system: Improved tumor imaging with small unilamellar vesicles. Science 220:502\u2013505, 1983.", "journal-title": "Science"}, {"key": "8_CR90", "doi-asserted-by": "publisher", "first-page": "739", "DOI": "10.1016/S0140-6736(82)90923-0", "volume": "2", "author": "RHJ Begent", "year": "1982", "unstructured": "Begent RHJ, Keep PA, Green AJ, et al: Liposomally entrapped second antibody improves tumor imaging with radiolabeled (first) antitumor antibody. Lancet 2:739\u2013742, 1982.", "journal-title": "Lancet"}, {"key": "8_CR91", "author": "RL Ceriani", "first-page": "207", "year": "1985", "unstructured": "Peterson JA and Ceriani RL: International workshop on monoclonal antibodies and breast cancer. In: Breast cancer research and treatment (Volume 5), Ceriani RL (ed). Boston; Martinus Nijhoff, 1985, pp. 207\u2013214.", "volume-title": "Breast cancer research and treatment (Volume 5)"}, {"key": "8_CR92", "doi-asserted-by": "publisher", "first-page": "938", "DOI": "10.1126/science.6474160", "volume": "225", "author": "IJ East", "year": "1984", "unstructured": "East IJ, Keenan AM, Larson CM, Dean J: Scintigraphy of normal mouse ovaries with monoclonal antibodies to ZP-2, the major zonal pellucida protein. Science 225:938\u2013941, 1984.", "journal-title": "Science"}, {"key": "8_CR93", "first-page": "233", "volume": "2", "author": "AA Epenetos", "year": "1985", "unstructured": "Epenetos AA: Clinical results with regional antibody-guided irradiation. Cancer Drug Deliv 2:233 (abstract), 1985.", "journal-title": "Cancer Drug Deliv"}], "container-title": ["Cancer Treatment and Research", "Malignant Melanoma: Biology, Diagnosis, and Therapy"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4613-1751-7_8", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 13]], "date-time": "2019-04-13T09:57:39Z", "timestamp": 1555149459000}, "score": 24.080873, "issued": {"date-parts": [[1988]]}, "ISBN": ["9781461289838", "9781461317517"], "references-count": 93, "URL": "http://dx.doi.org/10.1007/978-1-4613-1751-7_8", "relation": {"cites": []}, "ISSN": ["0927-3042"], "issn-type": [{"value": "0927-3042", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T04:22:50Z", "timestamp": 1574223770409}, "publisher-location": "New York", "reference-count": 82, "publisher": "Springer-Verlag", "isbn-type": [{"value": "0387229493", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/0-387-28274-2_52", "type": "book-chapter", "created": {"date-parts": [[2006, 8, 1]], "date-time": "2006-08-01T12:27:56Z", "timestamp": 1154435276000}, "page": "778-797", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Gene Therapy for Malignant Pleural Mesothelioma"], "prefix": "10.1007", "author": [{"given": "Steven M.", "family": "Albelda", "sequence": "first", "affiliation": []}, {"given": "Larry R.", "family": "Kaiser", "sequence": "additional", "affiliation": []}, {"given": "Daniel H.", "family": "Sterman", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "52_CR1", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/S1569-2558(08)60338-0", "volume": "14", "author": "D.T. Curiel", "year": "1996", "unstructured": "Curiel DT, Pilewsky JM, Albelda SM. Gene therapy approaches for inherited and acquired diseases of the lung. Am J Respir Cell Mol Biol 1996;14:1\u201318.", "journal-title": "Am J Respir Cell Mol Biol"}, {"key": "52_CR2", "doi-asserted-by": "publisher", "first-page": "483", "DOI": "10.1016/S0889-8588(05)70004-6", "volume": "12", "author": "N.A. Wivel", "year": "1998", "unstructured": "Wivel NA, Wilson JM. Methods of gene delivery. Hematol Oncol Clin North Am 1998;12:483\u2013501.", "journal-title": "Hematol Oncol Clin North Am"}, {"key": "52_CR3", "first-page": "2499", "volume": "95", "author": "G.L. Buchschacher Jr", "year": "2000", "unstructured": "Buchschacher GL Jr, Wong-Stall F. Development of lentiviral vectors for gene therapy for human diseases. Blood 2000;95:2499\u20132504.", "journal-title": "Blood"}, {"key": "52_CR4", "doi-asserted-by": "publisher", "first-page": "24", "DOI": "10.1038/sj.gt.3301109", "volume": "7", "author": "P.E. Monahan", "year": "2000", "unstructured": "Monahan PE, Samulski RJ. AAV vectors: is clinical success on the horizon. Gene Ther 2000;7:24\u201330.", "journal-title": "Gene Ther"}, {"key": "52_CR5", "first-page": "6313", "volume": "61", "author": "S. Ponnazhagan", "year": "2001", "unstructured": "Ponnazhagan S, Curiel DT, Shaw DR, Alvarez RD, Siegal GP. Adenoassociated virus for cancer gene therapy. Cancer Res 2001;61:6313\u20136321.", "journal-title": "Cancer Res"}, {"key": "52_CR6", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1146/annurev.biophys.29.1.27", "volume": "29", "author": "S. Chesnoy", "year": "2000", "unstructured": "Chesnoy S, Huang L. Structure and function of lipid-DNA complexes for gene delivery. Annu Rev Biophys Biomol Struct 2000;29:27\u201347.", "journal-title": "Annu Rev Biophys Biomol Struct"}, {"key": "52_CR7", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.1038/sj.cgt.7700024", "volume": "6", "author": "W.W. Zhang", "year": "1999", "unstructured": "Zhang WW. Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther 1999;6:113\u2013138.", "journal-title": "Cancer Gene Ther"}, {"key": "52_CR8", "doi-asserted-by": "crossref", "first-page": "615", "DOI": "10.1096/fasebj.11.8.9240963", "volume": "11", "author": "P. Yeh", "year": "1997", "unstructured": "Yeh P, Perricaudet M. Advances in adenoviral vectors: from genetic engineering to their biology. FASEB J 1997;11:615\u2013623.", "journal-title": "FASEB J"}, {"key": "52_CR9", "doi-asserted-by": "crossref", "first-page": "2047", "DOI": "10.1089/hum.1996.7.16-2047", "volume": "7", "author": "J. Treat", "year": "1996", "unstructured": "Treat J, Kaiser LR, Sterman DH, et al. Treatment of advanced mesothelioma with the recombinant adenovirus H5.010RSVTK: a phase 1 trial (BB-IND 6274). Hum Gene Ther 1996;7:2047\u20132057.", "journal-title": "Hum Gene Ther"}, {"key": "52_CR10", "first-page": "168", "volume": "150", "author": "P. Schwarzenberger", "year": "1998", "unstructured": "Schwarzenberger P, Harrison L, Weinacker A, et al. Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana. J La State Med Soc 1998;150:168\u2013174.", "journal-title": "J La State Med Soc"}, {"key": "52_CR11", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1097/00002371-199805000-00007", "volume": "21", "author": "B.W. Robinson", "year": "1998", "unstructured": "Robinson BW, Mukherjee SA, Davidson A, et al. Cytokine gene therapy or infusion as treatment for solid human cancer. J Immunother 1998;21:211\u2013217.", "journal-title": "J Immunother"}, {"key": "52_CR12", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1002/jlb.56.2.203", "volume": "56", "author": "P. Tiberghien", "year": "1994", "unstructured": "Tiberghien P. Use of suicide genes in gene therapy. J Leukoc Biol 1994;56:203\u2013209.", "journal-title": "J Leukoc Biol"}, {"key": "52_CR13", "first-page": "1315", "volume": "56", "author": "D.K. Hoganson", "year": "1996", "unstructured": "Hoganson DK, Batra RK, Olsen JC, Boucher RC. Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma. Cancer Res 1996;56:1315\u20131323.", "journal-title": "Cancer Res"}, {"key": "52_CR14", "doi-asserted-by": "crossref", "first-page": "S494", "DOI": "10.1093/clinids/10.Supplement_3.S490", "volume": "10", "author": "T. Matthews", "year": "1988", "unstructured": "Matthews T, Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis 1988;10:S494.", "journal-title": "Rev Infect Dis"}, {"key": "52_CR15", "doi-asserted-by": "publisher", "first-page": "1005", "DOI": "10.1016/S0959-8049(96)00483-2", "volume": "33", "author": "I.M. Pope", "year": "1997", "unstructured": "Pope IM, Poston GJ, Kinsella AR. The role of the bystander effect in suicide gene therapy. Eur J Cancer 1997;33:1005\u20131016.", "journal-title": "Eur J Cancer"}, {"key": "52_CR16", "first-page": "83", "volume": "53", "author": "Z. Ram", "year": "1993", "unstructured": "Ram Z, Culver KW, Walbridge B, Blaese RM, Oldfield EH. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993;53:83\u201388.", "journal-title": "Cancer Res"}, {"key": "52_CR17", "first-page": "5274", "volume": "53", "author": "S.M. Freeman", "year": "1993", "unstructured": "Freeman SM, Abboud CN, Whartenby KA, et al. The \u201cbystander effect\u201d: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993;53:5274\u20135283.", "journal-title": "Cancer Res"}, {"key": "52_CR18", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1165/ajrcmb/8.6.655", "volume": "8", "author": "Y. Hasegawa", "year": "1993", "unstructured": "Hasegawa Y, Emi N, Shimokata K, et al. Gene transfer of herpes simplex virus type I thymidine kinase gene as a drug sensitivity gene into human lung cancer lines using retroviral vectors. Am J Respir Cell Mol Biol 1993;8:655\u2013661.", "journal-title": "Am J Respir Cell Mol Biol"}, {"key": "52_CR19", "doi-asserted-by": "publisher", "first-page": "7024", "DOI": "10.1073/pnas.90.15.7024", "volume": "90", "author": "M. Caruso", "year": "1993", "unstructured": "Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL, Klatzmann D. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 1993;90:7024\u20137028.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "52_CR20", "first-page": "85", "volume": "3", "author": "A.A. Elshami", "year": "1996", "unstructured": "Elshami AA, Saavedra A, Zhang HB, et al. Gap junctions play a role in the bystander effect of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther 1996;3:85\u201392.", "journal-title": "Gene Ther"}, {"key": "52_CR21", "first-page": "3989", "volume": "60", "author": "M. Mesnil", "year": "2000", "unstructured": "Mesnil M, Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res 2000;60:3989\u20133999.", "journal-title": "Cancer Res"}, {"key": "52_CR22", "first-page": "2055", "volume": "54", "author": "W.R. Smythe", "year": "1994", "unstructured": "Smythe WR, Hwang HC, Amin KM, et al. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res 1994;54:2055\u20132059.", "journal-title": "Cancer Res"}, {"key": "52_CR23", "doi-asserted-by": "publisher", "first-page": "1395", "DOI": "10.1016/0003-4975(94)90090-6", "volume": "57", "author": "W.R. Smythe", "year": "1994", "unstructured": "Smythe WR, Kaiser LR, Amin KM, et al. Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann Thorac Surg 1994;57:1395\u20131401.", "journal-title": "Ann Thorac Surg"}, {"key": "52_CR24", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1097/00000658-199507000-00013", "volume": "222", "author": "W.R. Smythe", "year": "1995", "unstructured": "Smythe WR, Hwang HC, Elshami AA, et al. Successful treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex-thymidine kinase gene. Ann Surg 1995;222:78\u201386.", "journal-title": "Ann Surg"}, {"key": "52_CR25", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1165/ajrcmb.13.1.7598939", "volume": "13", "author": "H.C. Hwang", "year": "1995", "unstructured": "Hwang HC, Smythe WR, Elshami AA, et al. Gene therapy using adenovirus carrying the herpes simplex thymidine kinase gene to treat in vitro models of human malignant mesothelioma and lung cancer. Am J Respir Cell Mol Biol 1995;13:7\u201316.", "journal-title": "Am J Respir Cell Mol Biol"}, {"key": "52_CR26", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1089/hum.1996.7.2-141", "volume": "7", "author": "A. Elshami", "year": "1996", "unstructured": "Elshami A, Kucharczuk J, Zhang H, et al. Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the HSV-thymidine kinase gene. Hum Gene Ther 1996;7:141\u2013148.", "journal-title": "Hum Gene Ther"}, {"key": "52_CR27", "doi-asserted-by": "publisher", "first-page": "280", "DOI": "10.1038/sj.gt.3300385", "volume": "4", "author": "M.C. Esandi", "year": "1997", "unstructured": "Esandi MC, van Someren GD, Vincent AJ, et al. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene. Gene Ther 1997;4:280\u2013287.", "journal-title": "Gene Ther"}, {"key": "52_CR28", "doi-asserted-by": "crossref", "first-page": "2225", "DOI": "10.1089/hum.1996.7.18-2225", "volume": "7", "author": "J.C. Kucharczuk", "year": "1996", "unstructured": "Kucharczuk JC, Raper S, Elshami AA, et al. Safety of adenoviral-mediated transfer of the herpes simplex thymidine kinase cDNA to the pleural cavity of rats and non-human primates. Hum Gene Ther 1996;7:2225\u20132233.", "journal-title": "Hum Gene Ther"}, {"key": "52_CR29", "doi-asserted-by": "crossref", "first-page": "1083", "DOI": "10.1089/hum.1998.9.7-1083", "volume": "9", "author": "D.H. Sterman", "year": "1998", "unstructured": "Sterman DH, Treat J, Litzky LA, et al. Adenovirus-mediated herpes simplex virus thymidine kinase gene delivery in patients with localized malignancy: results of a phase 1 clinical trial in malignant mesothelioma. Hum Gene Ther 1998;9:1083\u20131092.", "journal-title": "Hum Gene Ther"}, {"key": "52_CR30", "doi-asserted-by": "crossref", "first-page": "2121", "DOI": "10.1089/hum.1998.9.14-2121", "volume": "9", "author": "K.L. Molnar-Kimber", "year": "1998", "unstructured": "Molnar-Kimber KL, Sterman DH, Chang M, et al. Humoral and cellular immune responses induced by adenoviral-based gene therapy for localized malignancy: results of a phase 1 clinical trial for malignant mesothelioma. Hum Gene Ther 1998;9:2121\u20132133.", "journal-title": "Hum Gene Ther"}, {"key": "52_CR31", "doi-asserted-by": "publisher", "first-page": "1511", "DOI": "10.1038/sj.cgt.7700269", "volume": "7", "author": "D.H. Sterman", "year": "2000", "unstructured": "Sterman DH, Molnar-Kimber K, Iyengar T, et al. A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma. Cancer Gene Ther 2000;7:1511\u20131518.", "journal-title": "Cancer Gene Ther"}, {"key": "52_CR32", "first-page": "8934", "volume": "70", "author": "G.P. Gao", "year": "1996", "unstructured": "Gao GP, Yang Y, Wilson JM. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol 1996;70:8934\u20138943.", "journal-title": "J Virol"}, {"key": "52_CR33", "first-page": "A237", "volume": "159", "author": "D.H. Sterman", "year": "1999", "unstructured": "Sterman DH, Recio A, Molnar-Kimber K, et al. Herpes simplex virus thymidine kinase (HSVtk) gene therapy utilizing an E1/E4-deleted adenoviral vector: preliminary results of a phase I clinical trial for pleural mesothelioma. Am J Respir Crit Care Med 1999;159:A237.", "journal-title": "Am J Respir Crit Care Med"}, {"key": "52_CR34", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1006/mthe.2001.0305", "volume": "3", "author": "I.H. Carmen", "year": "2001", "unstructured": "Carmen IH. A death in the laboratory: the politics of the Gelsinger after-math. Mol Ther J Am Soc Gene Ther 2001;3:425\u2013428.", "journal-title": "Mol Ther J Am Soc Gene Ther"}, {"key": "52_CR35", "doi-asserted-by": "publisher", "first-page": "1856", "DOI": "10.1016/S0003-4975(00)01815-4", "volume": "70", "author": "E.S. Lambright", "year": "2000", "unstructured": "Lambright ES, Force SD, Lanuti M, et al. Efficacy of repeated adenoviral suicide gene therapy in a localized murine tumor model. Ann Thorac Surg 2000;70:1856\u20131870.", "journal-title": "Ann Thorac Surg"}, {"key": "52_CR36", "doi-asserted-by": "publisher", "first-page": "553", "DOI": "10.1067/mob.2000.104837", "volume": "182", "author": "A. Al-Hendry", "year": "2000", "unstructured": "Al-Hendry A, Magliocco AM, Al-Tweigeri T, et al. Ovarian cancer gene therapy: repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model. Am J Obstet Gynecol 2000;182:553\u2013559.", "journal-title": "Am J Obstet Gynecol"}, {"key": "52_CR37", "doi-asserted-by": "publisher", "first-page": "3525", "DOI": "10.1073/pnas.93.8.3525", "volume": "93", "author": "M.E. Black", "year": "1996", "unstructured": "Black ME, Newcomb TG, Wilson HMP, Loeb LA. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc Natl Acad Sci USA 1996;93:3525\u20133529.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "52_CR38", "doi-asserted-by": "publisher", "first-page": "1569", "DOI": "10.1089/10430340050083298", "volume": "11", "author": "H.J. Qiao", "year": "2000", "unstructured": "Qiao HJ, Black ME, Caruso M. Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with retroviral vector carrying a herpes simplex thymidine kinase gene mutant. Hum Gene Ther 2000;11:1569\u20131576.", "journal-title": "Hum Gene Ther"}, {"key": "52_CR39", "first-page": "3022", "volume": "61", "author": "M.E. Black", "year": "2001", "unstructured": "Black ME, Kokoris MS, Sabo P. Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing. Cancer Res 2001;61:3022\u20133026.", "journal-title": "Cancer Res"}, {"key": "52_CR40", "unstructured": "Wiewrodt R, Amin K, Keifer M, et al. Adenovirus-mediated gene transfer of enhanced herpes simplex thymidine kinase mutants improves prodrug-mediated tumor cell killing. Cancer Gene Ther, in press.", "DOI": "10.1038/sj.cgt.7700589", "doi-asserted-by": "crossref"}, {"key": "52_CR41", "first-page": "3221", "volume": "58", "author": "S.J. Hall", "year": "1998", "unstructured": "Hall SJ, Sanford MA, Atkinson G, Chen SH. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer. Cancer Res 1998;58:3221\u20133225.", "journal-title": "Cancer Res"}, {"key": "52_CR42", "doi-asserted-by": "publisher", "first-page": "2", "DOI": "10.1016/S0140-6736(97)22001-5", "volume": "349", "author": "S.M. Freeman", "year": "1997", "unstructured": "Freeman SM, Ramesh R, Marogi AJ. Immune system in suicide gene therapy. Lancet 1997;349:2\u20133.", "journal-title": "Lancet"}, {"key": "52_CR43", "doi-asserted-by": "publisher", "first-page": "267", "DOI": "10.1002/(SICI)1097-0215(19970410)71:2<267::AID-IJC23>3.0.CO;2-D", "volume": "71", "author": "R.G. Vile", "year": "1997", "unstructured": "Vile RG, Castleden S, Marshall J, Camplejohn R, Upton C, Chong H. Generation of an anti-tumor immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression. Int J Cancer 1997;71:267\u2013274.", "journal-title": "Int J Cancer"}, {"key": "52_CR44", "doi-asserted-by": "publisher", "first-page": "581", "DOI": "10.1038/nm0598-581", "volume": "4", "author": "A. Melcher", "year": "1998", "unstructured": "Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile R. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med 1998;4:581\u2013587.", "journal-title": "Nat Med"}, {"key": "52_CR45", "doi-asserted-by": "publisher", "first-page": "2577", "DOI": "10.1073/pnas.92.7.2577", "volume": "92", "author": "S.H. Chen", "year": "1995", "unstructured": "Chen SH, Li Chen XH, Wang Y, et al. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci USA 1995;92:2577\u20132581.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "52_CR46", "first-page": "A563", "volume": "157", "author": "J. Kolls", "year": "1998", "unstructured": "Kolls J, Freeman S, Ramesh R, et al. The treatment of malignant pleural mesothelioma with gene modified cancer cells: a phase I study. Am J Respir Crit Care Med 1998;157:A563.", "journal-title": "Am J Respir Crit Care Med"}, {"key": "52_CR47", "doi-asserted-by": "crossref", "first-page": "356", "DOI": "10.1038/icb.1997.55", "volume": "75", "author": "C.C. Leong", "year": "1997", "unstructured": "Leong CC, Marley JV, Loh S, Robinson BWS, Garlepp MJ. The induction of immune responses to murine mesothelioma by IL-2 gene transfer. Immunol Cell Biol 1997;75:356\u2013359.", "journal-title": "Immunol Cell Biol"}, {"key": "52_CR48", "doi-asserted-by": "crossref", "first-page": "591", "DOI": "10.1089/hum.1995.6.5-591", "volume": "6", "author": "H. Fakharai", "year": "1995", "unstructured": "Fakharai H, Shawler D, Gjerset R, et al. Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity. Hum Gen Ther 1995;6:591\u2013601.", "journal-title": "Hum Gen Ther"}, {"key": "52_CR49", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1089/jir.1993.13.9", "volume": "13", "author": "T. Christmas", "year": "1993", "unstructured": "Christmas T, Manning LS, Garlepp MJ, Mush AW, Robinson BW. Effect of Interferon-alpha 2a on malignant mesothelioma. Interferon Res 1993;13:9\u201312.", "journal-title": "Interferon Res"}, {"key": "52_CR50", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1378/chest.103.1.209", "volume": "103", "author": "P. Astoul", "year": "1993", "unstructured": "Astoul P, Viallat JR, Laurent JC, Brandley M, Boutin C. Intrapleural IL-2 in passive immunotherapy for malignant pleural effusion. Chest 1993;103:209\u2013213.", "journal-title": "Chest"}, {"key": "52_CR51", "doi-asserted-by": "publisher", "first-page": "2099", "DOI": "10.1002/(SICI)1097-0142(19981115)83:10<2099::AID-CNCR8>3.0.CO;2-3", "volume": "83", "author": "P. Astoul", "year": "1998", "unstructured": "Astoul P, Picat-Joossen D, Viallat J, Boutin C. Intrapleural administration of interleuken-2 for the treatment of patients with malignant pleural mesothelioma: a phase II study. Cancer 1998;83:2099\u20132104.", "journal-title": "Cancer"}, {"key": "52_CR52", "doi-asserted-by": "publisher", "first-page": "2033", "DOI": "10.1002/1097-0142(19910415)67:8<2033::AID-CNCR2820670804>3.0.CO;2-8", "volume": "67", "author": "C. Boutin", "year": "1991", "unstructured": "Boutin C, Viallat J, VanZandwijk N, et al. Activity of intrapleural recombinant gamma-interferon in malignant mesothelioma. Cancer 1991;67:2033\u20132037.", "journal-title": "Cancer"}, {"key": "52_CR53", "doi-asserted-by": "publisher", "first-page": "2460", "DOI": "10.1002/1097-0142(19941101)74:9<2460::AID-CNCR2820740912>3.0.CO;2-N", "volume": "74", "author": "C. Boutin", "year": "1994", "unstructured": "Boutin C, Nussbaum E, Monnet I, et al. Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma. Cancer 1994;74:2460\u20132467.", "journal-title": "Cancer"}, {"key": "52_CR54", "first-page": "220", "volume": "3", "author": "B. Robinson", "year": "1993", "unstructured": "Robinson B, Bowman R, Manning L, Musk A, Van Hazel G. Interleukin-2 and lymphokine-activated killer cells in malignant mesothelioma. Eur Respir Rev 1993;3:220\u2013222.", "journal-title": "Eur Respir Rev"}, {"key": "52_CR55", "doi-asserted-by": "crossref", "first-page": "1283", "DOI": "10.1038/bjc.1995.501", "volume": "72", "author": "S.H. Goey", "year": "1995", "unstructured": "Goey SH, Eggermont AM, Punt CJ, et al. Intrapleural administration of interleukin-2 in pleural mesothelioma: a Phase I-II study. Br J Cancer 1995;72:1283\u20131288.", "journal-title": "Br J Cancer"}, {"key": "52_CR56", "doi-asserted-by": "publisher", "first-page": "663", "DOI": "10.1038/sj.cgt.7700133", "volume": "7", "author": "S. Mukherjee", "year": "2000", "unstructured": "Mukherjee S, Haenel T, Himbeck R, et al. Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: persistent transgene expression despite antibody generation. Cancer Gene Ther 2000;7:663\u2013670.", "journal-title": "Cancer Gene Ther"}, {"key": "52_CR57", "doi-asserted-by": "crossref", "first-page": "738", "DOI": "10.1165/ajrcmb.19.5.3257m", "volume": "19", "author": "I. Caminschi", "year": "1998", "unstructured": "Caminschi I, Venetsanakos E, Leong CC, Garlepp MJ, Scott B, Robinson BWS. Interleukin-12 induces an effective antitumor response in malignant mesothelioma. Am J Respir Cell Mol Biol 1998;19:738\u2013746.", "journal-title": "Am J Respir Cell Mol Biol"}, {"key": "52_CR58", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1165/ajrcmb.21.3.3575", "volume": "21", "author": "I. Caminschi", "year": "1999", "unstructured": "Caminschi I, Venetsanakos E, Leong CC, Garlepp MJ, Robinson BW, Scott B. Cytokine gene therapy of mesothelioma. Immune and antitumor effects of transfected interleukin-12. Am J Respir Cell Mol Biol 1999;21:347\u2013356.", "journal-title": "Am J Respir Cell Mol Biol"}, {"key": "52_CR59", "doi-asserted-by": "publisher", "first-page": "345", "DOI": "10.1038/sj.gt.3300386", "volume": "4", "author": "K.V. Lukacs", "year": "1997", "unstructured": "Lukacs KV, Nakakes A, Atkins, CJ, Lowrie DB, Colston MJ. In vivo gene therapy of malignant tumors with heat shock protein-65 gene. Gene Ther 1997;4:345\u2013350.", "journal-title": "Gene Ther"}, {"key": "52_CR60", "first-page": "2955", "volume": "60", "author": "M. Lanuti", "year": "2000", "unstructured": "Lanuti M, Rudginsky S, Force S, et al. Cationic lipid:bacterial DNA complexes elicit anti-tumor effects and adaptive immunity in murine intraperitoneal tumor models. Cancer Res 2000;60:2955\u20132963.", "journal-title": "Cancer Res"}, {"key": "52_CR61", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1006/mthe.2001.0463", "volume": "4", "author": "S. Rudginsky", "year": "2001", "unstructured": "Rudginsky S, Siders W, Ingram L, Marshall J, Scheule R, Kaplan J. Antitumor activity of cationic lipid complexed with immunostimulatory DNA. Mol Ther J Am Soc Gene Ther 2001;4:347\u2013355.", "journal-title": "Mol Ther J Am Soc Gene Ther"}, {"key": "52_CR62", "doi-asserted-by": "publisher", "first-page": "253", "DOI": "10.1159/000226571", "volume": "45", "author": "R. Rosso", "year": "1988", "unstructured": "Rosso R, Rimoldi R, Salvati F, et al. Intrapleural natural beta interferon in the treatment of malignant pleural effusions. Oncology 1988;45:253\u2013256.", "journal-title": "Oncology"}, {"key": "52_CR63", "first-page": "6201", "volume": "61", "author": "M. Odaka", "year": "2001", "unstructured": "Odaka M, Sterman DH, Wiewrodt, et al. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-\u03b2 gene therapy is attributable to induction of systemic immunity. Cancer Res 2001;61:6201\u20136212.", "journal-title": "Cancer Res"}, {"key": "52_CR64", "doi-asserted-by": "publisher", "first-page": "210", "DOI": "10.1006/mthe.2002.0656", "volume": "6", "author": "M. Odaka", "year": "2002", "unstructured": "Odaka M, Wiewrodt R, DeLong PA, et al. Analysis of the immunological response generated by Ad.IFN-\u03b3 during successful peritoneal tumor gene therapy. Mol Ther 2002;6:210\u2013218.", "journal-title": "Mol Ther"}, {"key": "52_CR65", "doi-asserted-by": "publisher", "first-page": "3087", "DOI": "10.1038/sj.onc.1201870", "volume": "16", "author": "S.P. Frizelle", "year": "1998", "unstructured": "Frizelle SP, Grim J, Zhou JX, et al. Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression, and tumor regression. Oncogene 1998;16:3087\u20133095.", "journal-title": "Oncogene"}, {"key": "52_CR66", "doi-asserted-by": "publisher", "first-page": "1421", "DOI": "10.1038/sj.cgt.7700241", "volume": "7", "author": "S.P. Frizelle", "year": "2000", "unstructured": "Frizelle SP, Rubins JB, Zhou JX, Curiel DT, Kratzke RA. Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus. Cancer Gene Ther 2000;7:1421\u20131425.", "journal-title": "Cancer Gene Ther"}, {"key": "52_CR67", "doi-asserted-by": "publisher", "first-page": "636", "DOI": "10.1093/jnci/92.8.636", "volume": "92", "author": "C. Yang", "year": "2000", "unstructured": "Yang C, You L, Yeh C, et al. Cell cycle arrest and induction of apoptotic death in mesothelioma cells by the adenovirus-mediated p14ARF expression. J Natl Cancer Inst 2000;92:636\u2013641.", "journal-title": "J Natl Cancer Inst"}, {"key": "52_CR68", "first-page": "591", "volume": "5", "author": "M. Giuliano", "year": "2000", "unstructured": "Giuliano M, Catalano A, Strizzi L, Vianale G, Capogrossi M, Procopio A. Adenovirus-mediated wild-type p53 overexpression reverts tumourigenicity of human mesothelioma cells. Int J Mol Med 2000;5:591\u2013596.", "journal-title": "Int J Mol Med"}, {"key": "52_CR69", "doi-asserted-by": "publisher", "first-page": "61", "DOI": "10.1067/mtc.2001.111419", "volume": "121", "author": "A. Pataer", "year": "2001", "unstructured": "Pataer A, Smythe WR, Yu R, et al. Adenovirus-mediated Bak gene transfer induces apoptosis in mesothelioma cell lines. J Thorac Cardiovasc Surg 2001;121:61\u201367.", "journal-title": "J Thorac Cardiovasc Surg"}, {"key": "52_CR70", "first-page": "687", "volume": "9", "author": "C. Xia", "year": "2002", "unstructured": "Xia C, Xyu Z, Yuan X, et al. Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides. Mol Cancer Ther 2002;9:687\u2013694.", "journal-title": "Mol Cancer Ther"}, {"key": "52_CR71", "first-page": "1524", "volume": "142", "author": "C. Cicala", "year": "1993", "unstructured": "Cicala C, Pompetti F, Carbone M. SV40 induces mesothelioma in hamsters. Am J Pathol 1993;142:1524\u20131533.", "journal-title": "Am J Pathol"}, {"key": "52_CR72", "doi-asserted-by": "publisher", "first-page": "908", "DOI": "10.1038/nm0897-908", "volume": "3", "author": "M. Carbone", "year": "1997", "unstructured": "Carbone M, Rizzo P, Grimley PM, et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med 1997;3:908\u2013912.", "journal-title": "Nat Med"}, {"key": "52_CR73", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1006/scbi.2000.0348", "volume": "11", "author": "D.S. Schrump", "year": "2001", "unstructured": "Schrump DS, Waheed I. Strategies to circumvent SV40 oncoprotein expression in malignant pleural mesothelioma. Semin Cancer Biol 2001;11:73.", "journal-title": "Semin Cancer Biol"}, {"key": "52_CR74", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1006/scbi.2000.0349", "volume": "11", "author": "M.J. Imperiale", "year": "2001", "unstructured": "Imperiale MJ, Pass HI, Sanda MG. Prospects for an SV40 vaccine. Semin Cancer Biol 2001;11:81\u201385.", "journal-title": "Semin Cancer Biol"}, {"key": "52_CR75", "doi-asserted-by": "publisher", "first-page": "723", "DOI": "10.1038/77283", "volume": "18", "author": "R. Alemany", "year": "2000", "unstructured": "Alemany R, Balague C, Curiel DT. Replicative adenoviruses for cancer therapy. Nat Biotechnol 2000;18:723\u2013727.", "journal-title": "Nat Biotechnol"}, {"key": "52_CR76", "doi-asserted-by": "crossref", "first-page": "579", "DOI": "10.1165/ajrcmb.18.4.2943", "volume": "18", "author": "K. Kahlos", "year": "1998", "unstructured": "Kahlos K, Anttila S, Asikainen T, et al. Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma. Am J Respir Cell Mol Biol 1998;18:579\u2013580.", "journal-title": "Am J Respir Cell Mol Biol"}, {"key": "52_CR77", "doi-asserted-by": "publisher", "first-page": "1037", "DOI": "10.1097/00000478-199609000-00001", "volume": "20", "author": "C. Doglioni", "year": "1996", "unstructured": "Doglioni C, Dei Tos AP, Laurino L, et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996;20:1037\u20131046.", "journal-title": "Am J Surg Pathol"}, {"key": "52_CR78", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1016/S0344-0338(96)80208-1", "volume": "192", "author": "V. Gotzos", "year": "1996", "unstructured": "Gotzos V, Vogt P, Celio M. The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type. Pathol Res Pract 1996;192:137\u2013147.", "journal-title": "Pathol Res Pract"}, {"key": "52_CR79", "doi-asserted-by": "publisher", "first-page": "136", "DOI": "10.1073/pnas.93.1.136", "volume": "93", "author": "K. Chang", "year": "1996", "unstructured": "Chang K, Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci USA 1996;93:136\u2013140.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "52_CR80", "first-page": "3438", "volume": "62", "author": "K. Tsukuda", "year": "2002", "unstructured": "Tsukuda K, Wiewrodt R, Molnar-Kimber K, Jovanovic V, Amin K. An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potent antitumoral efficacy but no toxicity to normal cells. Cancer Res 2002;62:3438\u20133447.", "journal-title": "Cancer Res"}, {"key": "52_CR81", "doi-asserted-by": "publisher", "first-page": "917", "DOI": "10.1038/nm0897-917", "volume": "3", "author": "G. Ambrosini", "year": "1997", "unstructured": "Ambrosini G, Adid C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917\u2013921.", "journal-title": "Nat Med"}, {"key": "52_CR82", "first-page": "5959", "volume": "61", "author": "C. Yang", "year": "2001", "unstructured": "Yang C, You L, Yeh C, et al. p14ARF modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53. Cancer Res 2001;61:5959\u20135963.", "journal-title": "Cancer Res"}], "container-title": ["Malignant Mesothelioma"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/0-387-28274-2_52", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 11]], "date-time": "2019-02-11T21:15:59Z", "timestamp": 1549919759000}, "score": 23.869234, "issued": {"date-parts": [[null]]}, "ISBN": ["0387229493"], "references-count": 82, "URL": "http://dx.doi.org/10.1007/0-387-28274-2_52", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T08:51:33Z", "timestamp": 1574239893461}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "Supplement 1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Melanoma Research"], "published-print": {"date-parts": [[1997, 6]]}, "DOI": "10.1097/00008390-199706001-00109", "type": "journal-article", "created": {"date-parts": [[2006, 10, 27]], "date-time": "2006-10-27T09:12:17Z", "timestamp": 1161940337000}, "page": "S32", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Adjuvant therapy of malignant melanoma using rhGM-CSF"], "prefix": "10.1097", "volume": "7", "author": [{"given": "L E", "family": "Spitler", "sequence": "first", "affiliation": []}, {"given": "M L", "family": "Grossbard", "sequence": "additional", "affiliation": []}, {"given": "M S", "family": "Ernstoff", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Silver", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Jacobs", "sequence": "additional", "affiliation": []}, {"given": "F A", "family": "Hayes", "sequence": "additional", "affiliation": []}, {"given": "S J", "family": "Soong", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Melanoma Research"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T08:23:41Z", "timestamp": 1518164621000}, "score": 23.561367, "subtitle": ["109"], "issued": {"date-parts": [[1997, 6]]}, "references-count": 0, "journal-issue": {"issue": "Supplement 1"}, "URL": "http://dx.doi.org/10.1097/00008390-199706001-00109", "ISSN": ["0960-8931"], "issn-type": [{"value": "0960-8931", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:58:29Z", "timestamp": 1574243909850}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Melanoma Research"], "published-print": {"date-parts": [[1993, 9]]}, "DOI": "10.1097/00008390-199309002-00181", "type": "journal-article", "created": {"date-parts": [[2006, 11, 10]], "date-time": "2006-11-10T10:06:45Z", "timestamp": 1163153205000}, "page": "48", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Mutation and expression of the TP53 gene in malignant melanoma"], "prefix": "10.1097", "volume": "3", "author": [{"given": "J.", "family": "Weiss", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Heine", "sequence": "additional", "affiliation": []}, {"given": "K. C.", "family": "Arden", "sequence": "additional", "affiliation": []}, {"given": "E. G.", "family": "Jung", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Melanoma Research"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T09:21:19Z", "timestamp": 1518168079000}, "score": 23.37812, "subtitle": [""], "issued": {"date-parts": [[1993, 9]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1097/00008390-199309002-00181", "ISSN": ["0960-8931"], "issn-type": [{"value": "0960-8931", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T11:36:48Z", "timestamp": 1574249808669}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Melanoma Research"], "published-print": {"date-parts": [[1993, 3]]}, "DOI": "10.1097/00008390-199303000-00178", "type": "journal-article", "created": {"date-parts": [[2006, 12, 13]], "date-time": "2006-12-13T16:31:37Z", "timestamp": 1166027497000}, "page": "51", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Responses in subcutaneous and cutaneous metastases of malignant melanoma during cytostatic + interferon therapy"], "prefix": "10.1097", "volume": "3", "author": [{"given": "M.", "family": "Hahka-Kemppinen", "sequence": "first", "affiliation": []}, {"given": "T.", "family": "Muhonen", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Pyrhonen", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Melanoma Research"], "language": "en", "deposited": {"date-parts": [[2018, 2, 8]], "date-time": "2018-02-08T19:42:28Z", "timestamp": 1518118948000}, "score": 23.305805, "subtitle": ["183"], "issued": {"date-parts": [[1993, 3]]}, "references-count": 0, "journal-issue": {"issue": "1"}, "URL": "http://dx.doi.org/10.1097/00008390-199303000-00178", "ISSN": ["0960-8931"], "issn-type": [{"value": "0960-8931", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T15:00:24Z", "timestamp": 1574175624731}, "publisher-location": "Boston", "reference-count": 54, "publisher": "Kluwer Academic Publishers", "isbn-type": [{"value": "0306461919", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/0-306-46817-4_36", "type": "book-chapter", "created": {"date-parts": [[2005, 12, 30]], "date-time": "2005-12-30T00:49:25Z", "timestamp": 1135903765000}, "page": "411-422", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Suicide Gene Therapy"], "prefix": "10.1007", "author": [{"given": "Scott M.", "family": "Freeman", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "36_CR1", "first-page": "380", "volume": "43", "author": "E.A. Austin", "year": "1992", "unstructured": "Austin, E.A., and Huber, B.E., A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of escherichia coli cytosine deaminase. Mol Pharmacol, 1992. 43: p. 380\u2013387.", "journal-title": "Mol Pharmacol"}, {"key": "36_CR2", "doi-asserted-by": "crossref", "first-page": "4348", "DOI": "10.1073/pnas.91.10.4348", "volume": "91", "author": "D. Barba", "year": "1994", "unstructured": "Barba, D., Hardin, J., Sadelain, M., and Gage, F.H., Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci, 1994. 91: p. 4348\u20134352.", "journal-title": "Proc Natl Acad Sci"}, {"key": "36_CR3", "doi-asserted-by": "crossref", "first-page": "725", "DOI": "10.1089/hum.1993.4.6-725", "volume": "4", "author": "W.L. Bi", "year": "1993", "unstructured": "Bi, W.L., Parysek, L.M., Warnick, R., and Stambrook, P.J., In vitro evidence that metabolic cooperation is reponsible for the Bystander Effect observed with HSV tk retroviral gene therapy. Human Gene Therapy, 1993. 4: p. 725\u2013731.", "journal-title": "Human Gene Therapy"}, {"issue": "4", "key": "36_CR4", "first-page": "246", "volume": "4", "author": "W. Bi", "year": "1997", "unstructured": "Bi, W., Kim, Y.G., Feliciano, E.S., Pavelic, L., Wilson, K.M., Pavelic, Z.P., and Stambrook, P.J., An HSVtk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice. Cancer Gene Therapy, 1997. 4(4): p. 246\u2013252.", "journal-title": "Cancer Gene Therapy"}, {"key": "36_CR5", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.3322/canjclin.42.1.19", "volume": "42", "author": "C.C. Boring", "year": "1992", "unstructured": "Boring, C.C., Squires, T.S., and Tong, T., Cancer statistics 1992. Ca. A Cancer Journal for Clinicians, 1992.42: p", "journal-title": "Ca. A Cancer Journal for Clinicians"}, {"issue": "March", "key": "36_CR6", "doi-asserted-by": "crossref", "first-page": "2577", "DOI": "10.1073/pnas.92.7.2577", "volume": "92", "author": "S.H. Chen", "year": "1995", "unstructured": "Chen, S.H., Li Chen, X.H., Wang, Y., Kosai, K.I., Finegold, M.J., Rich, S.S., and Woo, S.L.C., Combination gene therapy for liver metastasis of colon carcioma in vivo. Proc Natl Acad Sci USA, 1995. 92(March): p. 2577\u20132581.", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "16", "key": "36_CR7", "first-page": "3758", "volume": "56", "author": "S.H. Chen", "year": "1996", "unstructured": "Chen, S.H., Kosai, K., Xu, B., Pham-Nguyen, K., Contant, C., Finegold, M.J., and Woo, S.L., Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Research, 1996. 56(16): p. 3758\u20133762.", "journal-title": "Cancer Research"}, {"key": "36_CR8", "doi-asserted-by": "crossref", "first-page": "763", "DOI": "10.1089/hum.1995.6.6-763", "volume": "6", "author": "B.M. Colombo", "year": "1995", "unstructured": "Colombo, B.M., Benedetti, S., Ottolenghi, S., Mora, M., Pollo, B., Poli, G., and Finocchiaro, G., The \u201cbystander effect\u201d: association of U87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Human Gene Therapy, 1995. 6: p. 763\u2013772.", "journal-title": "Human Gene Therapy"}, {"key": "36_CR9", "first-page": "5302", "volume": "154", "author": "M. Consalvo", "year": "1995", "unstructured": "Consalvo, M., Mullen, C.A., Modesti, A., Piero, M., Allione, A., Cavallo, F., Giovarelli, M., and Forni, G., 5-fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. J Immunol, 1995. 154: p. 5302\u20135312.", "journal-title": "J Immunol"}, {"key": "36_CR10", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1016/0042-6822(81)90132-X", "volume": "113", "author": "R.L. Davidson", "year": "1981", "unstructured": "Davidson, R.L, Kaufman, E.R., Crumpacker, C.S., and Schnipper, L.E., Inhibition of herpes simplex virus transformed and nontransformed cells by acycloguanosine: mechanisms of uptake and toxicity. Virology, 1981. 113: p. 9\u201319.", "journal-title": "Virology"}, {"key": "36_CR11", "doi-asserted-by": "crossref", "first-page": "5716", "DOI": "10.1073/pnas.74.12.5716", "volume": "74", "author": "G.B. Elion", "year": "1977", "unstructured": "Elion, G.B., Furman, P.A., Fyfe, J.A., de Miranda, P., Beauchamp, L., and Schaeffer, H.J., Selectivity of action of an antiherpetic agent. 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci USA, 1977. 74: p. 5716\u20135720.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "36_CR12", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/0065-2571(80)90008-4", "volume": "18", "author": "G.B. Elion", "year": "1980", "unstructured": "Elion, G.B., The chemotherapeutic exploitation of virus-specified enzymes. Adv Enzyme Regul, 1980. 18: p. 53\u201360.", "journal-title": "Adv Enzyme Regul"}, {"key": "36_CR13", "doi-asserted-by": "publisher", "first-page": "1394", "DOI": "10.1056/NEJM198611273152206", "volume": "315", "author": "A.R. Feldman", "year": "1986", "unstructured": "Feldman, A.R., Kessler, L., Myers, M.H., and Naughton, M.D., The prevalence of cancer. Estimates based on the Connecticut Tumor Registry. N Engl J Med, 1986. 315: p. 1394\u20131397.", "journal-title": "N Engl J Med"}, {"key": "36_CR14", "doi-asserted-by": "crossref", "first-page": "4139", "DOI": "10.1073/pnas.80.13.4139", "volume": "80", "author": "A.K. Field", "year": "1983", "unstructured": "Field, A.K., Davies, M.E., DeWitt, C., Perry, H.D., Liou, R., Germershausen, J., Karkas, J.D., Ashton, W.T., Johnston, D.B.R., and Tolman, R.L., Selectivity of action of an antiherpetic agent. 9-[2-hydroxy-1-(hydroxy-methyl) ethoxy] methyl guanine: a selective inhibitor of herpes group virus replication. Proc Natl Acad Sci USA, 1983. 80: p. 4139\u20134143.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "36_CR15", "first-page": "47", "volume": "16F", "author": "S.M. Freeman", "year": "1992", "unstructured": "Freeman, S.M., Whartenby, K.A., Keoplin, D.S., Moolten, F.L., Abboud, C.N., and Abraham, C.N., Tumor regression when a fraction of the tumor mass contains the HSV-TV gene. J Cell Biochem, 1992. 16F: p. 47.", "journal-title": "J Cell Biochem"}, {"key": "36_CR16", "first-page": "342", "volume": "3", "author": "S.M. Freeman", "year": "1992", "unstructured": "Freeman, S.M., McCune, C., Angel, C., Abraham, G.N., and Abboud, C.N., Treatment of ovarian cancer using HSV-TK gene-modified vaccine-regulatory issues. Human Gene Therapy, 1992. 3: p. 342\u2013349.", "journal-title": "Human Gene Therapy"}, {"key": "36_CR17", "first-page": "5274", "volume": "53", "author": "S.M. Freeman", "year": "1993", "unstructured": "Freeman, S.M., Abboud, C.N., Whartenby, K.A., and Abraham, G.N., The bystander effect: Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res, 1993. 53: p. 5274\u20135284.", "journal-title": "Cancer Res"}, {"key": "36_CR18", "first-page": "326", "volume": "4", "author": "S.M. Freeman", "year": "1994", "unstructured": "Freeman, S.M., Ramesh, R., Marrogi, A.J., Jensen, A., and Aboud, C.N., In vivo studies on the mechanism of the \u201cBystander Effect\u201d. Cancer Gene Therapy, 1994. 4: p. 326.", "journal-title": "Cancer Gene Therapy"}, {"issue": "2", "key": "36_CR19", "doi-asserted-by": "publisher", "first-page": "167", "DOI": "10.1016/0304-3835(95)03771-N", "volume": "92", "author": "S.M. Freeman", "year": "1995", "unstructured": "Freeman, S.M.. Ramesh. R., Shastri, M., Munshi, A., Jensen, A.K., and Marrogi, A.J., The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells. Cancer Letters, 1995. 92(2): p. 167\u2013174.", "journal-title": "Cancer Letters"}, {"key": "36_CR20", "doi-asserted-by": "crossref", "first-page": "927", "DOI": "10.1089/hum.1995.6.7-927", "volume": "6", "author": "S.M. Freeman", "year": "1995", "unstructured": "Freeman, S.M., McCune, C., Robinson, W., Abboud, C.N., Angel, C., Abraham, G.N., and Marrogi. A.J., Treatment of ovarian cancer using a gene-modified vaccine. Human Gene Therapy, 1995. 6: p. 927\u2013939.", "journal-title": "Human Gene Therapy"}, {"issue": "1", "key": "36_CR21", "first-page": "31", "volume": "23", "author": "S.M. Freeman", "year": "1996", "unstructured": "Freeman, S.M., Whartenby, K.A., Freeman, J.L, Abboud, C.N., and Marrogi, A.J., In situ use of suicide genes for cancer therapy. Seminars in Oncology, 1996. 23(1): p. 31\u201345.", "journal-title": "Seminars in Oncology"}, {"issue": "9044", "key": "36_CR22", "doi-asserted-by": "publisher", "first-page": "2", "DOI": "10.1016/S0140-6736(97)22001-5", "volume": "349", "author": "S.M. Freeman", "year": "1997", "unstructured": "Freeman, S.M., Ramesh, R., and Marrogi, A.J., Immune system in suicidegene therapy. Lancet, 1997. 349(9044): p. 2\u20133.", "journal-title": "Lancet"}, {"key": "36_CR23", "first-page": "542", "volume": "4", "author": "S.M. Freeman", "year": "1997", "unstructured": "Freeman, S.M., Ramesh, R., Munshi, A., and Marrogi, A.J., Tumor killing using the HSV-TK suicide gene. Cancer Gene Therapy, 1997. 4: p. 542.", "journal-title": "Cancer Gene Therapy"}, {"key": "36_CR24", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/1040-8428(92)90057-W", "volume": "12", "author": "L.J. Goldstein", "year": "1992", "unstructured": "Goldstein, L.J., Pastan, I., and Gottesman, M.M., Multidrug resistance in human cancer. Drit Rev Oncol Hematol, 1992. 12: p. 243\u2013253.", "journal-title": "Drit Rev Oncol Hematol"}, {"key": "36_CR25", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1007/978-1-4615-3872-1_5", "volume": "57", "author": "L.J. Goldstein", "year": "1991", "unstructured": "Goldstein, L.J., Gottesman, M.M., and Pastan, I., Expression of the MDR1 gene in human cancers. Cancer Treat Res, 1991. 57: p. 101\u2013119.", "journal-title": "Cancer Treat Res"}, {"key": "36_CR26", "doi-asserted-by": "crossref", "first-page": "8302", "DOI": "10.1073/pnas.91.17.8302", "volume": "91", "author": "B.E. Huber", "year": "1994", "unstructured": "Huber B.E., Austin, E.A., Richards, C.A., Davis, ST., and Good, S.S., Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA, 1994. 91: p. 8302\u20138306.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "36_CR27", "first-page": "3693", "volume": "151", "author": "C.G. Ioannides", "year": "1993", "unstructured": "Ioannides, C.G., Fisk, B., Jerome, K.R., Irimura, T. Wharton, J.T., and Finn, O.J., Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelia mucin core peptides. Journal of Immunology, 1993. 151: p. 3693\u20133703.", "journal-title": "Journal of Immunology"}, {"key": "36_CR28", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1007/BF02798356", "volume": "16", "author": "T. Katsuragi", "year": "1987", "unstructured": "Katsuragi, T, Sakai, T, and Tonomura, K., Implantable enzyme capsules for cancer chemotherapy from bakers yeast cytosine deaminase immobilized on epoxy-acrylic resin and urethane prepolymer. Appl Biochem Biotechnol, 1987. 16: p. 61\u201369.", "journal-title": "Appl Biochem Biotechnol"}, {"key": "36_CR29", "first-page": "62", "volume": "6", "author": "R. Kolberg", "year": "1994", "unstructured": "Kolberg, R., The bystander effect in gene therapy: Great, but how does it work. J N1H Res, 1994. 6: p. 62\u201364.", "journal-title": "J N1H Res"}, {"issue": "2", "key": "36_CR30", "first-page": "118", "volume": "4", "author": "C.A. Kruse", "year": "1997", "unstructured": "Kruse, C.A., Roper, M.D., Kleinschmidt-DeMasters, B.K., Banuelos, S.J., Smiley, W.R., Robbins, J.M., and Burrows, F.J., Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors. Cancer Gene Therapy, 1997. 4(2): p. 118\u2013128.", "journal-title": "Cancer Gene Therapy"}, {"key": "36_CR31", "first-page": "7", "volume": "2", "author": "M. Kuiper", "year": "1995", "unstructured": "Kuiper, M., Peakman, M., and Farzaneh, F., Ovarian tumour antigens as potential targets for immune gene therapy. Gene Therapy, 1995. 2: p. 7\u201315.", "journal-title": "Gene Therapy"}, {"issue": "6", "key": "36_CR32", "doi-asserted-by": "publisher", "first-page": "1838", "DOI": "10.1016/0270-9139(95)90213-9", "volume": "22", "author": "S. Kuriyama", "year": "1995", "unstructured": "Kuriyama, S., Nakatani, T, Masui, K., Sakamoto, T, Tominaga, K., Yoshikawa, M., Fukui, H., Ikenaka, K., and Tsujii, T, Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma. Hepatology, 1995. 22(6): p. 1838\u20131946.", "journal-title": "Hepatology"}, {"issue": "16", "key": "36_CR33", "doi-asserted-by": "crossref", "first-page": "2025", "DOI": "10.1089/hum.1996.7.16-2025", "volume": "7", "author": "T. Marcel", "year": "1996", "unstructured": "Marcel, T., and Grausz, J.D., The TMC Worldwide Gene Therapy Enrollment Report (June 1996). Human Gene Therapy, 1996. 7(16): p. 2025\u20132046.", "journal-title": "Human Gene Therapy"}, {"key": "36_CR34", "first-page": "279", "volume": "4", "author": "F.L. Moolten", "year": "1994", "unstructured": "Moolten, F.L., Drug sensitivity (\u201csuicide\u201d) genes for selective cancer chemotherapy. Cancer Gene Therapy, 1994. 4: p. 279\u2013287.", "journal-title": "Cancer Gene Therapy"}, {"key": "36_CR35", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1093/jnci/82.4.297", "volume": "82", "author": "F.L. Moolten", "year": "1990", "unstructured": "Moolten, F.L., and Wells, J.M., Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. Journal of the National Cancer Institute, 1990. 82: p. 297\u2013300.", "journal-title": "Journal of the National Cancer Institute"}, {"key": "36_CR36", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1089/hum.1990.1.2-125", "volume": "1", "author": "F.L. Moolten", "year": "1990", "unstructured": "Moolten, F.L., Wells, J.M., Heyman, R.A., and Evans, R.M., Lymphoma regression induced by ganciclovir in mice bearing a herpesthymidine kinase transgene. Human Gene Therapy, 1990. 1: p. 125\u2013134.", "journal-title": "Human Gene Therapy"}, {"key": "36_CR37", "first-page": "5276", "volume": "46", "author": "F.L. Moolten", "year": "1986", "unstructured": "Moolten, F.L., Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res, 1986. 46: p. 5276\u20135281.", "journal-title": "Cancer Res"}, {"key": "36_CR38", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1099/0022-1317-45-1-227", "volume": "45", "author": "Y. Nishiyama", "year": "1979", "unstructured": "Nishiyama, Y., and Rapp, F., Anticellular effects of 9-(2-hydroxy-ethoxymethyl) guanine against herpes simplex virus-transformed cells. J Gen Virol, 1979. 45: p. 227\u2013230.", "journal-title": "J Gen Virol"}, {"key": "36_CR39", "first-page": "1753", "volume": "45", "author": "T. Nishiyama", "year": "1985", "unstructured": "Nishiyama, T., Kawamura, Y., Kawamoto, K., Matsumura, H., Yamamoto, N., Ito, T., Ohyama, A., Katsuragi, T, and Sakai, T., Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules. Cancer Research, 1985. 45: p. 1753\u20131761.", "journal-title": "Cancer Research"}, {"key": "36_CR40", "doi-asserted-by": "publisher", "first-page": "84", "DOI": "10.1016/0042-6822(85)90203-X", "volume": "145", "author": "S. Oliver", "year": "1985", "unstructured": "Oliver, S., Bubley, G., and C., C., Inhibition of HSV-transformed murine cells by nucleoside analogs, 2\u2032-NDG and 2\u2032-nor-cGMP: mechanisms of inhibition and reversal by exogenous nucleosides. Virology, 1985. 145: p. 84\u201393.", "journal-title": "Virology"}, {"key": "36_CR41", "doi-asserted-by": "crossref", "first-page": "256", "DOI": "10.3171/jns.1994.81.2.0256", "volume": "81", "author": "Z. Ram", "year": "1994", "unstructured": "Ram, Z., Walbridge, S., Shawker, T, Culver, K.W., Blaese, R.M., and Oldfield, E.H., The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J Neurosurg, 1994. 81: p. 256\u2013260.", "journal-title": "J Neurosurg"}, {"issue": "7", "key": "36_CR42", "first-page": "829", "volume": "24", "author": "R. Ramesh", "year": "1996", "unstructured": "Ramesh, R, Marrogi, A.J., Munshi, A., Abboud, C.N., and Freeman, S.M., In vivo analysis of the \u201cbystander effect\u201d: a cytokine cascade. Experimental Hematology, 1996. 24(7): p. 829\u2013838.", "journal-title": "Experimental Hematology"}, {"issue": "6", "key": "36_CR43", "first-page": "373", "volume": "3", "author": "R. Ramesh", "year": "1996", "unstructured": "Ramesh, R., Munshi, A., Abboud, C.N., Marrogi, A.J., and Freeman, S.M., Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene. Cancer Gene Therapy, 1996. 3(6): p. 373\u2013384.", "journal-title": "Cancer Gene Therapy"}, {"key": "36_CR44", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1093/jnci/89.1.21", "volume": "89", "author": "J.A. Roth", "year": "1997", "unstructured": "Roth, J.A., and Cristiano, R.J., Gene therapy for cancer: What have we done and where are we going? J Natl Cancer Inst, 1997. 89: p. 21\u201329.", "journal-title": "J Natl Cancer Inst"}, {"key": "36_CR45", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1016/0168-1656(85)90052-5", "volume": "2", "author": "T. Sakai", "year": "1985", "unstructured": "Sakai, T., Katsuragi, T., Tonomura, K., Nishiyama, T, and Kawamura, Y, Implantable encapsulated cytosine deaminase havine 5-fluorocytosine deaminating activity. Journal of Biotechnology, 1985. 2: p. 13\u201321.", "journal-title": "Journal of Biotechnology"}, {"key": "36_CR46", "unstructured": "Santodonato, L., Ferrantini, M., Gabriele, L., Proietti, E., Venditti, M., Musiani, A., Modesti, A., Modica, A., Lupton, S.K., and Belardelli, F., Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both intereron-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir. Hum Gen Ther, 1996. 7: p. 1\u201310.", "DOI": "10.1089/hum.1996.7.1-1", "doi-asserted-by": "crossref"}, {"key": "36_CR47", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1093/jnci/86.2.82", "volume": "86", "author": "L. Seachrist", "year": "1994", "unstructured": "Seachrist, L., Successful gene therapy has researchers looking for the bystander effect. J Natl Cancer Inst, 1994. 86: p. 82\u201383.", "journal-title": "J Natl Cancer Inst"}, {"key": "36_CR48", "doi-asserted-by": "crossref", "first-page": "368", "DOI": "10.7326/0003-4819-103-3-368", "volume": "103", "author": "D.H. Shepp", "year": "1985", "unstructured": "Shepp, D.H., Dandiliker, P., DeMiranda, P., Burnette, T.C., Cederberg, D.M., Kirk, L.E., and Meyers, J.D., Activity of 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine in the treatment of cytomegalovirus pneumonia. Ann Intern Med, 1985. 103: p. 368\u2013373.", "journal-title": "Ann Intern Med"}, {"key": "36_CR49", "doi-asserted-by": "crossref", "first-page": "470", "DOI": "10.1126/science.3764421", "volume": "234", "author": "K.J. Tracey", "year": "1986", "unstructured": "Tracey, K.J., Beutler, B., Lowry, S.F., and et al., Shock and tissue injury induced by recombinant human cachectin. Science, 1986. 234: p. 470\u2013474.", "journal-title": "Science"}, {"issue": "4", "key": "36_CR50", "doi-asserted-by": "publisher", "first-page": "698", "DOI": "10.3171/jns.1995.83.4.0698", "volume": "83", "author": "F.D. Vrionis", "year": "1995", "unstructured": "Vrionis, F.D., Wu, J.K., Qi, P., Cano, W., and Cherington, V, A more potent bystander cytocidal effect elicited by tumor cells expressing the herpes simples virus-thymidine kinase gene than by fibroblast virus-producer cells in vitro. Journal of Neurosurgery, 1995. 83(4): p. 698\u2013704.", "journal-title": "Journal of Neurosurgery"}, {"issue": "23", "key": "36_CR51", "first-page": "6228", "volume": "54", "author": "R.G. Vile", "year": "1994", "unstructured": "Vile, R.G., Nelson, J.A., Castleden, S., Chong, H., and Hart, I.R., Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Research, 1994. 54(23): p. 6228\u20136234.", "journal-title": "Cancer Research"}, {"key": "36_CR52", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1002/(SICI)1097-0215(19970410)71:2<267::AID-IJC23>3.0.CO;2-D", "volume": "71", "author": "R.G. Vile", "year": "1997", "unstructured": "Vile, R.G., Castleden, S., Marshall, J., Camplejohn, R., Upton, C., and Chong, H., Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a monocuclear cell infiltrate and a th1-like profile of intratumoural cytokine expression. Intl J Cancer, 1997. 71: p. 267\u2013274.", "journal-title": "Intl J Cancer"}, {"issue": "2", "key": "36_CR53", "doi-asserted-by": "crossref", "first-page": "717", "DOI": "10.1042/bst0250717", "volume": "25", "author": "R.G. Vile", "year": "1997", "unstructured": "Vile, R.G., Diaz R.M., Castleden, S., and Chong, H., Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells. Biochemical Society Transactions, 1997. 25(2): p. 717\u2013722.", "journal-title": "Biochemical Society Transactions"}, {"issue": "6", "key": "36_CR54", "doi-asserted-by": "crossref", "first-page": "1094", "DOI": "10.1227/00006123-199412000-00012", "volume": "35", "author": "J.K. Wu", "year": "1994", "unstructured": "Wu, J.K., Cano, W.G., Meylaerts, S.A., Qi, P., Vrionis, F., and Cherington, V, Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery, 1994. 35(6): p. 1094\u20131102; discussion 1103-1103.", "journal-title": "Neurosurgery"}], "container-title": ["Advances in Experimental Medicine and Biology", "Cancer Gene Therapy"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/0-306-46817-4_36", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 12]], "date-time": "2019-04-12T20:24:28Z", "timestamp": 1555100668000}, "score": 23.251001, "issued": {"date-parts": [[null]]}, "ISBN": ["0306461919"], "references-count": 54, "URL": "http://dx.doi.org/10.1007/0-306-46817-4_36", "relation": {"cites": []}}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}